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8 Chapter 1 | Introduction
G protein-coupled receptors
Eukaryotes — including animals, plants, fungi, and protozoa — rely on specialised receptor 
molecules to receive and to process information both from their environment and their 
internal milieu. In terms of their modes of action and molecular structures, receptors 
represent a diverse group of cellular components. Probably the largest structural class 
in the animal kingdom is comprised of the G protein coupled receptors, or GPCRs. These 
proteins, embedded in cellular membranes, including those inside the cell, are activated by 
a large variety of molecules and other signals such as hormones, pheromones, amino-acids, 
peptides, proteins, lipids, odorants, drugs, sugars, nucleotides and photons. Activation of 
GPCRs triggers diverse signal transduction pathways that lead in turn, to cellular responses 
such as changes in enzyme activity, hormone or neurotransmitter secretion, cell migration 
or changes in membrane potential of nerve cells to elicit a sense of taste or smell.
With an estimated size of about 800 different members, the GPCR gene family is one of 
the largest in the human genome [1]. The GPCRs can be divided into 6 classes based on 
structure and sequence similarity [2, 3] as shown in Table 1. 
Table 1, GPCR classes
Class Type Features
Class A Rhodopsin-like Comprises ca. 80% of human GPCRs including Rhodopsin (light), 
olfactory and taste receptors
Class B Secretin receptor family Large N-terminal extracellular domain 
[4], ligands are typically peptides or hormones
Class C Metabotropic glutamate/
pheromone
Receptor homo- or heterodimers, Venus Flytrap (VFT) domain, and 
cysteine-rich hinge. Includes sweet and umami receptors [5] 
Class D Fungal mating 
pheromone receptors
Two subfamilies of yeast GPCRs; STE2 and STE3 involved in sensing 
mating pheromones of opposite yeast mating haploid types [6]
Class E Cyclic AMP receptors GPCR type specifically expressed on Dictyostelium discoideum cell 
surface [7]
Class F Frizzled/Smoothened Frizzled GPCR mediates Wnt binding [8] and the smoothened GPCR 
mediates hedgehog signalling [9]
Even though this family of proteins is large and diverse, its basic structure has been well 
preserved over the course of evolution [10]. The receptor proteins are embedded in the cell 
membrane. Like stitches, the amino-acid string swings up and down seven times through the 
lipid bilayer. For the majority of GPCRs, the N-terminus (or start) of the protein is oriented 
to the outside or luminal side of the cell membrane and the C-terminus tail is oriented to 
the inside or cytoplasmic side. There are three extracellular loops and three intracellular 
loops, each with unique properties and functions [11] (see Figure 1). Meanwhile, the 
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complete 3D structure of some GPCRs have been elucidated providing insight into the 
molecular mechanisms of ligand binding. This information can be used for computational 
and structure-based discovery of new ligands [12].
Ligand-gated ion channels
Besides GPCRs, there are also ion channels which can be activated by the binding of specific 
ligands. Binding of a ligand to these ion channels changes the ion channel conformation 
allowing the passage of ions into the cell which has a direct effect on the cells polarization 
[13-15]. In Chapter 3, we used an example of this receptor type as a model, the transient 
receptor potential channel vanilloid 1 (TRPV1) ion channel. TRPV1 is the receptor for 
capsaicin, a pungent compound found in chili peppers. The receptor is however, a 
promiscuous cation channel, with a high preference for calcium, that can be activated by 
low pH as well as by physical factors such as heat (>42 °C) and membrane depolarization. 
More background information is provided in Chapter 3.
GPCRs involved in taste perception
Taste receptors, located in ‘onion’ shaped taste buds within the tongue tissue, are specialized 
receptors for delivering the sensation of taste. Less known but equally important, the same 
receptors are also expressed in many non-buccal tissues, and are likely to be involved in a 
variety of physiological functions not related to taste [16].
Molecules from food or other substances which enter through the mouth and can dissolve 
in the saliva are screened by the taste receptors and their responses are subsequently 
analyzed and interpreted by the brain. There are 5 distinct taste sensations which can be 
discriminated by the tongue; sweet, salty, bitter, sour and umami, the latter also known as 
protein or delicious taste [17]. There is one more controversial taste sensation, the taste of 
fat or fatty acids [18, 19], but evidence is not conclusive. 
Salty and sour tastes are sensed by sodium ion channels and proton ion channels 
respectively [20-22]. The sweet and umami tastes are recognized by the class C receptors 
that form dimers of two GPCRs [23]. The heterodimer of TAS1R2 and TAS1R3 mediates the 
sweet sense from sugars as well as non-caloric sweeteners [23-25]. While some studies [26] 
suggest that T1R3 alone may form a homodimer which senses sweeteners, the evidence is 
scarce and seems limited to specialized cells. 
The heterodimer of TAS1R1 and TAS1R3 mediates the umami taste [23]. The umami 
receptor is activated by L-Glutamate as well as some other amino acids and can be 
enhanced by allosteric modulators like inosine-5’-monophosphate (IMP) or guanosine-5’-
monophosphate (GMP) [27, 28]. This synergistic effect of IMP and GMP to mono sodium 
glutamate (MSG) is known to enhance the umami receptor activation by binding to a 
secondary binding site in TAS1R1 and stabilizing the receptor-ligand interaction. Similar 
allosteric modes of action have been suggested for the sweet receptor [29, 30] and may 
also apply to other type C GPCRs. Next to the TAS1R1/TAS1R3 umami receptor there are 
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other class C receptors involved in L-Glutamate sensing; the mGluR1 and mGLuR4 receptors 
(so-called metabotropic glutamine receptors) can sense glutamate, but these are not linked 
to taste physiology. Glutamate also functions as a neurotransmitter, which is reflected by 
the predominant distribution of mGluRs in both brain and neurological tissues [31]. 
Bitter taste is recognized by the TAS2R receptor family of which 25 GPCRs have been 
putatively identified in humans [32]. The ability to taste bitter substances is considered as 
an evolutionarily-developed mechanism that allows mammals to recognize toxins in plants. 
Since these toxins are structurally very diverse, a wide range of bitter receptors have 
evolved to cover different classes of compounds. These bitter taste receptors have evolved 
into either broadly-tuned ones or more-specialized ones. Three TAS2R members (TAS2R10, 
-R14 and –R46) have a broad spectrum of agonists while TAS2R members R3, R5, R8, R13, 
R49, R50 and R9 are activated by only a few agonists known so far. While most bitter 
receptors have been de-orphanised, meaning that at least one agonist has been found, 
there are still a few orphan bitter receptors with unknown ligands, in particular TAS2R19, 
-R42, -R45, and –R60. Bitter taste receptors are activated by compounds in concentrations 
ranging from nanomolar to millimolar [33]. The sensitivity of the bitter taste receptors is 
generally in accordance with the toxicity of their ligands; the more toxic compounds are 
therefore sensed at lower concentrations [34]. 
Apart from taste receptor cells in the tongue, researchers have found taste GPCRs in many 
other tissues. These include, but are not limited to the respiratory epithelia, gastrointestinal 
tissue, reproductive organs and the brain [16, 35-37]. The function of sweet taste receptors 
in the gut probably involves the control of blood sugar levels in a glucose-dependent 
manner. Activation of gut sweet receptors triggers the release of the Glucagon-like peptide 
1 (GLP-1) hormone which, in turn, stimulates the release of insulin from the pancreas. 
Insulin then decreases blood sugar levels [38]. Bitter receptor expression in the nasal cavity 
is involved in detecting irritants and bacterial infections in order to evoke an inflammatory 
response from the upper respiratory innate immune system [39]. The observation that taste 
receptors not only function in taste cells, but also as sensors linked to various functions of 
the human physiology makes them interesting targets to study [40]. 
GPCR signal transduction
The G protein coupled receptor signaling, or signal transduction, starts with the interaction 
of an agonist with the extracellular domains of the receptor. The ligand fits between the 
extracellular loops like a key in a lock and stabilizes the receptor into an active conformation 
(step one in Figure 1) [41]. Some receptors are specifically tuned and only certain types of 
molecules fit the uniquely shaped binding pocket. In contrast, some GPCRs are less specific 
and can interact with many different molecules. Just like turning a key that sets the internal 
mechanism of the lock in motion, the interaction with the ligand causes conformational 
changes of the receptor protein. The extracellular loops change position to fit the newly 
bound molecule. The motion is carried through the transmembrane domains and, in turn, 
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affects the intracellular loops to change their conformation. These conformational changes 
lead to a more stable or “closed” receptor conformation which is called the activated state. 
This new conformation of the intracellular loops allows a G protein complex to interact with 
the intracellular part of the GPCR. 
Inside the cell, G protein complexes are either docked at the intracellular side of the receptor 
or reside attached to the cell membrane in close proximity of the GPCR. A G protein complex 
is composed of three regions; alpha, beta and gamma. The Gα is the leading part because 
this protein interacts most with the intracellular side of the receptor and initiates the next 
step in the signal transduction. 
Figure 1, Canonical GPCR signal transduction for Gαq and Gαs. Step 1 shows ligand binding and 
receptor activation. In the Gα-protein, GDP is exchanged to GTP. Step 2 shows G protein dissociation 
and interaction of the Gα subunit with an effector component of its signal transduction pathway. 
In this example the Gα
q
 protein interacts with PLC which converts PIP
2
 into IP
3
, and the Gαs protein 
interacts with AC which converts ATP into cAMP, see paragraph Gα pathways. Step 3 shows the 
hydrolysis of GTP back to GDP on the Gα protein and GRK interaction with the receptor. Step 4 
shows the phosphorylated receptor and the reformation of the G protein complex. Step 5 shows the 
recruitment of the receptor by β-arrestin leading to internalization of the receptor. Step 6 shows the 
receptor after recycling back to the plasma membrane. 
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The Gα protein carries a guanosine diphosphate (GDP) molecule. When the Gα protein 
interacts with the receptor, the Gα protein reshapes to take up one inorganic phosphate 
allowing the conversion of GDP into guanosine triphosphate (GTP). Now the whole G 
protein complex is affected because as a consequence of the GDP to GTP exchange, the G 
protein complex undocks from the receptor and splits into two; the Gα and the Gβγ part. 
Both parts are now free to play their roles in the further transduction of the intracellular 
signal (step two in Figure 1). The fate of the signal depends on the G protein type as shown 
in Table 3; the G proteins can take different routes to influence cellular processes. Once the 
Gα is released from the receptor, signaling can be prolonged by binding of a new G protein 
complex or receptor de-activation is initiated. 
The Gβγ proteins are able to recruit G protein-coupled receptor kinases (GRK’s) to the 
receptor [42]. Without a G protein complex, the ligand-bound receptor is exposed for 
phosphorylation. The GRK’s phosphorylate the receptor at Serine (S) or Threonine (T) 
amino acids in the third intracellular loop or the C-terminal tail (steps three and four in 
Figure 1). The Gα protein-GTP is hydrolyzed back to GDP with the aid of so-called regulator 
proteins (RGS or regulators of G protein signaling). After this conversion, the βγ-parts can 
bind again. This regenerated inactive G protein complex then resides on the membrane 
ready for a new interaction (step three and four in Figure 1).
Phosphorylation of the receptor stimulates β-arrestin to interact with the receptor. Beta-
arrestin signals the recruitment of clathrin and AP-2 which then internalizes the receptor. 
What happens then depends on receptor type. For example, class A receptors lose β-arrestin, 
are dephosphorylated and recycled back to the membrane, whereas class B receptors keep 
β-arrestin and are labeled (ubiquitylated) for degradation by the lysosome. Receptors that 
are recycled back to the plasma membrane are in open conformation, meaning that they 
are without a ligand and thus are ready to be re-activated and start the signal transduction 
again. [41, 43-45]
Orthosteric and allosteric regulation of GPCRs
The activation of the GPCR sets a whole chain of events in motion which ultimately leads 
to a cellular response. The target molecule, or agonist, that interacts with the receptor 
stabilizes the active conformation of the GPCR. However, with such a large diversity of 
molecules available, receptors have evolved to fit various molecules. For example, the class 
C GPCRs are known for their large extracellular domain, called the Venus Flytrap domain 
(VFT). This additional domain serves as an antenna, or trap, for many different molecules. 
The human sweet receptor which is a heterodimer of two class C GPCRs (hTAS1R2 and R3), 
has extracellular sites tuned for a wide range of molecules, including monosaccharides, 
disaccharides, polysaccharides, artificial and natural sweeteners and even sweet proteins 
[25, 46]. These agonists all bind on different sites, either on the VFT, the hinge between 
the receptor and the VFT, or on the extracellular loops of the receptor. Every site on the 
receptor that is able to bind an agonist and stabilizes the GPCR into an active conformation 
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is called an orthosteric site. Orthosteric sites, therefore, have direct effect on the structure 
and activation of the GPCR. Besides agonists, other molecules may interact with the 
orthosteric sites. Some molecules partially stabilize the GPCR structure and are, therefore, 
called partial agonists resulting in a partial or lowered activation compared to the full 
agonists. Molecules that bind to the orthosteric sites, but have no stabilizing effect on the 
GPCR structure are called antagonists. They are like keys that cannot turn in the lock and 
therefore do not set the GPCR chain of events into action. 
Besides orthosteric sites, the GPCR may also have allosteric sites. These are distinct from 
the orthosteric sites, but have an effect on receptor stabilization. The target molecules for 
the allosteric sites are called allosteric modulators. When an allosteric modulator binds 
to the allosteric site, it changes the affinity and activity of the orthosteric site. There are 
positive allosteric modulators (PAM’s) which aid an agonist to stabilize the GPCR active 
conformation of the receptor, and there are negative allosteric modulators (NAM’s) which 
obstruct the stabilization of the GPCR by for example locking the 7TM domains in an 
inactive conformation.
G protein signalling pathways
Depending on the type and functionality of the receptors, their signaling is steered by the G 
proteins that are co-expressed in a specific tissue type. In G protein signaling there are two 
independent pathways; the Gα and the Gβγ pathway. Both the Gα and the Gβγ pathways 
will now be discussed with a focus on olfaction and taste receptors.
Table 2, ligand types and effect on GPCR
Ligand type Binding site Signaling effect Example
Full agonist orthosteric Maximal activation of GPCR Substance P is a agonist to the 
Neurokinin receptor [47]
Partial agonist orthosteric Partial activation and partial 
inactivation
Cannabidiol is a partial agonist to the 
dopamine receptor [48]
Inverse agonist orthosteric Opposite effect of agonist Cannabidiol is a partial agonist to the 
GPR12 receptor [49]
Competitive 
antagonist
orthosteric Competition between 
agonist and antagonist for 
the same site
CP-96,345 is a non-peptide antagonist 
to NK1 [50]
Irreversible 
antagonist
orthosteric Termination of signaling Phenoxybenzamine is an irreversible 
antagonist to α-adrenoreceptor [51]
PAM allosteric IMP or GMP and the hTAS1R1 [27, 28]
NAM allosteric Lactisole and the hTAS1R3 [27]
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Gα pathways
There are many different Gα proteins known in humans. These Gα proteins may be co-
expressed in the same tissue or cells and may even couple to the same receptor. This 
variability of the G protein coupling is called biased agonism (where the agonist-induced 
conformational changes set a preference for a Gα-type)[52, 53]. For example, the Gα
Gustducin
 
is expressed in gustatory tissue in combination with taste receptors [54]. But taste receptors 
are able to couple other Gα-proteins as well, like Gα
i/o
 [55] and Gα
12
 [56]. Different agonists 
can, therefore, bind to the same taste receptor but induce different cellular effects.
Table 3, Human G protein families
Galpha 
family members
Signal 
transduction
Second 
messengers Example type of receptors Refs
Gs Gαs, GαOLF Activation of 
adenylate cyclase
cAMP up Olfactory receptors [57]
Gi Gαi, Gαo, 
Gα
z
Inhibition of 
adenylate cyclase
cAMP down Chemokine receptors, 
Adrenoreceptors, Serotonin 
5-HT
1
 receptors, Histamine 
H
3
 and H4, Dopamine D2-like 
receptors
[58-63]
Gα
Transducin
, 
Gα
Gustducin
Activation of 
phosphodiesterase 
cAMP/cGMP 
down
 
Taste receptors and rhodopsins [54, 64-66]
Gq Gα
q
, Gα
11
, 
Gα
14
, 
Gα
15
, Gα
16
Activation of 
phospholipase C, 
IP
3
 pathway
IP
3
 and 
calcium up
NK1, Beta-adrenoreceptors; 
Serotonin 5-HT4, 5-HT6 and 
5-HT
7
; Dopamine D
1
-like 
receptors, Histamine H
2
[67, 68]
G12/13 Gα
12
, Gα
13
Activation of the 
Rho family of 
GTPases
NK1 and various proteins 
responsible for cytoskeleton 
regulation
[67, 69]
Gbeta and gamma family
Gβ
3
/ Gγ
13
Activation of 
phospholipase C, 
IP
3
 pathway
calcium up Taste receptors [66]
Gα proteins can be divided into four classes as shown in Table 3. Each type of Gα leads to a 
different signaling pathway and these will be discussed separately.
The Gαs-type proteins activate the cAMP pathway, named after the second messenger 
cyclic adenosine mono-phosphate, and target the membrane-bound adenyl cyclase (AC). 
The AC catalyzes the conversion of ATP to cAMP. When cAMP increases inside the cell it 
can exert its effect via protein kinase A (PKA) or it can bind to cyclic-nucleotide-gated (CNG) 
ion channels in the cell membrane. When these ion channels are activated they transport 
Na+ or Ca2+ ions across the plasma membrane. The influx of these ions depolarize the cell 
and activate Ca2+ and Cl- gated ion channels. A sequence of polarization and de-polarization 
events is initiated, allowing a signal to travel via neurons and synapses to the brain. These 
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action potentials are found for example in olfactory sensory neurons. When an odorant 
binds to an olfactory receptor (OR), the Gα
OLF
 pathway is activated leading to an increase in 
cAMP production [57, 70]. 
In contrast, Gα
i/o 
proteins inhibit AC activity and thereby decrease levels of cAMP. The 
activity of PKA is decreased causing opposite effects compared to Gαs type signalling. 
This group of Gα proteins also includes Gα
Transducin
 and Gα
Gustducin
. Both G proteins are very 
similar in structure and function [65] with transducin being involved in photo transduction 
and eyesight and gustducin in taste perception. Activation of Gα
Transducin/Gustducin
 leads to the 
phosphodiesterase-mediated decrease in cAMP (see Figure 2).
The Gα
q
, Gα
11
 but also Gα
15/16 
proteins that activate the inositol triphosphate or IP
3
 pathway 
target membrane bound phospholipase C (PLC). The PLC hydrolyses phosphatidylinositol 
4,5-bisphosphate (PIP
2
) to IP
3
 and diacylglycerol (DAG). DAG targets protein kinase C (PKC) 
which plays a role in phosphorylation of other effectors leading to a cellular response [71]. 
IP
3
 can activate the IP
3
 receptors/ion channels on the endoplasmic reticulum (ER) within the 
cell which then opens to release calcium ions into the cytoplasm. 
Chimeric Gα pathway
In specialized tissues like the sensory epithelium of the nose and tongue, where olfactory 
and taste receptors are expressed, highly-specific Gα type subunits bind to these receptors. 
The downstream signaling pathways of Gα
Gustducin
 and Gα
OLF 
involve many tissue-specific 
genes that are not readily expressed in the cell lines commonly used in high throughput 
screening assays [72, 73]. In order to steer the signalling pathway of these receptor types 
towards a more suitable route for GPCR screening cell lines, Gα chimera’s have been 
developed. Examples are Gα
15
 (human) and Gα
16 
(rodent), which can promiscuously bind 
to many receptors [74] and have been used as templates for these chimera’s. A C-terminal 
chimeric Gα protein of Gα
16
 with 44 residues of gustducin (Gα
16GUST44
) is able to functionally 
bind with heterologous expressed bitter receptors [75], see Figure 2B. Likewise, a chimera 
of Gα
15
 with 47 residues of Gα
OLF
 (Gα
15OLF47
, [76]) has been developed for the coupling to 
odorant receptors and steer the pathway towards calcium. 
Gβγ pathway
Besides the Gα signal transduction pathways, the Gβγ proteins also play a part in the cellular 
response. Gβγ may affect ion channels, PLC and other signaling effectors. In bitter taste 
receptors the Gβ
3
 and Gγ
13
 proteins activate Phospholipase C Beta 2 (PLCβ2) to activate the 
IP
3
 signaling route and increase intracellular calcium.
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Reverse transfection
Receptor research in general and receptor-ligand pairing research in particular require an 
effective and efficient screening approach. Reverse transfection is one such approach with 
huge potential. Almost two decades ago, Ziauddin and Sabatini published a breakthrough 
technology which had the potential to greatly improve our efficiency in receptor analysis 
research; a simple method to make a living cell array on a carrier surface [78]. Later, this 
method was adapted to create various modified versions of reverse transfected cell arrays 
[79], including the printing of RNAi [80], cDNA, viral vectors and even compound libraries. 
All sorts of reverse transfected cell arrays have since been designed over the years, printed 
on for example, the surface of a glass microscope slide or inside a well of a 96 wells plate 
Figure 2, A Signalling pathway in bitter taste cells. Gα
Gustducin
 activates phosphodiesterase (PDE) 
which converts cAMP into AMP. The cyclic nucleotide inhibited ion channels (CNG) which are 
blocked by cAMP can open and allow passage of calcium ion into the cells. At the same time, the 
Gβγ
Gustducin
 proteins activate phospholipase beta 2 to initiate the IP
3
 pathway increasing calcium from 
intracellular calcium stores. The increase of intracellular calcium from both Gα and Gβγ pathways 
stimulate TRPM5 ion channels to depolarize the cell initiating an action potential.[66] [77] B, Signaling 
pathway in screening assay cells. Using chimera G protein Gα
16GUST44
 the bitter taste receptor can 
directly couple to the IP
3
 pathway resulting in a calcium increase in HEK293 cells [75]
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[81]. Methods have been developed to prepare highly densely populated transfected cell 
microarrays [80, 82] by creating hydrophobic barriers between the printed DNA spots. These 
barriers prevent cross-contamination of arrayed spots and the migration of cells. Some 
groups have even prepared an integrated microfluidic cell-culture platform that allows 
for on-chip transfections in small reaction chambers [83, 84]. The level of complication 
and sophistication that has been reached over the years is extensive and has resulted in 
specialized niches. One of these niches includes the expression of GPCRs in a cell array 
format which was previously done by printing DNA arrays inside multi-well plates [81] or in 
fabricated micro reaction wells [85]. The combination of a GPCR cell array in a microfluidic 
flowcell is, however, a new field of application which will be explored in this thesis. 
GPCR screening assays
GPCRs are important pharmacological targets (30-40% of medicines target a GPCR, [86-
88]) and are therefore commonly used in high throughput screening assays to develop new 
drugs. These assays test compound libraries, either natural or synthetic, in an automated 
manner [89]. Strategies to detect GPCR activation involve live cell assays expressing 
target GPCRs and monitoring of the GPCR activation chain of events. Events like changes 
in second messenger (calcium, cAMP or IP
3
) levels can be monitored [90, 91], using for 
example, beta-arrestin [92] or expressed reporter genes (CRE – luciferase, [93]). High 
throughput platforms are now available for almost every signalling pathway [94]. These 
micro-well plate based high-throughput screening platforms of compound libraries are well 
established. Furthermore, microarray and microfluidic technologies may hold potential for 
miniaturization, automation, and biosensor integration [94-96] (Figure 3).
Receptomics
The term receptomics was first coined in 2004 to describe the systematic study of the 
receptorome, i.e. the collection of receptors and ligand-gated ion channels that serve as 
sensors and potential drug targets[101, 102]. Covering an estimated 8% of the total human 
genome [101] this protein class is significantly represented. Receptor cell microarrays, 
especially in combination with microfluidics, are considered as a very promising road 
towards reducing the cost and increasing the throughput of screening receptor libraries 
[94]. Only few studies have combined GPCR microarrays with microfluidics so far. In some of 
those studies, each spot of the cell array was enclosed by a chamber that allowed individual 
fluidic control [84, 103, 104]. These micro-chambers mimic a multi-well plate where each 
well or chamber is individually addressable for measurements by different compounds/
samples. However, a set-up applying controlled fluidics to individual chambers is relatively 
complex and inefficient for a generic “receptomics-type” screening of GPCR libraries which 
aims to screen the entire library with the same compound or extract rather than a single 
receptor with a library of compounds [100, 105, 106]. 
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Figure 3, Receptor cell assay platforms (diagram adapted from Martins et al 2012). A, The multi-
well plate format; cells are seeded on the surface of a multi well plate and (top-down) transfected 
with receptor coding plasmid DNA. Calcium dye loading, subsequent washing steps and test sample 
dosing are done using fluid dispensers. The test conditions are multiplexed by using multiple wells 
and multiple plates making this platform compatible with automation but at relatively high costs 
and low assay flexibility [90]. B, Receptor cell arrays are created within one well chamber by printing 
cells [97] or by printing receptor coding plasmid DNA into a micro well and by reverse transfection 
with cells [81, 85]. Arrays are co-transfected with fluorescent indicator proteins to locate the array. 
Array washing and sample dosing are done using fluid dispensers. This combines the HTS nature of 
multi-well plates with the possibility to screen multiple receptors and controls in a single well. C, In 
microfluidic platforms the cells are cultured or assembled into a microfluidic system [98, 99]. A system 
can be designed so that different channels address different chambers with (reverse transfected) 
cells analogous to A but with the option of repeated exposures [84] or a reverse transfected array 
can be enclosed in one large flowcell, sequentially addressing all spots at once with different samples 
analogous to B but with the option of repeated challenges and larger arrays [100].
Fluid 
dispenser
Fluid 
dispenser
Adherent cells
Substrate 
Cover layer / flowcell with gasket
Fluid
Multiwell plate
Adherent cell 
layer
Adherent cells
Substrate / well plate
(A) Well plate HTS
(B) Cell microarrays
(C) Cell microfluidics
Live cell assay platform Multiplexing
Single flowcell cell array: Receptomics 
Multiple chambers
Cell array in a well or on a slide
Multiple well plates
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Large potential
The function(s) and ligand-specificity of many GPCRs are still unknown. These receptors 
are therefore called “orphan” receptors [1, 107]. Additionally, the large number of single 
nucleotide polymorphisms (SNP’s) and splicing variants of the receptor or ion-channel 
genes further increases their diversity for potential ligands, as well as the potential to 
couple to different G protein complexes [108-110]. As a consequence, the number of 
potential receptor conformations is remarkably high. Receptomics projects may promote 
the systematic screening of large compound libraries. Such treasure-hunt like projects have 
therefore the potential to deliver many new compound leads. 
Aims and layout of the thesis
The receptomics platform described in this thesis has led to a novel enabling technology. 
The technology was developed to enable applications for sensing taste-relevant molecules 
and bioactivity of molecules in extracts by monitoring the activation of GPCRs. The 
combination of existing technologies, such as reverse transfection to create living cell 
arrays, calcium imaging, microfluidics to allow controlled and repeated sample exposure, 
and the development of specific software for the statistical analysis, could enable new 
types of GPCR studies that provides data in a novel format and allows novel applications. 
In this thesis the aim is to present the technical as well as biological development of a 
fully functional receptomics platform. We have studied exposure-controlled receptor 
responses in stable cell lines and in reverse transfected cell arrays; we have determined 
key parameters in gene dosing that control the sensitivity and robustness of the receptor 
responses; we have developed specialized software and statistical approaches for the 
analysis of injection series and we have laid out a methodology for the analysis of complex 
mixtures. This thesis also further discusses the potential directions of future developments, 
focussing in particular on the potential benefits of a microfluidic receptomics assay.
The chapters in this thesis cover different steps in the development of the receptomics 
technology. 
In Chapter 2 we describe the general principles, setup and characterization of the 
microfluidic biosensor to measure GPCR activation via imaging of [Ca2+] changes in 
recombinant human HEK293 cells. These cells expressed a combination of the Neurokinin 
1-receptor and Cameleon YC3.6 protein as calcium indicator.
In Chapter 3 we show how the biosensor, coding for the transient receptor potential channel 
vanilloid 1 (TRPV1) ion channel and the Cameleon YC3.6 calcium sensor, can be used to 
determine bioactivity in chilli pepper varieties by measuring LC-MS-purified fractions in 
sequential injections as well as measuring bioactivity in the crude extract. 
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In Chapter 4 we provide an extensive characterization of the preparation and measurement 
of reverse transfected cell arrays using fluorescent proteins. The response of the Neurokinin 
1-receptor in relation to its gene dose in reverse transfection is studied as well as the 
response behaviour during repeated activations. 
In Chapter 5 we switch to the bitter taste receptor family and aim to enhance the sensitivity 
and robustness of the receptor assay by changing the calcium sensor type and adjusting the 
sensor gene dose. 
In Chapter 6 we present a linear mixed model for a spot-based analysis and comparison of 
receptor responses. A host cell response, induced by ATP, is used to show that specific bitter 
receptor responses from compound spikes are additive to the host cell response and can be 
retrieved from a host cell response signal by means of comparative analysis. 
The general discussion places the receptomics technology in the context of existing receptor 
screening technologies and discusses the current limitations and potential benefits. The 
microfluidic nature of the platform is discussed in relation to potential novel applications 
and the promise of new technological developments to overcome certain limitations is 
outlined. 
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Abstract
Cell lines expressing recombinant G-protein coupled receptors (GPCRs) are activated by 
specific ligands resulting in transient [Ca2+] rises that return to basal levels in 30-60 seconds. 
Yellow Cameleon 3.6 (YC3.6) is a genetically encoded calcium indicator which can be co-
expressed to monitor these cytosolic [Ca2+] changes in real-time using Förster (Fluorescence) 
resonance energy transfer (FRET). On this basis, we designed the prototype of a generic 
microfluidic biosensor of GPCR activation, imaging [Ca2+] changes in recombinant human 
HEK293 cells, which express a combination of a GPCR (Neurokinin 1) and YC3.6. An internal 
reference for non-specifically induced [Ca2+] changes were YC3.6 cells without GPCR but 
expressing a red fluorescent protein (mCherry) for identification. These cell lines were 
grown as a mixed population in a flow cell with a volume of ~50 µl and a flow cell surface of 
170 mm2. Cells were activated by brief exposures to specific and non-specific analytes using 
an injection valve with a flexible sample volume (tested range 5 to 100 µl) at a flow speed 
of 100 µl/min. A flow cell surface of 0.2 mm2 with 50 cells was imaged every 2-4 seconds to 
obtain signal kinetics. The lower limit of detection was 30 pM Substance P (SP, 2 pg/50 µl), 
and reproducible responses to repeated injections every 3 minutes were obtained at 1 nM 
SP. This biosensor was designed for ~50 cells for statistical reasons, but at a lower limit of 1 
receptor- and 1 reference-cell, specific ligand detection is still feasible.
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Introduction
G protein-coupled receptors (GPCRs) in humans represent a family of around 800 genes 
which play key roles in many physiological or disease-related processes and also determine 
our sense of smell and taste. For this reason these receptors are favorite targets for both 
the pharmaceutical and food industries [111-115]. Microtiter plate based high-throughput 
screening platforms are well established, but microfluidic technologies hold potential for 
miniaturization and automation that are predicted to redefine the format and application 
areas of GPCR screening assays [116-120]. 
The most common methods of measuring GPCR activation in vivo in real time are by 
recording concentration dynamics in generic secondary messengers such as [Ca2+], cAMP 
and IP
3
 using various indicator dyes [121, 122]. The concentration of cytosolic [Ca2+] is very 
low (nM range) when cells are not triggered. External signals can cause the rapid release of 
micromolar concentrations of calcium into the cytosol from organelles like the endoplasmic 
reticulum (ER), mitochondria and nuclei or from extracellular sources [123]. Once released 
into the cytosol, the [Ca2+] rise is transient and levels fall back to basal levels within less than 
one minute after the ligand is washed away due to uptake by the ER and mitochondria. In cell 
populations concentrations of cytosolic [Ca2+] are directly related to the concentrations of 
the activating ligand, except for a subclass of GPCR receptors, which couple to Gα proteins 
(e.g. G
i/o
, Gs, G12/13) that, depending on the cell line, actually inhibit this response or bypass 
it. In those cases, overexpression of specific promiscuous Gα proteins or cAMP-gated ion 
channels can steer the response towards the desired [Ca2+] assay [124]. The duration of the 
[Ca2+] transient depends a.o. on receptor sensitivity and ligand concentration and duration.
The increase of [Ca2+] concentration in the cytosol resulting from GPCR signaling can be 
measured by small molecule organic indicators like fura-red, indo-1 and many others [122], 
but genetically encoded calcium indicators (GECIs), such as cameleon and GECO can also 
be used [125-129]. The choice of the calcium indicator type largely depends on the spatial 
and temporal resolution that is required to monitor calcium signaling processes. Current 
advantages of small molecule indicators are their expanded dynamic range for measuring 
[Ca2+] concentrations and faster response kinetics. The use of GECIs, however, offers 
advantages in other areas. Here, we used a GECI, because it can be fused to any receptor 
protein of interest allowing the measurement of [Ca2+] in micro-domains in its immediate 
vicinity. Furthermore, co-expression of GECI with receptor genes allows that only transfected 
cells are monitored. In case of stably transfected lines, the GECIs are immediately available 
for measurements and do not leak out over time, which is an important advantage when 
they are used in diagnostics and microfluidic biosensors. Cameleon YC3.6 is a GECI with 
a suitable dynamic range for measuring calcium dynamics from GPCR activation, while 
displaying acceptable response kinetics [130, 131]. Calcium signaling from YC3.6 is based 
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on fluorescence energy transfer (FRET) that can occur when the two fluorescent proteins 
of the yellow cameleon molecule; CFP and YFP are in close vicinity. These fluorescent 
proteins are linked together by a calmodulin domain and M13 peptide. The M13 peptide 
binds calcium-bound calmodulin, and thereby changes the conformation of the sensory 
part upon calcium binding.
Co-expression of GECI and GPCR proteins can be achieved from a polyprotein by employing 
a 2A polypeptide sequence between the two proteins [132]. This has the advantage that 
the GECI expression level is correlated with the GPCR density on the membrane. The 2A 
peptide of 20 amino acids is cloned to link the coding sequences of the two recombinant 
proteins. During translation of the 2A part of the polyprotein the ribosomal machinery 
fails to create a peptide bond between two specific amino acids of the 2A peptide, but 
continues translation of the remaining mRNA molecule. This results in the expression of 
both proteins at equimolar levels [133, 134].
Despite their predicted importance only very few studies have shown successful methods 
of studying [Ca2+] changes in microfluidic formats [135] and with recombinant expressed 
GPCRs [129, 136]. These reports have neither explored the limits of detection, nor the 
dynamics of the cell response under different conditions. Also at a practical level, the 
robustness of the set-ups for automated, repeated dosage of analytes was not explored 
[116]. In this study we developed a biosensor of GPCR activation, based on the co-expression 
of a GPCR and a GECI in human HEK293 cells. A new commercially available microfluidic 
set up is described, which allows sequential injections of small and defined volumes of 
ligands at short time intervals, while maintaining a constant flow of medium across the 
cells contained in a resealable flow cell. As model GPCR, we used the Neurokinin 1 receptor 
(NK1) for this study. Upon interaction with its substrate Substance P (SP), the NK1 receptor 
activates the Gα subunit and effects downstream signalling by IP
3
, resulting in an increase 
of intracellular calcium ions by release from the ER [47, 67, 137]. Calcium responses are 
monitored in real-time using a confocal fluorescent microscope setup. Reference cells 
monitoring endogenous activation of the cell line at the experimental conditions, thus allow 
determination of the specificity of activation in relation to the GPCR response. Addition of a 
known concentration of a fluorescent marker to the flow cell microfluidics provides a semi-
quantitative real-time correlation of extracellular ligand concentrations to intracellular 
[Ca2+] concentration changes.
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Material and Methods
DNA constructs
The NK1 receptor gene was purchased at the UMR cDNA Resource Center of the 
University of Missouri-Rolla, USA (cat. Nr. TACR100000). The YC3.6 gene in pCDNA3 
(Invitrogen) was obtained from Roger Tsien (USA). The NK1 gene was cloned into 
pSNAPf (New England Biolabs) without stop codon using the EcoRV and EcoRI 
sites of MCS1. Oligo’s of T2A (GAATTCGAGGGCAGAGGAAGTCTTCTAACATGC 
GGTGACGTGGAGGAGAATCCCGGCCCTGGATCC=EGRGSLLTCGDVEENPGP) and T2A-
NC (GAATTCGAGGGCAGAGGAAGTCTTCTAACATGCGGTGACGTGGAGGAGAAT 
GCCGCACCTGGATCC=EGRGSLLTCGDVEENAAP) were hybridized and cloned into pSNAPf 
using EcoRI and BamHI replacing the SNAPf gene. The YC3.6 gene is cloned without start 
codon, but with stop codon into MCS2 using BamHI and XhoI. Control construct mCherry-
T2A-YC3.6 was cloned by PCR (FW 5’ATATGGCGCGCC ATGGTGAGCAAGGGCGAGGA and RV 5’ 
ATATGAATTCCTTGTA CAGCTCGTCCATGC) from plasmid pENTRmCherry (Life Technologies 
Europe BV, Bleiswijk, NL), using AscI and EcoRI restriction sites. Plasmids containing single 
CFP and YFP; pcDNA3-CFP (Addgene plasmid 13030) and pcDNA3-YFP (Addgene plasmid 
13033) were obtained from Addgene Inc. 
Cell culture and transfection
HEK293 cells (Invitrogen, 11631-017) were grown as a monolayer in cell culture medium 
(Dulbecco’s Modified Eagle Medium (DMEM) containing 1x MEM non-essential Amino 
Acids, 1x Penicillin-Streptomycin (Invitrogen, 15140-122) and 10% Fetal bovine serum FBS 
(Invitrogen, 26140)). Cells were transfected with expression vectors pNK1-T2A-YC3.6, pNK1-
T2ANC-YC3.6 and mCherry-T2A-YC3.6 using Effectene transfection reagent (Qiagen 301425). 
Selection with Geneticin at 600µg/ml (Invitrogen) was started 24 hour after transfection 
and maintained for several weeks until stable expressing cell cultures were obtained. From 
a stable expressing cell culture a clonal line with intermediate YC3.6 expression, visually 
identified based on mean fluorescence intensity, was selected.
Western blotting
Cells were harvested at about 80% confluency, and resuspended in 1/5 volume RIPA buffer 
(Sigma-Aldrich, R0278) containing complete protease inhibitor cocktail (Roche 11 697 498 
001). Samples were denatured in reducing SDS-PAGE sample buffer, separated on 12.5% 
SDS PAGE gel and transferred to nitrocellulose membrane by Western blotting. The GFP 
protein and spectral variants CFP and YFP were detected with mouse anti-GFP (Roche 11 
814 460 001) 1:5000 diluted in blocking buffer and sheep anti-mouse HRP (Jackson Immuno 
515-035-062) 1:5000 diluted in blocking buffer. 
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Flow cell assembly and microfluidics
All imaging was performed in resealable borosilicate glass flow cells (Micronit Microfluidics 
B.V., Enschede, The Netherlands). Temperatures were maintained at 22°C (RT) unless 
otherwise noted. Recombinant HEK293 cells were seeded on a disposable 15 x 45 mm2 
borosilicate cover-slide of standard (1.5 #) 175 µm thickness, coated with 100 µg/ml poly-L-
Lysine (Sigma P6282) at a density of ~3x105 cells/ml. The slides were incubated overnight in 
a sterile petridish in a CO
2
 incubator at 37oC. Next, a re-usable borosilicate glass slide of 15 x 
45 mm2 and 1.1 mm thickness with a central 0.3 mm high gasket of 5 x 43 mm (defining a flow 
cell inner surface area of ~170 mm2) was placed over the cover-slide with cells to create the 
flow cell with cells inside (Fig. 1, Micronit Microfluidics BV, Enschede, The Netherlands). Two 
Figure 1, Diagram of the microfluidic biosensor setup. The microfluidic flow cell of 50 µl is assembled 
in the blue Fluidic Connect Pro flow cell holder by mounting the indicated parts. Closing the holder 
connects the capillaries for dosing media and samples. Two syringe pumps maintain a constant flow 
of cell media by alternated uptake and dosing into the flow cell through ports 5 and 6 of the injection 
valve. Ports 2 and 3 are used to fill and empty/wash an injection loop using the third syringe. Switching 
the injection valve from LOAD to INJECT assures that samples of various volumes depending on the 
loop size are injected into the flow cell and vice versa that the loop can be reloaded. Fluorescence 
changes in the cell monolayer are imaged from below.
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fluidic ports in the slide, 40 mm apart, served for microfluidic connections. The assembled 
flow cell was placed on a metal supporting plate of 15 x 45 mm2 with opening of 5 x 11 mm2 
at the bottom to prevent deformation of the thin lower cover slide. The slides were sealed 
together in a Fluidic Connect Pro flow cell holder (Micronit Microfluidics B.V., Enschede, the 
Netherlands), which allowed immediate fluidic connection of the flow cell to a set of syringe 
pumps (Nemesis, Cetoni GmbH) that controlled a constant flow of cell culture medium (100 
µl/min; port 5 and 6 in Fig. 1). Injection of samples loaded in a sample loop was performed 
using an injection valve (Upchurch, V-451); 5-100 µl loop volume between port 1 and 4 for 
injection and port 2 and 3 for loading and rinsing of the sample loop.
FRET imaging using confocal laser scanning microscopy
Imaging of cameleon YC3.6 was performed with a Zeiss LSM 510-META 18 confocal laser 
scanning microscope on an Axiovert 200M equipped with a 20x 0.5 NA Plan-Neofluar 
DIC objective using the 458 nm line from a 30 mW Ar laser. With a series of detectors in 
the META channel a stack of 10.7 nm spectrally resolved images were recorded, called 
Lambda Stacks (465-610 nm). This allowed pixel-by-pixel collection and separation of the 
simultaneously recorded CFP and YFP emissions, based on reference spectra taken at 
identical imaging settings. Imaging was done at the cellular mid-plane with wide pinholes of 
2.91 AU (Airy Unit) corresponding with a 10 µm thick optical slice. The emission fingerprint-
based CFP and YFP intensities of regions of interest were plotted in 2 second interval time 
series and their ratiometric FRET signals analysed. For this, HEK293 cells were transfected 
with reference plasmids pcDNA-CFP or pcDNA-YFP. Both cultures were used to record 
reference lambda stacks required for spectral unmixing at 458 nm excitation. An additional 
reference emission spectrum for fluorescein was recorded at 458 nm with imaging settings 
as used during experiments, to allow spectral unmixing in the presence of this internal 
dilution standard. Fluorescein concentrations were below saturating concentrations in 
all experiments to avoid errors in spectral unmixing. Confocal imaging of TAMRA-labelled 
Substance P (SPTAMRA, Anaspec cat nr. 61202) was done with HeNe laser of 543 nm and 
pinhole at 1 AU to obtain the maximal z-resolution.
Results and discussion
DNA constructs for biosensor cell lines 
To enable a GECI-based system, genetic constructs were developed to co-express a model 
G-protein coupled receptor, Neurokinin 1 (NK1), and the GECI Cameleon YC3.6 from 
a single transcript, but as separate proteins (Fig. 2A). The two genes were separated by 
either the native T2A peptide linker, resulting in two translation products, or the mutated 
non-cleavable version T2ANC, resulting in a single multiprotein [132-134, 138]. The aim of 
using a 2A construct was to obtain correlated expression levels of the receptor unit and the 
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genetically encoded calcium indicator. The aim of using the T2ANC construct was to allow 
the visualization of the receptor on the plasma membrane and creating a single molecule 
capable of both extracellular sensing and monitoring of intracellular [Ca2+] proximal to the 
plasma membrane.
The HEK293 cell line used to express these DNA constructs also carries native receptors 
on its surface which can also generate [Ca2+] changes signals which may interfere with the 
signal from the NK1 receptor. To distinguish specific responses induced by the targeted 
receptor from non-specific cell responses, it is necessary, to measure in parallel reference 
cells, which do not ectopically express any recombinant [Ca2+] changes inducing receptor, 
but do possess the fluorescent calcium reporter YC3.6. To recognize such cells we replaced 
the gene for the receptor with the one encoding red fluorescent protein, mCherry (Fig. 2A). 
Subcellular localization of the membrane receptor and calcium-indicator protein 
For all constructs, stable HEK293 clonal cell lines were made by selecting recombinant 
cell lines with stable integrated plasmid DNA and sub-culturing into a clonal line. The 
T2A and T2ANC peptides determine whether the protein fusions are expressed as one or 
two separate proteins. To verify the presence of the expected translation products and 
the efficiency of the T2A-induced ribosome skipping, protein extracts were analysed by 
Western blot using an antibody against GFP and spectral variants CFP and YFP (Fig. 2B). A 
YC3.6 expressing cell line (without the mCherry protein or receptor) showed a 72 kDa band, 
Figure 2, DNA and protein constructs to generate green GPCR and red reference cells. A, Top bar 
the DNA construct used for the transformation of HEK293 cells with either a GPCR target receptor 
(NK1) as biosensor or a red protein (mCherry) to tag reference cells. Lower three bars represent 
the expressed proteins. B, Western blot identifying YC3.6 containing polypeptides. Protein extracts 
of HEK293 cell lines expressing various constructs were separated by 12.5% SDS-PAGE, blotted to 
nitrocellulose membrane, and detected with anti-GFP antibody. The molecular weight of GFP is 
27kDa, YC3.6 is 72 kDa and NK1 is 45 kDa. Lane 1: pNK1-T2A-YC3.6; Lane 2: pNK1-T2ANC-YC3.6; Lane 
3: YC3.6; Lane 4: GFP.
A B
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which corresponds with the expected size of the cameleon protein. The cell line expressing 
the NK1 receptor and YC3.6 linked by the T2A polyprotein linker showed a single band with 
a size of 72 kDa as well, which indicates that the first protein, the NK1 receptor, is fully 
cleaved from YC3.6 and that T2A-mediated ribosome skipping is very efficient. The cell 
line expressing the NK1 receptor and YC3.6 linked by the non-cleavable T2ANC peptide 
was expected to yield a fusion protein of 117 kDa. Next to two minor bands of 100 kDa 
and 130 kDa most signal, however, is of higher molecular weight. Since cameleon is fused 
to a membrane protein, which is known to resist complete SDS denaturation, it probably 
represents poorly dissolved fusion protein. 
To demonstrate the functional plasma membrane localization of the NK1 receptor, SPTAMRA 
was used [139]. Confocal imaging showed that SPTAMRA is bound to the plasma membrane of 
cells expressing recombinant NK1 receptor from both T2A and T2ANC constructs (Fig. 3A, D). 
SPTAMRA did not bind to the membrane of WT cells, since HEK293 cells do not endogenously 
express the NK1 receptor (results not shown). Differences between the two constructs 
Figure 3, Confocal images of HEK 293 cells expressing cytoplasmic cameleon from NK1-T2A-YC3.6. 
A, B and C, and membrane associated cameleon from NK1-T2ANC-YC3.6. D, E and F, shortly after 
adding 50nM SPTAMRA. Pictures A and D show SPTAMRA localized on the cell membrane by excitation 
at 543 nm. B and E show cameleon YC3.6 localization by direct excitation of YFP at 514 nm. B 
shows cytoplasmic localization of YC3.6 and E shows localization of YC3.6 on the membrane and in 
intracellular compartments like the ER. C and F are overlay images of A + B and D + E respectively. 
SP-induced membrane blebbing is indicated.
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were clearly visible from the localization of the cameleon protein (Fig. 3B, E). The T2A 
construct releases the cameleon protein which accumulates in the cytoplasm. The T2ANC 
construct on the other hand fuses the cameleon protein to the cytoplasmic C-terminus of 
the membrane bound NK1 receptor, and as a result membrane co-localization of YC3.6 and 
SPTAMRA on the membrane is visible in Fig. 3F, but not in 2C. 
Previous studies [67] have shown that binding of SP to NK1 results in activation of the 
downstream signalling pathway leading to a temporal rise in cytoplasmic calcium ion 
concentrations (section 3.5) and, also, irregular bulges of the plasma membrane known as 
membrane blebbing as clearly visible for both constructs in Fig. 3.
Design of a resealable microfluidic flow cell
We aimed to develop a biosensor capable of specifically measuring GPCR-activating analytes 
in a series of samples using fluorescence imaging. For best optical and chemical properties 
and easy handling, a resealable flow cell was designed composed of two borosilicate glass 
slides separated by a gasket of fluorinated elastomer which included a microfluidic inlet 
and outlet (Fig. 1). The slides were sealed together in a Fluidic Connect Pro flow cell holder 
(Micronit), which allowed immediate fluidic connection to a set of 3 syringe pumps that 
provided a constant flow of cell culture medium, and, using an injection valve (5-100 µl 
loop volume), seamless introduction of samples. Cells remained adherent to the poly-lysine 
modified surface at flow speeds below 400 µl/min. The flow cell dimensions were 170 mm2 
x 0.3 mm, but in principal the surface could be 800x smaller as we monitored an area of 
only ~0.2 mm2 containing ~50 cells.
Image acquisition and analysis
After excitation with 458 nm a confocal laser microscope collected image emission spectra 
every 2 seconds for 512 x 512 pixels. This image series was automatically analysed by 
spectral unmixing on a pixel-by-pixel base to provide a value of the change in FRET (YFP/CFP 
ratio) resulting from the cytosolic calcium transients. For image processing we applied a 
custom made plugin named PRI-FRET on ImageJ (v1.46). This plugin can set lower and upper 
threshold values on the YFP and CFP images to remove background noise and saturated 
intensity pixels, and subsequently ratio and average relative intensities of all remaining 
dynamic YFP and CFP pixels over time. All ratio averages were subsequently normalized by 
subtraction of the averages of those ratios obtained before injection.
Without an internal reference to remove non-specific responses this biosensor would be 
a general sensor of [Ca2+] changes inducing analytes, but not of a particular GPCR. As we 
only observe statically within a single flow channel, we introduced a method for automatic 
detection and subtraction of non-specific signals by mixing the GPCR cells 3:1 with red 
coloured reference cells expressing the red fluorescent protein mCherry instead of the 
receptor (Fig. 2A). We made use of the fact that mCherry has an excitation optimum of 543 
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Figure 4, NK1-biosensor evaluation in terms of specificity, sensitivity, dose-response, time-to-
recovery, and re-usability. Cameleon FRET ratioing monitors [Ca2+] changes in the mixed NK1 and 
mCherry reference cells. Response profiles of ca 50 mixed cells were imaged every 2 seconds in one 
field of view (0.2 mm2) while injecting A, 10nM SP and B, 2 µM ionomycin. Red mCherry cell pixels 
were graphically separated from the green NK1 cell pixels. Injection of the NK1-specific ligand SP 
yielded only a [Ca2+] changes in NK1 expressing cell(s), and injection of the non-specific ionophore 
ionomycin yielded [Ca2+] changes in both NK1 and reference cells. The signals for both 50 and single 
cells are given. Dose-response curves based the integrated peak area C and the maximum peak 
height D, are plotted against the ligand concentration. In E the recovery time of the NK1 receptor 
response after a saturating injection of 50nM SP is shown. In F the response of NK1 cells to injections 
repeated every 200 seconds with lower 1nM concentrations of SP is shown. Images were taken every 
4 seconds. All experiments A-F were performed at a flow rate of 100 µl/min and with 50 µl sample.
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nm, which does not excite the YFP or CFP proteins of YC3.6. Processing of images with a mix 
of receptor and reference cells was done by input of a reference cell image. Before or after 
the FRET time series a single mCherry image was made to determine which cameleon pixels 
were derived from reference cells. The software then generated separate normalized ratio 
curves for the receptor and reference cells.
Specificity 
To test the GPCR biosensor specificity Fig. 4A and B show the results after injection of an 
NK1-specific ligand versus a non-specific ionophore for calcium ions across membranes. 
Plotted are the signal averages from single cells and ~50 cells in the same view. The receptor 
specific ligand SP (10 nM) increased FRET signals only in the receptor cells and not in 
mCherry cells (Fig. 4A). Injection of 2 µM ionomycin (Free Acid, S. conglobatus, Calbiochem) 
resulted in responses in both NK1 receptor and mCherry reference cells. Thus this design 
allows that non-specific signals from mCherry cells can be deducted automatically from 
signals obtained from the GPCR cell fraction to ensure that the recorded responses are 
GPCR-specific. 
Sensitivity range 
To determine the lower and upper sensitivity range of the NK1 receptor, response curves 
were made for both the T2A and T2ANC receptor constructs of NK1. Injections of 50 µl SP at 
concentrations ranging from 1 pM to 100 nM at a flow speed of 100 µl/min were performed 
to measure the activation of the NK1 receptor. At concentrations above 1 nM SP a fresh 
slide was used for each measurement to avoid effects of receptor saturation from previous 
runs. Fig. 4C and D show the correlation of peak area and height of transient FRET ratio 
curves with SP concentration. For the NK1-T2A-YC3.6 clone the optimal SP concentration 
range (linear part of the S-curve) based on measured peak heights (Fig. 4D) was 25-2500 
pM, whereas for peak area (Fig. 4C) it ranged from 100-5000 pM. For the NK1-T2A-NC-
YC3.6 clone the optimal SP concentration range based on peak height (Fig. 4D) was 100-
2500 pM and for peak area (Fig. 4C) it ranged from 250-25000 pM. In both dose response 
curves the T2ANC cell line reached higher maximum values. The cell lines were clonal lines, 
which meant that all cells express approximately the same number of receptor molecules 
on the membrane. The response differences may be explained by the possibility that clone 
NK1-T2ANC-YC3.6 has more or stronger expressed copies of the NK1 receptor gene, and, 
therefore, a higher density of receptors available on the surface compared to the NK1-T2A-
YC3.6 clone. Higher densities of receptors lead to stronger activation of the transient [Ca2+] 
changes and higher maximum values in the dose-response curve.
Measurement throughput and regeneration time 
Earlier studies describe that after activation, the NK1 receptor internalizes in endosomes 
followed by receptor dissociation from the ligand and receptor recycling back to the 
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membrane, while the ligand is degraded internally [47]. As a result there is a transient 
drop in the number of available receptor sites. This phenomenon is especially relevant 
for a biosensor application in which cells are repeatedly exposed to potentially high 
concentrations of activating ligands which would saturate and remove available receptor 
sites from the membrane. 
In Fig. 4E we show, that, while maintaining cells at RT and 100 µl/min continuous flow of 
fresh cell culture medium, full recovery of the FRET signal, after exposing the receptor to a 
saturating dose of 50 nM SP, is a gradual process taking around 80 minutes to complete. In 
biosensor measurements knowledge of this recovery curve helps to interpret the reliability 
of subsequent measurements after the response has passed a certain threshold value. 
To demonstrate the throughput of the biosensor to yield accurate responses to repeated 
injections of 1 nM SP, an experiment was done repeating 8 injections every 200 seconds 
using the NK1-T2A-YC3.6 cell line (Fig. 4F). A slight fluctuation in peak height was observed, 
probably due to fact that data points are 4 seconds apart, thus missing the maximum 
peak height between two subsequent scans. A larger time interval between data points 
(4 seconds) was chosen to prevent photo bleaching of the YC3.6 fluorophore during 
continuous measurements for 30 minutes. The limited but apparent signal reduction of 
around 10% across the 8 measurements may reflect a reduction in receptor density due to 
the repeated activations at that concentration and frequency. 
Relationship of injected sample volume to flow cell volume
Our test samples were injected via fused silica capillaries of 0.15 mm inner diameter 
(0.018 mm2) and released into a flow cell of cross section 0.3 mm height x 4 mm width (1.2 
mm2). This 68-fold expansion in cross-section slows the linear flow speed, and increases 
the surface area over which diffusion can occur of sample analyte with media ahead and 
behind it. For the standard flow cell of 50 µl volume we determined the peak shapes of both 
the analyte concentrations and the biosensor responses after injecting 5, 50 and 100 µl of 1 
nM SP at a continuous flow of 100 µl/min. The relative concentrations of analyte contacting 
the cells in the microscope field of view, were determined by mixing SP samples with an 
inert fluorescent dye as internal standard (1 µM fluorescein). By taking injection volumes 2x 
larger and 10x smaller than the flow cell volume, we were able to characterize the changes 
in the shape of the sample concentration profile due to increased diffusion and laminar 
flow effects. Fig. 5 shows the profiles of the sample concentration and FRET ratio response 
after injection of 100 µl SP (Fig. 5A), 50 µl SP (Fig. 5B) or 5 µl SP (Fig. 5C). Table 1 summarizes 
the results of Fig. 5 by giving the deviation from the expected value if there would be no 
diffusion or other dispersive effects. When no dispersive effects would take place, the 
fluorescein signal from the 5µl loop would be expected to have the same peak height as 
the larger injected volumes with the same sample concentration, a duration of 3 seconds 
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(FWHM) and a peak area proportional to the injected quantity. Peak height, however, was 
72% lower than the injected concentration value, and peak width over 4 times broader due 
to diffusion. Peak area was 128% the expected value, possibly due to slower speeds of the 
compound close to the flow cell surface where the cells are and measurements are taken. 
The results show that sample diffusion has pronounced effects on sample concentration 
when the sample volume is much smaller (10x) than the flow cell volume. Also the FRET 
ratio response signals deviated from the expected values. Peak height was 60% lower 
than the expected value in correspondence with the 72% lower sample concentration. 
Peak width, when including the shoulder peak, was shorter than sample exposure time at 
long exposures of 60 seconds (Fig. 5A), the same at sample exposures of 30 seconds (Fig. 
5B), and longer at sample exposures of around 13 seconds (Fig. 5C). This shows how these 
responses follow their own internal dynamics after the initial trigger. This is also visible from 
the two longer exposure times, which show a peak response plus an additional shoulder, 
which is the result of calcium oscillations [121]. The longer the receptor is exposed to the 
ligand, the more and the longer these oscillations occur. These peak shoulders are not very 
informative and the larger volumes passed through the sensor are potentially wasteful. We 
conclude, therefore, that the optimal sample volumes for GPCR-based cellular biosensors 
are equal to the volume of the biosensor flow cell and apply flow rates that allow the entire 
sample to be passed in less than 30 seconds. 
Table 1, Effects of sample volume in relation to flow cell volume (50 µl) on the sample concentration 
(fluorescein) and FRET ratio response characteristicsa
Injected 
volume
Fluorescein 
characteristicsa
Deviation from 
the expected 
value (%)a
FRET response 
characteristicsa
Deviation from 
the expected 
value (%)a
Peak height 100 µl 69 FU 0% 9.9 RU 0%
50 µl 68 FU -2% 9.6 RU -3%
5 µl 19 FU -72% 3.9 RU -60%
FWHMb 100 µl 64 sec +6% 21.5 secc n.d.d
50 µl 32 sec +6% 22.0 sec n.d.
5 µl 13 sec +332% 10.5 sec n.d.
Peak areae 100 µl 4388e +6% 356e n.d.d
50 µl 2280 +10% 236 n.d.
5 µl 282 +36% 47 n.d.
 a Substance P (1nM) mixed with 1 µM fluorescein as internal standard wasinjected into a flow cell of 50 µl in 
volumes of 100, 50 or 5 µl. The effect of substrate dilution is quantified relative to 100 µl injected in the 50 µl 
flow cell.
b Full Width at Half Maximum (FWHM) measured in seconds
c The main calcium response peak, not including the right shoulder.
d The deviation from the expected value for FRET signal areas was not determined since longer exposure times 
influence peak areas in a non-linear manner.
e The peak area (FU or RU x sec) includes the peak shoulder.
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Conclusions
The presented NK1 GPCR biosensor provides proof of principle for GPCR biosensors in 
general as systems with large potential for highly sensitive, flexible and quantitative 
microfluidic sensing devices. Unlocking the potential of utilizing the 800 human members 
of the GPCR gene family (and of genes of other organisms) for a broad array of biosensing 
needs in the medical, pharmaceutical, environmental, food and cosmetic domains promises 
to be an exciting area of research and development. The unique components of this GPCR 
biosensor device provide important potential advantages over other available detection 
systems.
1. Cameleon – Cameleon YC3.6 is a genetically encoded calcium indicator which allows 
immediate measurement of cytoplasmic calcium ions concentrations, independent 
of indicator concentration, due to ratiometric imaging. Other systems require loading 
of small molecule indicators, that might get sequestered or leak out over time 
compromising measurement accuracy. The use of this GECI, furthermore reduces 
costs of chemicals and time, and improves reproducibility of measurements.
2. T2A for correlated concentrations of receptor and calcium indicator – The use of T2A 
or T2ANC allows a direct assessment of the receptor concentration and localization 
in any evaluated cell. Low expression of cameleon will be directly correlated to low 
expression of the receptor. This aids in the selection of the desired expression levels 
in clonal cell lines and provides an internal check that the receptor is expressed. 
3. High content imaging – The flow cell is embedded in a chip holder, which provides a 
microscope viewing window, that currently allows the use of microscope objectives 
for detailed imaging with 20x objectives. Other designs of the current commercially 
available chipholder could allow spatial access of objectives with shorter working 
Figure 5, Activation of the NK1 receptor by different volumes of 1nM SP using a fluorescent marker 
as internal standard of the ligand concentration. Injections were done of 100µl (A), 50µl (B), and 
5 µl (C) of 1nM SP into a 50 µl flow cell at a constant flow rate of 100 µl/min. The YFP/CFP ratio 
is plotted on the left-axis axis and the fluorescein intensity on the right-axis. Fluorescein intensity 
(1µM) is measured in the background. Measurements were taken every 4 seconds.
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distances and higher numerical apertures to obtain images with further increased 
optical resolution and thus provide information about subcellular processes.
4. Sensitivity – The sensitivity of ligand detection will typically depend on the EC
50
 for 
the chosen receptors. In our example with NK1 and SP we could detect ca. 30 pM SP 
in 50 µl of sample corresponding to 2 pg of analyte. However, the system operates 
on sample loop injections that are optimal when they approach the flow cell volume. 
The commercial flow cell we used was ~50 µl with a surface area of 170 mm2. Large 
reductions in flow cell volume are possible in the current design as the volume 
depends on the circumference of the gasket which is 850 times larger now than the 
monitored area of 0.2 mm2. 
5. In- or at-line measurements – The procedure of injecting samples from an injection 
loop into the biosensor device can be easily automated and is potentially suitable 
for in- or at-line measurements. We estimate that a cell based biosensor needs to be 
replaced every 8 hours and is potentially capable of 100 measurements.
6. Data analysis – Images were processed based on an ImageJ plugin which can be 
automated to provide online digital graphic outputs of activities in samples.
7. Low cost detection – The system was operated on an advanced Zeiss confocal 
microscope using spectral unmixing. However, a normal fluorescence microscope 
could be used as well since YFP and CFP measurements are well possible using 
excitation and emission filters and even CFP measurements alone could provide 
a reliable output (although CFP concentration dependent). Furthermore, as signal 
intensity is more important for biosensors than localization confocality is not needed 
to measure signalling events.
The system also carries certain potential disadvantages:
1. Throughput – Even though the frequency of measurements could be raised to a 
sample every 3 minutes, these are sequential, and there are issues of fluorescence 
bleaching and receptor internalization which at high imaging frequencies and high 
doses affect subsequent measurements. A possible solution to this problem would 
be to use the current flow cell principle to design highly parallel flow cells which 
can be addressed sequentially and/or in parallel at optimal frequencies to ensure 
reliability and to improve throughput [140].
2. Handling and assembly must be done by skilled laboratory personnel – like 
maintaining cell cultures and operating a fluidic system and microscope. This is 
also true of microtiter plate based cell assays, but could be simplified if dedicated 
instruments will be developed.
3. Transcriptional fusions based on the T2A-peptide can also be a disadvantage – 
Some receptors do not allow high expression in cell lines. Selecting low expressors 
will then also reduce the signal intensity from cameleon. In some cases these two 
proteins may therefore better be uncoupled. A stable cell line with high expression 
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of cameleon could be used for transfection of receptor proteins using a different 
selectable marker, thus avoiding this potential issue.
4. In a situation that a sample contains mixed compounds which trigger cumulative 
specific and non-specific responses, the net difference between the GPCR and 
reference cell line responses may still contain information of the specific response. 
The visibility of this difference will however depend on the relative induced signal 
strength.
Acknowledgements
We thank Gerrit Polder from WUR-Biometris for designing Image J plugin PRI-FRET, Jan-
Willem Borst from WUR Biochemistry for getting us started on FRET measurements of 
cameleon, Doug Golenbock, principal investigator, who submitted pcDNA3-CFP and 
pcDNA3-YFP to the Addgene plasmid bank, and Harrie Verhoeven and Joachim Goedhart 
for critically reading the manuscript. Financial support was obtained from Nano4Vitality 
program 2008-I, and from NanoNextNL, a micro- and nanotechnology consortium of the 
Government of the Netherlands and 130 partners.
CHAPTER
Metabolomics meets 
functional assays: coupling 
LC-MS and microfluidic 
cell-based receptor-ligand 
analyses
Maurice G.L. Henquet *, Margriet Roelse *, Ric C.H. de Vos, Bert Schipper, Gerrit Polder, 
Norbert C.A. de Ruijter, Robert D. Hall, and Maarten A. Jongsma
*These authors contributed equally to this article 
Henquet et al, Metabolomics 2016, 12:115 
DOI 10.1007/s11306-016-1057-y
Abstract 
Metabolomics has become a valuable tool in many research areas. However, generating 
metabolomics-based biochemical profiles without any related bioactivity is only of 
indirect value in understanding a biological process. Therefore, metabolomics research 
could greatly benefit from tools that directly determine the bioactivity of the detected 
compounds. We aimed to combine LC-MS metabolomics with a cell based receptor assay. 
This combination could increase the understanding of biological processes and may provide 
novel opportunities for functional metabolomics. We developed a flow through biosensor 
with human cells expressing both the TRPV1, a calcium ion channel which responds to 
capsaicin, and the fluorescent intracellular calcium ion reporter, YC3.6. We have analysed 
three contrasting Capsicum varieties. Two were selected with contrasting degrees of 
spiciness for characterization by HPLC coupled to high mass resolution MS. Subsequently, 
the biosensor was then used to link individual pepper compounds with TRPV1 activity. 
Among the compounds in the crude pepper fruit extracts, we confirmed capsaicin and also 
identified both nordihydrocapsaicin and dihydrocapsaicin as true agonists of the TRPV1 
receptor. Furthermore, the biosensor was able to detect receptor activity in extracts 
of both Capsicum fruits as well as a commercial product. Sensitivity of the biosensor to 
this commercial product was similar to the sensory threshold of a human sensory panel. 
Our results demonstrate that the TRPV1 biosensor is suitable for detecting bioactive 
metabolites. Novel opportunities may lie in the development of a continuous functional 
assay, where the biosensor is directly coupled to the LC-MS.
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Introduction
Metabolomics has become well-established as a valuable approach to investigate the 
metabolite profiles of living organisms. The technologies used are now firmly embedded 
in medical, microbial and plant research and are providing detailed snapshots of unique 
chemical fingerprints of biological responses. [141, 142]. We are however, still facing two 
significant technical and biological challenges. Firstly, determining the chemical identity 
(annotation) of the myriad of metabolites now detectable, but often never observed 
or studied before [143]. Secondly, determining their potential bioactivity. Generating 
metabolomics-based biochemical profiles without any associated assessment of the 
function of the extract or its biochemical component parts is only of indirect value in 
understanding a biological process [144]. This paper focuses on the latter aspect by coupling 
LC-MS mass identification with a flow through bioactivity screening on living cells. 
Many metabolites interact with organisms at the cellular level through binding with 
membrane-bound receptors such as G-protein coupled receptors (GPCRs) and ligand gated 
ion channels (LGICs) [145, 146]. Some of these receptors already have well-described specific 
ligand interactions. Many others however, are still poorly or even fully uncharacterized. 
In order to characterize individual receptors and find their equivalent ligands, a multi-
well plate, cell-based end point assay is often the approach employed [147-150]. This 
screening process could be improved if the LC-MS analysis could be directly coupled to 
a continuous biological assay. For that, a flow assay format would be required to allow a 
dynamic monitoring of bioactivity in the course of an analysis and the direct association of a 
metabolite to a biological response. Here, we have chosen the transient receptor potential 
channel vanilloid 1 (TRPV1) ion channel as a model sensor. This ion channel has been well-
studied for its role in pain and heat perception. TRPV1 is a promiscuous cation channel, 
with a high preference for calcium, that can be activated by low pH as well as by physical 
factors such as heat (>42°C) and membrane depolarization [151]. However, TRPV1 was first 
identified as a receptor for capsaicin; a pungent compound found in foods containing chili 
peppers.
We used capsaicin as standard to test the general properties of the TRPV1 biosensor which 
uses the intracellular calcium ion sensor, YC3.6, to detect the cytosolic calcium changes 
that are induced by the activation of the TRPV1 ion channel [95, 131]. We tested the TRPV1 
biosensor using fruit pericarp extracts from three contrasting Capsicum varieties. Two 
were selected with contrasting degrees of spiciness for characterization by HPLC coupled 
to high mass resolution MS. LC-MS fractions from one pepper extract were screened in 
a semi-continuous manner, to identify the different bioactive compounds. To confirm 
biological relevance and complete the proof of concept, we have performed an analysis 
of the sensation of pungency of tabasco by comparing results from the TRPV1 biosensor 
with a human taste panel. All findings are discussed in the context of the potential to 
use this microfluidic biosensor as the first significant step towards an online functional 
metabolomics tool. 
44 Chapter 3 | LC-MS and microfluidic cell-based receptor-ligand analyses
Materials and Methods
Plasmid construction
The TRPV1 receptor gene was obtained as a cDNA clone from GeneCopoeia (W1312) and 
cloned into pT2A-YC3.6 without a stop codon using the AscI and EcoRI sites. The expression 
vector containing T2A [132], [133] and YC3.6 in a single reading frame and the control 
construct mCherry-T2A-YC3.6 have been previously described [95]. Plasmids containing 
single CFP (cyan fluorescent protein) and YFP (yellow fluorescent protein), pcDNA3-
CFP (Addgene plasmid 13030) and pcDNA3-YFP (Addgene plasmid 13033) were used for 
recording reference spectra.
Cell culture and transfection
HEK293H cells (ThermoFisher Scientific, 11631-017) were grown as a monolayer in DMEM 
(Dulbecco’s modified eagle medium, Gibco, 21063-029) containing 1x non-essential 
amino acids (Gibco, 11140-035), 1x Penicillin-Streptomycin (Gibco, 15140-122) and 10% 
FBS (Foetal bovine serum, Gibco, 26140). Cells were transfected with expression vectors 
pTRPV1-T2A-YC3.6 or pmCherry-T2A-YC3.6 using Effectene transfection reagent (Qiagen, 
301425). Selection with Geneticin at 600 µg/ml (Gibco, 10131-027) was initiated 24 h after 
transfection and maintained for several weeks until stable insertion lines were obtained. 
From a mixed culture of insertion lines, based on mean fluorescence intensity, a suitable 
clonal line with intermediate YC3.6 expression was selected for all further experimentation.
Pepper and tabasco extracts
Three Capsicum lines from a large pepper genotype collection (nrs 12, 18 and 28, 
representing C. annuum, C. chinense and C. frutescens, respectively) were chosen for their 
reported contrasting levels of capsaicinoids [152]. Approximately 500 mg frozen pepper 
pericarp (fruits excluding seeds stored at -80oC) per variety or 500 mg tabasco suspension 
(a commercial water and vinegar extract of Capsicum frutescens var. tabasco) was diluted 
to 25% (w/v) with 1.5 ml 100% methanol. The samples were sonicated for 15 minutes, 
centrifuged, filtered through a 0.2 µM PTFE membrane into an amber glass vial and stored 
at -20oC prior to analysis. Aqueous-methanol extracts were analysed by HPLC (see 2.5) and 
directly diluted 1:300 or 1:3000 in buffer used in the biosensor assay.
LC-MS-fractionation of pepper extracts
Our standard LC-MS-based metabolomics profiling platform, composed of a HPLC–
PDA–LTQ–Orbitrap FTMS system (Thermo Scientific), was extended with a chip-based 
nano-electrospray ionization source/fractionation robot (NanoMate Triversa, Advion 
BioSciences), mounted between the PDA (photodiode array detector) outlet and the inlet 
of the LTQ-Orbitrap FTMS hybrid system [153]. The sample injection volume was 10 μl. For 
chromatographic separation a Luna C18 analytical column (150 × 2.0 mm, 3 μm particle 
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size; Phenomenex) was used with H
2
O and acetonitrile as carriers, both containing 0.1% v/v 
formic acid, at a flow rate of 190 µl/min and a column temperature of 40°C. A linear gradient 
from 5 to 65% acetonitrile in MQ water was applied over a period of 45 min, followed by 15 
min washing and equilibration before the next injection. Isopropanol (at a flow of 30 µl/min 
using a syringe pump) was added to the LC eluent flow between the PDA and the NanoMate 
via a T-junction, to ensure a stable nanospray into the FTMS. The NanoMate source was 
operated in negative electrospray ionization mode with a HD_A_384 chip at a spray voltage 
of 1.7 kV. The NanoMate was used in the LC coupling mode with fraction collection. The 
total flow into the NanoMate (220 µl/min) was split using different capillary tubes for both 
MS spray (0.480 µl/min) and for 96-wells plate fractionation (219.5 µl/min). LC-fractions 
were collected every 28 s (i.e., 102.6 μl) into a 96 wells plate (Twin tec, Eppendorf) cooled 
to 10°C. After collection, the plate was quickly sealed and stored at -20°C before further 
usage. The fractions were assayed on the TRPV1 biosensor as either pools or as separate 
96-wells fractions. To firstly create the 8 pools of 12 fractions, half of the well volume (51.3 
µl) was used. The pooled and individual fractions were freeze-dried, in order to remove the 
LC solvent, and then dissolved in 10 µl DMSO (Dimethylsulfoxide). Since 10 µl extract was 
injected and only half of each fraction was re-dissolved in 10 µl DMSO the sample was two 
times diluted compared to the original extract. Both pooled (8 pools of 12 fractions) and 
individual fractions were 200x or 1000x diluted in assay buffer, resulting in a 400x or 2000x 
dilution from the original extract, depending on their bioactivity.
Quantification of capsaicinoids in tabasco
Capsaicinoids in the tabasco product and pericarp extracts were quantified essentially 
as described for pepper pericarp [152], by injecting 10 µl of the 75% methanol extract 
into a Waters Alliance 2695 HPLC system equipped with a Luna C18 (4.6 X 150mm; 3µm 
particles) at 40°C and a Waters 2996 PDA detector. A 30 min linear gradient of 50 to 75% 
acetonitrile in MQ water (both acidified with 0.1% formic acid) was applied to separate the 
capsaicinoids. The areas under the chromatographic peaks detected at 280 nm were used 
to calculate the concentrations of the individual and total capsaicinoids, using commercial 
standards (capsaicin and dihydrocapsaicin) from Sigma (St. Louis, USA).
TRPV1-biosensor assay
Assays using the TRPV1 cell lines were performed with a assay buffer of 100 µl/min DMEM 
medium containing 1x non-essential amino acids, 1x Penicillin-Streptomycin and 10% FBS. 
Extract and fraction samples, diluted in assay buffer, were injected with an injection loop 
volume of 50 µl which is equal to the flowcell volume. Data series including the control 
cell line mCherry-T2A-YC3.6 were generated by mixing the two cell types at a 3:1 ratio of 
TRPV1:mCherry expressing cells. Both cell lines accurately reported receptor activations 
that induced subcellular cytoplasmic Ca2+ ion rise and fall. Imaging of Cameleon YC3.6 was 
performed using a Zeiss LSM 510-META 18 confocal laser scanning microscope as previously 
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described in Roelse et al, 2013. Rapid simultaneous acquisition of CFP and YFP emission 
allowed the use of FRET (Förster resonance energy transfer) ratios as a monitor of ligand 
induced calcium dynamics. The ImageJ plugin PriFRET was used for the image analysis and 
pixel-based YFP/CFP ratio calculations according to the following equation:
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Where: f is the YFP/CFP ratio as a function of timestep t; y and c are the pixel 
values of the YFP and CFP images respectively. One of the images YFP or CFP, 
selected by the user, is thresholded, taking only values larger than q into account. 
The threshold value can be set by the user or calculated automatically, where it 
optimizes for a maximum f(t) ratio. The function is normalized by subtracting the 
average YFP/CFP ratio over the first n time steps.  
For the experiments described in this paper the threshold q was set at zero and 
the normalization steps n at 5. For each experiment, the first injection was done 
after a minimum of 5 images. The PriFRET ImageJ plugin is publically available at 
the WageningenUR website; http://www.wageningenur.nl/en/show/prifret.htm 
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Human sensory panel evaluation
A sensory panel experiment using tabasco was performed by the taste research company 
“Centrum voor Smaak onderzoek B.V.” in Wageningen, The Netherlands. A panel of 41 
humans were given a series of 6 samples, representing a dilution series of 5 samples 
from the pure tabasco product and 1 blank control without tabasco. Dilutions of tabasco 
were prepared in bottles of 1.5L commercial mineral water (Spa Blauw). To prevent visual 
colour and density differences between the tabasco dilutions, 7 g of tomato sauce (Grand 
Italia Soffritto traditionale) was added to each 1.5 L mineral water. The panel members 
were given the tabasco dilutions in random order and asked to score the percentage 
perceived pungency. Individual scoring ranges were first normalized so that the highest and 
lowest score of each individual would have the same value. All intermediate scores were 
recalculated proportionally to maintain the relative differences. An ANOVA analysis was 
performed to determine significance of perceived taste differences between subsequent 
tabasco dilutions and results were tested for reliability using the Statistical Package for the 
Social Sciences software (SPSS version 15.0). 
Results and discussion
Metabolomics and functional assays on pepper extracts
We first analysed pericarp extracts of three different Capsicum lines (lines 12, 18 and 28) 
that were chosen for their contrasting capsaicinoid levels. These three pepper lines were 
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analysed for capsaicinoids by targeted HPLC-PDA (Table 1) and their levels corresponded 
well to previously determined levels [152]. 
Functional assays of these pepper extracts were subsequently performed with the TRPV1 
biosensor. Figure 1 shows the TRPV1 and control cell responses to these pepper extracts. 
Line 12 showed no response at a 300x dilution of the extract (Figure 1a), corresponding to 
the HPLC analysis indicating the undetectable levels of both capsaicin and dihydrocapsaicin 
(Table 1). When line 12 extract was spiked with 50 nM capsaicin, a normal TRPV1 cell 
response was observed, showing that the previously observed lack of response is not due 
to a masking effect by this line 12 (Figure 1b). In contrast to line 12, line 18 induced a clear 
response in the TRPV1 cells when exposed to a 300x dilution of the aqueous-methanol 
extract (Figure 1c) representing a final concentration of 24 nM total capsaicinoids in the 
bioassay (Table 1). No response was observed with a 3000x dilution of line 18, representing 
2.4 nM of capsaicinoids (data not shown). The most pungent accession, line 28 (Figure 1d), 
which contained an approximately 110x higher level of capsaicinoids compared to line 18 
(Table 1), gave the highest signal even for the highest dilution tested (3000x). At this dilution, 
representing 274 nM capsaicinoids, a brief, relative minor response in control cells lacking 
the exogenous TRPV1 receptor was observed (Fig 1d). This calcium response in control cells 
indicates the activation of an endogenous receptor to either the relative high capsaicinoids 
concentrations or an unknown component only present in the 3000x diluted Capsicum line 
28 extract. Such responses from control cells were not observed in the 300x diluted extract 
Figure 1, TRPV1 and control cell responses to crude pepper extracts. Cameleon calcium sensor 
YFP/CFP ratio changes in HEK239 cells were measured after injection of pericarp extracts from 
three different pepper lines with or without capsaicin spikes. The flow-cell contained both TRPV1-
expressing cells (black traces) and control cells (grey traces). a Line 12, 300X diluted; b line 12, 600X 
diluted and spiked with 50 nM capsaicin; c line 18, 300X diluted; d line 28, 3000X diluted.
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of line 18, containing 24 nM capsaicinoids. Therefore the control cell response is most likely 
caused by the high capsaicinoid concentration of line 28. 
The specific differential responses of the TRPV1 biosensor to the various Capsicum extracts 
at appropriate dilutions demonstrate that the microfluidic assay can be used on methanol 
plant extracts dissolved in cell culture medium without a need for further sample clean-up 
or compound purification. Furthermore, there appears to be a direct and (semi) quantitative 
relationship between the TRPV1 biosensor response, detected as a change in YFP/CFP 
fluorescence ratio, and the concentration of ligands present in the extracts (in this case 
to capsaicinoids), as analytically quantified by HPLC-PDA. This quantitative relationship is 
shown for pure capsaicin in section 3.3 of the results.
Metabolomics and functional assays on pepper compounds
The pericarp extracts of the two most contrasting pepper lines 12 and 28 were subjected 
to HPLC-PDA coupled to both chip-based nano-ESI with accurate mass Orbitrap FTMS 
and fractionation into 96 wells plates. The overlaid LC-MS chromatograms showed clear 
differences between these two red pepper lines in their metabolite profiles (Figure 2a, 
upper panel). As it was not the aim of the present study to determine all differentially 
accumulating compounds using comprehensive comparative metabolomics approaches, 
only the most obvious peaks were specified (Table 2), using the annotations previously 
reported by [154]. In general, line 28, which showed highest activity in the TRPV1 bioassay, 
contained relatively high levels of capsaicinoids, while the TRPV1-inactive line 12, contained 
relatively high levels of quercetin-type flavonoids. 
To identify which specific compounds in pepper line 28 interact with the TRPV1 ion channel, 
96 LC-fractions each of 28 sec of elution time were collected in a micro-well plate, using a 
TriVersa Nanomate fractionation robot, to be tested for their bioactivity. Initially, 8 pools 
(A-H), each containing 12 consecutive LC-fractions, were semi-continuously tested in the 
TRPV1 biosensor. The results in Figure 2a (lower panel) indicate a significant TRPV1-specific 
response, i.e. a clear signal above the baseline drift of the control cells, for only pools G and 
H. Subsequently, we analysed the individual fractions from these pools G and H, at 400x or 
Table 1, HPLC quantification of capsaicinoids in crude extracts of three varieties of red chili 
peppers and a tabasco extract
Capsaicin (mg/100 g 
FW)
Dihydrocapsaicin 
(mg/100 g FW)
Capsaicinoids in extract 
(µM)a
Line 12 n.d. n.d. n.d.
Line 18 0.9 n.d. 7.2
Line 28 75.3 25.3 821.8
Tabasco 14.4 9.2 192.6
FW fresh weight, n.d. not detectable (<0.1 mg/100 g FW)
a sum of capsaicin and dihydrocapsaicin the crude extract
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Figure 2, TRPV1 and control cell responses to LC–MS fractions of line 28. a, Overlaid LC–MS 
chromatograms (ESI neg mode; base peak intensity) of lines 28 (red) and 12 (blue). Chromatograms 
are at the same Y-scale to enable direct comparison of the metabolite profiles of both pepper lines. 
The highest peaks were labelled (1–20) and annotated (Table 2). The NanoMate fractions obtained 
during LC–MS analysis were subsequently pooled in eight pools of 12 fractions as indicated with A–H. 
Responses (maximum slope from moving average of five measurements) to the pooled fractions are 
displayed below the chromatograms: TRPV1 in black and control in grey bars. b, and c, Details of 
LC–MS chromatogram and TRPV1 responses of line 28 corresponding to the individual fractions of 
bioactive pools G b and H c. All LC fractions were diluted 400X, except fractions G10 and G11 (coded 
with asterisk) which were diluted 2000X, as compared to the original pericarp extract. d, Cameleon 
calcium sensor YFP/CFP ratio curves; from left to right: individual fractions G8, G9, G10 and G11 at 
400X dilution (G8 and G9) and 2000X dilution (G10 and G11)
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2000x dilution of the original pericarp extract. The TRPV1 cells responded to the individual 
fractions G9, G10, G11, H7 and H8 (Figure 2b and c). The control cells showed a relatively 
high calcium response with fraction G9, G10 and G11, this control response is caused by 
the high concentrations of capsaicinoids in these fractions. (Figures 2b and d). In all cases, 
TRPV1 responding LC-fractions contained compounds detectable by their UV absorbance 
at 280 nm, indicating the presence of an aromatic (phenolic) backbone. Analysis of the 
accurate mass data associated with these bioactive LC-MS peaks revealed several known 
pepper capsaicinoids, including nordihydrocapsaicin, capsaicin, dihydrocapsaicin and 
homocapsaicin, as well as less, known capsaicin derivatives (Supplementary Table 1). To 
our knowledge, we have shown that both nordihydrocapsaicin and dihydrocapsaicinare are 
also true agonists of the human TRPV1 ion channel, in addition to capsaicin. 
Dynamics of the TRPV1 biosensor
The performance of the biosensor was characterized in more detail by measuring its 
response to different capsaicin concentrations in the sensor. Each capsaicin concentration 
was tested twice. Figure 3a shows the TRPV1 responses of the calcium indicator, expressed 
as the normalized YFP/CFP ratio, to a range of capsaicin concentrations. These data 
demonstrate that, in our flowcell system, HEK293 cells expressing TRPV1 are able to detect 
capsaicin in a dose-dependent manner within the concentration range of 5-500 nM. 
Concentrations above 500 nM were not assayed because these may lead to desensitization 
of the TRPV1 ion channel [155, 156]. To better visualize the dynamics of the system, the 
exposure time -or dose time- of 30 seconds is shown as a transparent grey area (Figure 3a). 
Related to this dose time we observed four response features: 1) The rate of response, or 
slope, appeared to be dose dependent. High concentrations of capsaicin showed a fast rise, 
while low concentrations showed a slower rise. 2) The response duration also appeared 
to be dose dependent: high concentrations showed a slow return to baseline levels, while 
low concentrations showed a faster return. 3) At the two highest capsaicin concentrations 
tested, 250 and 500 nM, the fluorescence ratios remained at their maximum values for 
about 30 and 50 seconds, respectively, even after the ligand solution had passed through the 
flow cell. We call this an elongated response maximum. 4) In contrast, low concentrations 
of capsaicin, <50 nM, showed a delayed response which only reached its maximum at 50 
to 80 seconds, i.e. at least 20 seconds after the ligand solution had already passed through. 
We call this a delayed response maximum. These observed differences in dynamics give us 
greater insights into the receptor-ligand interactions at different ligand concentrations and 
hence represents a significant advantage of such a microfluidic system as compared to the 
currently used, multi-well, endpoint assay.
Differences in response dynamics of TRPV1 may be explained by existing models for 
TRPV1 binding stages [15, 157-159]. These models describe partial and full binding stages 
for capsaicin which affect the opening of the ion channel to partial and full opening, 
respectively. These binding stages of the TRPV1 ion channel are an effect of the ligand 
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binding to the ligand specific binding sites, of which there are at least two according to Hui 
et al 2003. At “high” concentrations of capsaicin, all binding sites on the TRPV1 receptor 
are occupied resulting in a full opening of the ion channel, while at “low” concentrations 
there is only a partial occupation of the available binding sites and therefore only a partial 
ion channel opening. The results we observed in the differential response dynamics of our 
TRPV1 biosensor at the various ligand concentrations (Fig 3a) fit well with such model. 
Two experiments with repeated capsaicin injections were performed to obtain some 
insight into TRPV1 response and stability upon repeated exposure to ligands: I) 7 times 30 
nM capsaicin at 6 min intervals and II) 3 times injections with 50 nM capsaicin at 10 min 
intervals. 
Figure 3, TRPV1 response to capsaicin. a, Cameleon calcium sensor YFP/CFP ratio changes upon 
injection of increasing capsaicin concentrations. Cell were exposed to 5–500 nM capsaicin for 30 
s (indicated by the grey area) and their response followed up to 200 s after injection. b, Cameleon 
calcium sensor YFP/CFP ratio changes upon repeated exposure to 30 nM capsaicin, by injecting 
seven times at intervals of 6 min. c, YFP/CFP ratio changes upon 50 nM doses injected three times at 
intervals of 10 min.
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At the relative lower concentration and intervals (Figure 3b), the response tended to vary 
considerably (standard deviation of 0.103), but without an obvious decline in sensitivity. In 
contrast, in the second experiment with the longer interval, and higher ligand concentration 
(Figure 3c), we observed a highly reproducible pattern with signals fully returning to 
baseline values and with successive response levels equivalent to the previous ones 
(standard deviation of 0.014). The relatively high variation at lower concentrations may be 
due either to the shorter recovery periods (6 minutes) or may reflect the lower consistency 
Figure 4, TRPV1 and taste panel responses to tabasco dilutions. a, benchmarking of the TRPV1 
biosensor with human test panel results for detecting pungency of tabasco samples. The maximum 
increase rate of the Cameleon YFP/CFP ratio changes in the biosensor is plotted on the left axis (black 
squares TRPV1 cells; grey circles control cells). The result of the taste panel assay (grey triangles) 
is plotted on the right axis as a pungency score from 0 to 100; ns not significant, * = p B 0.05; ** 
= p B 0.01; *** = p B 0.001. b–g, Cameleon calcium sensor YFP/CFP ratio changes upon increasing 
tabasco concentrations (water control, 50.000X, 12.000X, 3.000X, 750X and 187.5X for plot b–g, 
respectively) in TRPV1 expressing cells (black curves) and control cells (grey curves).
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in response at a ligand concentration close to the detection limit (as is also evident in Figure 
3a). Nevertheless, while more detailed and dedicated experiments are required related to 
the injection frequency, uniformity and stability of the biosensor response, it is clear that 
this system has potential for sequential use in semi-quantitative / qualitative bioactivity 
screens.
Biosensor response benchmarked against a human sensory panel
To allow direct prediction of analysed plant samples to human taste, it is necessary to 
compare the TRPV1 biosensor system with in vivo taste perception by human individuals. 
For this reason, the TRPV1 biosensor was benchmarked against a human taste panel using 
a dilution series (187- 50.000x) of a commercial tabasco sauce sample (Figure 4a and 
b) which had also been analysed for its capsaicinoid content. The most diluted tabasco 
sample was indistinguishable from the blank control by both the sensory panel and the 
biosensor assay. The tabasco pepper has a Scorville scale score ranging from 30.000 to 
70.000 SHU, meaning that a dilution in this order of magnitude does not evoke a hot or 
pungent sensation. The taste panel however, was able to recognize the second-most 
diluted (12.500x) tabasco sample, just as the biosensor assay was able to detect a small 
signal for this dilution. This dilution corresponded to a capsaicin concentration of ~15 nM 
(Table 1). Higher concentrations (lower dilutions) gave increasingly large, responses from 
the panel as well as in the biosensor assay. With the two highest concentrations in the 
biosensor assay (equivalent to~250 and ~1000 nM capsaicin, respectively), the control cells 
also showed a response, likely caused by either too high concentrations of capsaicinoids 
or a native response to other compounds present in the tabasco. These results emphasise 
the importance of using control cells for determining ligand or matrix-induced a specific 
reactions and the use of the appropriate dilution series for more quantitative analyses of 
specific bioactivities. Interestingly, the sensitivity thresholds of in vivo (taste panel) and in 
vitro (receptor microfluidics) measurements were essentially the same, so that these in 
vitro results can be extrapolated directly to predict human sensory experience. 
Potential for online functional metabolomics
The results presented were designed to provide a starting point for combining LC-MS 
analysis with bioactivity assays in series. Existing, online biochemical assays for anti-oxidant 
detection linked to LC-MS based component identification have already demonstrated the 
advantages of such online methods [160-162]. Our study provides the proof of concept 
that a microfluidic assay with living cells using analytical-scale LC-MS fractions can deliver 
detectable signals that allow the identification of bioactive molecules present in (crude) 
plant extracts. The next technical challenge is to design a truly continuous online functional 
metabolomics application in a flow through system using living cells as the biosensor. 
A continuous flowcell assay could allow direct measurement of LC output in a single 
experiment without the need for clean-up / extraction / re-dissolving steps which can 
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lead to compound degradation or modification. Additionally, measuring in a flow-through 
system readily allows the direct study of receptor dynamics. Figure 5 shows a schematic 
representation of how such an online LC-MS-based metabolomics-biosensor platform 
could be realized. 
There are, however, some key issues that still need to be addressed to realize such an online 
biosensor platform. Firstly, there is the issue that the LC solvent maybe incompatible with 
cell measurements. Acetonitrile or methanol, formic acid, low or high pH, and deviant 
osmolality are toxic to cells. However, there are several ways to deal with this. Toxicity 
may be reduced or avoided by significant post column dilution of the sample, prior to cell 
exposure. Such a dilution is realistic, the plant LC fractions in this study could be diluted with 
cell culture medium up to 2000 times and still give a clearly measurable sensor response. 
Alternatively, detoxification of the running buffer may also be achieved by techniques 
like online post-column solvent evaporation, such as recently developed by [163]. Here 
the solvent leaving the analytical LC column is evaporated online and the compounds 
subsequently re-dissolved online in deuterated solvent needed for the NMR analysis.
A second issue is the long-term cell viability and the potential for repeated re-activation of 
the biosensor cells. In our study with the TRPV1 expressing HEK293 cells, the cells remained 
vital for at least 1 hour at room temperature while continuously imaging the receptor 
Figure 5, Scheme of an online functional metabolomics setup. The microfluidic flowcell with sensory 
cells is placed in a microscopic fluorescence detector, which will continuously monitor the cellular 
response of sample compounds eluting from the LC column. Simultaneous detection of compounds 
by UV–Vis lower chromatogram) and MS (upper chromatogram) can provide identification of 
bioactive compounds. LC-fractions, preferably separated into individual compounds, are collected 
as well in order to keep a compound record of the run when further functional analysis or metabolite 
identification experiments are required. This figure is modified from www.galenica.cl
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activation. Repeated dosage of up to 50 nM capsaicin produced reproducible activation 
peaks. At higher dosages of capsaicin, the sensor can easily become saturated. Sample 
concentration should therefore be carefully monitored and adjusted to avoid receptor over 
exposure. These are key aspects that need further optimization in the current biosensor 
setup. However, an investment in time and effort is highly justified as online functional 
metabolomics using a cell based assay will provide valuable opportunities in automation / 
high throughput biochemical and bioactivity screening. 
Concluding remarks 
Here we have shown that a flowcell containing the HEK239 cell line expressing the TRPV1 
ion channel coupled to intracellular calcium sensing, in combination with an appropriate 
control cell line, provides a sensitive method for semi-continuous functional metabolomics. 
TRPV1 was activated, resulting in dynamic intracellular calcium levels, both when cells are 
stimulated with the pure ligand, capsaicin, as well as with crude extracts of capsaicinoid-
containing Capsicum accessions. Additionally, we have shown that this biosensor 
compares in sensitivity to a human sensory panel. Furthermore, through application of 
this system we have been able to determine that, next to the well-known ligand capsaicin, 
nordihydrocapsaicin and dihydrocapsaicin are true agonists of the human TRPV1 ion 
channel in hot pepper. A next step will be to tackle the next technical challenges, and meet 
all biological demands needed to convert this system into a truly continuous and high 
throughput online functional metabolomics tool.
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Abstract 
Reverse-transfected cell arrays in microfluidic systems have great potential to perform 
large-scale parallel screening of G protein-coupled receptor (GPCR) activation. Here 
we report preparation of a novel platform using reverse transfection of HEK293 cells, 
imaging by stereo-fluorescence microscopy in a flowcell format, real-time monitoring of 
cytosolic calcium ion fluctuations using the fluorescent protein Cameleon, and analysis of 
GPCR responses to sequential sample exposures. To determine the relationship between 
DNA concentration and gene expression we analyzed cell arrays made with variable 
concentrations of plasmid DNA encoding fluorescent proteins and the Neurokinin 1 (NK1) 
receptor. We observed pronounced effects on gene expression of both the specific and 
total DNA concentration. Reverse transfected spots with NK1 plasmid DNA at 1% of total 
DNA still resulted in detectable NK1 activation when exposed to its ligand. By varying the 
GPCR DNA concentration in reverse transfection, the sensitivity and robustness of the 
receptor response for sequential sample exposures was optimized. An injection series is 
shown for an array containing NK1 receptor, bitter receptor TAS2R8 and controls. Both 
receptors were exposed 14 times to alternating samples of two ligands. Specific responses 
remained reproducible. This platform introduces new opportunities for high throughput 
screening of GPCR libraries.
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Introduction
Reverse transfection is a technique to create arrays of transiently transfected cells on a 
solid surface. Since the first publication of Ziauddin and Sabatini in Nature in 2001 [78], 
the technique has found versatile application addressing different cellular and biological 
questions using printed cDNAs, siRNAs, viruses and even chemical compounds [164-169].
The generation of cell arrays through reverse transfection using plasmid DNA involves three 
basic steps: (i) printing a DNA micro-array, (ii) coating the DNA microarray with transfection 
reagents, and (iii) seeding with adherent cells to cover the pre-treated DNA micro-array. 
Steps (i) and (ii) are sometimes combined [166, 170, 171], but typically these three basic 
steps can transform a printed DNA microarray into a transfected cell array via efficient 
contact-mediated uptake of plasmid DNA by the adhering cells. This is visualized in Figure 
1, steps 1 and 2, Video S1 and Figure S1 . Protein expression efficiency depends, to a great 
extent, on correct formation and delivery of DNA transfection complexes. These aspects 
have been studied for both surface-immobilized and solution-mediated transfection 
systems [172-174]. Other important parameters influencing protein expression efficiency 
are the cell cycle [175, 176] the concentration [177-179], and the purity of plasmid DNA 
[180]. Higher plasmid concentrations have a direct effect on intracellular plasmid copy 
numbers in both the cytoplasm and the nucleus up to a certain maximum. Cohen et al [177] 
have shown that with increasing DNA levels, the maximum gene expression depends on 
cell type, the vector used and the method of transfection, so that no single protocol can be 
applied in all situations. 
Only few studies have combined reverse transfection with microfluidics [84, 181-183]. In 
those studies, each spot of the cell array was enclosed by a chamber that allowed individual 
fluidic control. These micro-chambers mimic a multi-well plate where each well or chamber 
is individually used for measurements. However, a set-up applying controlled fluidics to 
individual spots is relatively complex for generic screening of GPCR libraries. This merited 
developing a system allowing simultaneous exposure of multiple receptors within a single 
chamber, thereby simplifying the set-up and increasing the efficiency of screening and 
analysis. In this article we show how we have developed such a screening system involving 
an array in a single flowcell and a stereomicroscope to simultaneously image all spots over 
time (Figure 1, steps 3 and 4, Video S1 and Figure S1). 
Reverse-transfected cell arrays have been used before to screen GPCR libraries, but those 
arrays were small and spotted in the static environment of 96 well plates [81, 85]. These 
setups did not allow for a sequential microfluidic screening of samples. The latter enables 
not only a dynamic analysis of receptor-ligand interaction, but also a more powerful spot-
based, statistical analysis of sequential injections. In the present study, we placed a reverse 
transfected cell array in a re-sealable microfluidic chamber that covered the entire array 
(Figure S1). This set-up allowed routine monitoring of the ionic calcium responses of each 
individual spot to sequentially injected samples. As a proof-of-concept, we used the NK1 
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receptor which was previously characterized in this flowcell [95, 96] and the bitter taste 
receptor hTAS2R8 [33]. The activation of these receptors by their respective ligands led to 
a transient increase in the cytoplasmic calcium ion concentration via a signal transduction 
pathway involving uncoupling of the G proteins, activation of phospholipase C, inositol 
trisphosphate (IP
3
) production, and opening of an IP
3
-gated calcium channel of the 
endoplasmic reticulum [67, 137]. Such calcium responses are transient and were monitored 
real-time using the fluorescent calcium-ion sensor protein Cameleon YC3.6 [125, 131, 184] 
by means of FRET imaging. Previously, we expressed the NK1 and YC3.6 genes from a single 
plasmid. Here, we have designed and applied a more flexible system using separate plasmids 
for each gene. This enabled the modulation of receptor gene expression, independently of 
calcium sensor expression, by modifying plasmid DNA ratios. In this paper, we focused on 
the parameters of the reverse transfection procedure to optimize GPCR response in our 
microfluidic system and on the appropriate data analysis. In such a system, the following 
properties are paramount for optimal use: protein expression efficiency; transfection 
uniformity over the array; co-transfection and a reproducible response to repeated 
challenges (robustness). The potential of this system for high throughput screening of GPCR 
receptor libraries is discussed.
Figure 1, Schematic overview of array preparation and measurement in the microfluidic system. 
Steps 1 and 2 show array preparation involving DNA spot contact printing, overlay with transfection 
reagent, subsequent seeding of cells and expression of DNA after cell division. Step 3 shows the 
assembly of the flowcell and placement into the Micronit FluidConnect Pro flowcell holder. Once 
the holder is closed, fluidic connections are established and the microfluidic system produces a 
pressure controlled flow. Specific volumes of samples are injected sequentially into the constant 
flow to stimulate cell responses on the micro array (Step 4). Continuously, the entire array within the 
flowcell is imaged to capture the fluorescence from the calcium indicator YC3.6 over time and allow 
high-throughput screening. See also Supplementary Materials Video S1 and Figure S1.
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Materials and Methods 
An animation of the array preparation, flowcell assembly and array measurement is 
presented in Supplementary Materials Video S1 and Figure 1 
Expression vectors 
The NK1 receptor gene was purchased at the UMR cDNA Resource Center (University 
of Missouri-Rolla, cat.nr. TACR100000). The hTAS2R8 (NCBI Reference Sequence: 
NM_023918.1) bitter receptor gene was PCR amplified from genomic DNA from HEK293 
cells and cloned into a pcDNA3 expression vector. This vector contained a DNA sequence 
encoding the first 45 amino acids of the rat somatostatin receptor type 3 to improve 
membrane targeting of the bitter receptor protein. The Gα
16GUST44
 gene in vector pcDNA3 
was a gift from Dr Takashi Ueda (Nagoya City University, Nagoya, Japan). The YC3.6 gene 
in pCDNA3 (ThermoFisher scientific, Waltham, MA) was a gift from Prof. Roger Tsien (UC 
San Diego). Plasmid containing CFP and RFP were from Addgene (#13030 and #13032 
respectively). All plasmids used were of similar size and carried the same CMV promotor.
Cleaning and printing of DNA arrays 
Glass slides (15x45 mm) were cleaned with 2% Hellmanex solution (Hellma Analytics, 
Müllheim, Germany) by dipping the slides in the solution, sonication for 15 minutes and 
subsequent incubation for a maximum of 2 hours at room temperature. The slides were 
then thoroughly rinsed and incubated overnight at room temperature in ultra-pure water 
to remove any residue left by the Hellmanex solution. After incubation, the slides were 
dried in a 50oC incubator and coated for one hour with poly-L-lysine 100 µg/ml solution 
(Sigma, St. Louis, MO, P1274). The slides were then rinsed with ultra-pure water, dried and 
stored at room temperature in a dust free container until use. The slides were printed by 
a Microgrid II DNA printer (BioRobotics) using modified SMP3 pins (arrayit) which were 
slightly blunted to generate square ~200 µm x 200 µm spots (Figure S2B). Slides were 
printed at ~55% relative humidity and left to dry for one hour after printing. The spots 
were initially printed using a 400 µm grid spacing, but as the resulting transfected cell spots 
appeared at risk of cross-contamination because of slight cellular motility, spot spacing 
was subsequently increased to 600 µm (Figure S2D). The print solution was composed of 
purified plasmid DNA (Qiagen, Plasmid Mini kit, 12123), 0.4% gelatine (Sigma, G9391) and 
50 mM sucrose dissolved in ultra-pure water. The gelatine was prepared fresh before use 
by dissolving 1% gelatine in ultra-pure water at 60 oC for 15 minutes and filtering it through 
a 0.2 µm filter. After printing, the slides were stored at room temperature in a dust-free and 
dry container. Slides could be stored for up to 6 months without loss of transfection yields. 
Print solutions were freshly made, but can be stored at -20oC and re-used after adjusting 
volumes and heating to 60oC for 15 minutes. 
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Cell culture and reverse transfection 
HEK293H cells (ThermoFisher scientific, Waltham, MA11631-017) were maintained as a 
monolayer in DMEM (Gibco, 21063-029) containing 1x MEM non-essential Amino Acids 
(Gibco, 11140-035), 1x Penicillin-Streptomycin (Gibco, 15140-122) and 10% FBS (Gibco, 
26140) in a 37 oC incubator with 5% CO
2
. HEK293H cells stably expressing the chimeric 
G protein subunit Gα
16GUST44
 [75] were used for the expression of hTAS2R8. The reverse 
transfection method was adapted from the Sabatini lab description [78]. In short, we 
prepared a transfection mix from the Effectene kit with transfection reagents (Qiagen, 
301425) by mixing 75 µl EC buffer with 8 µl enhancer, pre-incubating for 5 minutes at room 
temperature and then adding 12.5 µl Effectene lipids. The transfection mix was vortexed 
for 10 seconds and carefully applied, dropwise, onto the glass surface submerging the 
entire 15x18 spot array. The slides were incubated for 20 minutes at room temperature. 
The transfection mix was removed by tilting the array and carefully pipetting off the 
transfection mix. Once the slides were air-dried, a flexiPERM chamber (Greiner, 90032039) 
that was cut to the appropriate size, was mounted over the array (Figure S1A). The 0.9 cm2 
chamber was filled from the edge with HEK293H cells (2.2x105 cells/cm2) and incubated at 
37 oC incubator with 5% CO
2
 for at least 27 hours before use. 
Flowcell and array imaging setup 
The reverse transfected arrays (270 spots and ~100 mm2) were mounted with a resealable 
borosilicate glass flowcell (Micronit Microfluidics B.V, Resealable FC 4515, Extended 10 
mm) and fitted in a flowcell holder (Micronit Microfluidics B.V., Fluidic Connect PRO Chip 
Holder with 4515 Inserts, Figure S1A). The arrays were imaged by a Leica fluorescent stereo 
microscope (Leica M205FA with DFC 345 FX camera and 2.0x PlanApo objective with 
NA 0.35) fitted with a 0.32x C-Mount and filters for CFP (ET CFP 10447409, exc. 436/20 
and em. 480/40) and YFP FRET (ET FRET 10450566, exc. 436/20 and em. 535/30). Lamp 
intensity (Osram, HXP-R 120W/45C VIS) was set at maximum and exposure time was 400 
msec. Large cell arrays as shown in Figure S1B and S3 were imaged at maximal field of view 
(FOV) in order to image fluorescent signal from the entire array. Compared to the confocal 
microscope images of Figure 2B (~0.16 mm2), this led to a loss of cellular resolution due to 
the larger working distance, but a ~625x larger area that was imaged. From Figure S3B it is 
evident that due to this zooming out, cellular contours were lost and that a single pixel of 
about 11 μm diameter, can cover one or partially two cells. In the time series acquisition 
a 2x binning was used resulting in a 23x23 μm pixel size on chip, which corresponds with 
single HEK cells in the sample. The variation in fluorescent protein expression between 
cells is therefore correlated with the variation in individual pixel intensity. The graph in 
Figure S3C shows the pixel intensity against the ranked pixels of the enlarged section. At 
8-bit resolution, pixels with a fluorescence intensity of 256 have reached the detector 
limit. Pixels that represent the background in the selection (e.g. at the edge of this section) 
have a background intensity of 0-~20, and pixels with intensities between ~20 and 256 
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represent those with fluorescent protein expression. To distinguish fluorescent pixels from 
the background we set a lower limit (threshold) using the background algorithm in the 
CellProfiler software. On large arrays expressing the receptor proteins, calcium responses 
from receptor activation were imaged in time. A continuous flow of 100 µl/min culture 
medium or microscopy buffer (NaCl 130mM, KCl 5mM, Glucose 10mM, CaCl
2
 2mM, HEPES 
10 mM at pH 7.4) was applied for 10 minutes before the samples were injected. Sample 
injections were done using a manual injection valve (Upchurch, V-451) containing a 50µl 
loop. Channel gains were maintained after initial separate adjustment for CFP and YFP FRET 
channels to measure fluorescence intensity amplitudes and minimize pixel saturation of the 
reverse transfected array. Images were taken every 3-5 sec (Figure S1B). 
Live imaging of reverse transfection time course 
A series of images of the reverse transfected cell array was taken to monitor cell motility 
and fluorescence intensity in time. Minimal light stress during acquisitions was achieved by 
spinning disk confocal imaging (Andor-Revolution system with Yokogawa disk) on a Nikon 
Ti Eclipse inverted microscope equipped with autofocus (PFS3), piezo stage (ASI XY-LE) 
and EMCCD camera (Andor Ixon888, 1024x1024 pixels, 13x13 µm). Optimal physiological 
conditions were maintained by a stage top incubator (Tokai Hit, Shizuoka, Japan) at 37oC ± 
0.1oC with continuous humidified 5% CO
2
 flow. Images were acquired every 30 minutes over 
a period of 33 hours with a 10x CFI Plan-Fluor NA 0.3). Signal expression from CFP, YFP or 
RFP was monitored in corresponding domains of the reverse transfected cell array. Images 
were recorded with MetaMorph Imaging series 7.8.3 (Molecular Devices).
Data analysis of fluorescent protein expression 
Pixel intensity data were obtained from the Leica software (LAS AF Lite, version 3.1.0). 
A grid of equally sized regions of interest (ROI) was created, each containing one array 
spot. The intensity histogram of each ROI was then exported to a spreadsheet program. 
There, the pixels were sorted against the intensity value and numbered, starting with the 
highest intensity value. When ranked pixels from different reverse transfection conditions 
(e.g. input DNA concentration) were compared, a ranking range was chosen that yielded a 
value between the upper and lower thresholds for each condition. To avoid skewed data 
comparisons, only pixels in this dynamic range rather than an ROI average were used to 
yield a valid analysis of DNA concentration effects. 
Data analysis of calcium responses 
The images recorded on the Leica fluorescence stereo microscope were first analyzed using 
CellProfiler software version 2.1.1 [185]. Two CellProfiler pipelines were created. In the first 
pipeline, one YFP image was used to create a mask of the array. This mask separates signal 
pixels from background pixels and is based on the threshold algorithm given in the pipeline. 
In the second pipeline, a grid overlay was created to define the array spot positions. The 
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mask image from the first pipeline was used as overlay on every CFP and YFP image of the 
recorded time series. The intensity values of the pixels within the mask for both CFP and 
YFP images were measured and the signal was defined by calculating YFP/CFP ratios. Peak 
heights were then determined for all spots and all injections by measuring the range of 
the signal within the first 40 cycles. In order to be able to compare receptor responses to 
different types of injection a linear mixed model was constructed relating the injection type 
to the receptor type. Since different spots of the same receptor type can sometimes have 
quite different baseline responses, the spot number was taken into account as a random 
factor. The outcome of the model consists of estimated responses (including confidence 
intervals) of each receptor type to all injection types. The estimated differences with a 
reference injection (here the blank) can then be visualized, including confidence intervals 
calculated for each injection type separately. Model calculations were performed using in 
house software (publication in preparation) 
Results
Time course of protein expression after reverse transfection at the cell and spot level 
Protein expression of fluorescent proteins was followed live and used to establish the time-
course of protein accumulation both at the single cell and the reverse-transfected spot 
levels. Fluorescence emission of a reverse transfected spot carrying the RFP plasmid DNA 
was imaged using a spinning disk confocal fluorescence microscope at 30 minute intervals 
for a period of 33 h. (Figure 2, Video S2). Imaging was initiated directly after seeding the 
cells on top of a DNA array pre-treated with Effectene. Cells became fully attached to the 
surface in ca. 5 h, initially covering about 50% of the slide. At 3-5 h post cell inoculation, 
the first cells started to show detectable fluorescence above background levels. To follow 
this in detail, we counted the number of transfected cells at each time point and measured 
the total fluorescence intensity of the image (Figure 2A). It should be noted that accurate 
counting of fluorescent cells was difficult, because these tended to overlap and move 
between images which is a sign of vitality in HEK293 cells [186]. Together with effects of cell 
division this did result in fluctuations of the number and intensity of (ranked) cells (Figure 
2A,C). The total fluorescence of the image showed a nearly linear increase between 14 - 30 
h, post inoculation (Figure 2A). We also observed a large variation in fluorescence intensity 
between the transfected cells as shown in Figure 2B, even though the spot was transfected 
with a fixed RFP-encoding plasmid DNA concentration. The range in fluorescence intensity 
between individual cells increased over time. To understand this, we ranked the fluorescence 
intensities from high to low for each time point, and plotted the average intensities in pools 
of 10 cells per rank, also from high to low, as shown in Figure 2C. We observed that the 
fluorescence of cells did not decrease in time or increase faster when detected later. Thus, 
the figure shows that cell groups with early expression of RFP indeed reach the highest 
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Figure 2, Time course of RFP expression after reverse transfection. A, Graph of the number of 
fluorescent cells (left axis, black dots) and the total fluorescence of all cells (right axis, open 
diamonds) in time. Based on bright field images, the complete cell attachment and the moment 
when complete confluence of the cell layer was reached are indicated in the figure. B, Overlay of 
bright field and RFP fluorescence at 10, 15, 20, 25, and 30 hours after inoculation. Scale bar = 50 µm. 
C, Graph of the average intensity within pools of ranked fluorescent cells over the time course of 
the reverse transfection. The pools represent up to 10 fluorescent cells ranked from the highest to 
lowest expressing cells at each timeframe. The start time of each pool is indicated in the graph, and 
the average intensity of the pool at 33 hrs post transfection is shown on the right within the graph.
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final level. The delay in visible RFP expression in subsequent classes of cells is not only 
characterized by a time delay but also by lowered maxima. For example, a 4 hour delay in 
expression of the first two classes, resulted in a circa 2.5 fold lower RFP expression level 
after 30 hours, and a 10 hour delay in a ~30 fold lower expression. Since the variation in 
RFP expression within the reverse transfected spot was large, we investigated, given the 
intercellular variation in the expression of proteins, how large reverse transfected DNA 
arrays could best be imaged by fluorescence stereomicroscopy and how expression relates 
to the DNA dosage. 
Effect of DNA concentration on protein expression
To determine the effect of DNA concentration on protein expression, an array was prepared 
using various concentrations of CFP plasmid DNA. A fluorescence image of a representative 
part of this array is shown in Figure 3A, with over-exposed pixels in blue. Like Figure 1, each 
spot in Figure 3 contains pixels with a wide range of fluorescence intensity levels which 
reflects the differences in cellular expression levels. In these recordings the detector gain 
was deliberately set to allow some saturation at the highest expressing cells in order to keep 
the low expressing cells within the detection range. With increasing DNA concentration an 
increase in both fluorescence intensity and number of pixels per spot was observed (Figure 
3B, Figure S2), which also increased the number of saturated pixels. If saturated pixels would 
be included in an analysis of the effect of different total DNA concentrations, expression 
efficiency would be underestimated. Vice versa, leaving out underexposed pixels with no 
Figure 3, The effect of total DNA concentration and coding DNA concentration on protein expression 
displayed as pixel intensity. The boxplots of Figure 3 show the distribution of spot intensities per 
category. Each category includes about 10 spots. The black line indicates the median value of the 
data distribution, the box represents the first and third quarter of the data distribution and the 
whiskers represent the minimum and maximum value of the data set. The open circles are outliers in 
the data set. A, Fluorescence image of 4 spot types representing from left to right 10, 20, 30 and 40 
ng/µl total DNA. The image is shown with a range indicating LUT where over-exposed pixels display 
in blue. Scale bar = 200 µm. B, Average spot intensity (based on pixels above background intensity 
including saturated pixels) of spots containing total DNA at concentration of 10 ng/µl (n=9 spots), 
20 ng/µl (n=8 spots), 30 ng/µl (n=9 spots) and 40 ng/µl (n=8 spots). Numbers above the boxplots 
indicate the average amount of pixels of the spots. C, Pixel ranking of spots containing 0 ng/µl, 10 
ng/µl, 20 ng/µl, 30 ng/µl and 40 ng/µl total DNA. The grey dashed lines show an upper limit (with 
value 256) and a lower threshold (background level with value ~20). The grey area (pixel 110-212) is 
the range of pixels where all spots can be compared using the same pixel range and within the upper- 
and lower limits. D, Boxplots of CFP fluorescence intensity of all pixels in range (grey bar) as indicated 
in C with increasing total CFP plasmid DNA concentration. E, Boxplots of CFP fluorescence intensity 
of all pixels in range with 10 ng/µl (n=9 spots), 20 ng/µl (n=9 spots) and 30 ng/µl (n=9 spots) total 
DNA and constant 10 ng/µl CFP plasmid DNA. F, Boxplots of CFP fluorescence intensity of all pixels 
in range with increasing CFP plasmid DNA concentration and constant total DNA concentration. 
The array of Figure 3F was measured on a different array (all conditions n=26 spots) with a 12 bit 
intensity scale (4096 levels) leading to higher intensity values and a different pixel range for intensity 
comparison than D and E.
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value leads to overestimation of expression efficiency. This is shown graphically in Figure 
3C using a pixel ranking of all pixels in spots transfected using 0-40 ng/µl CFP plasmid DNA. 
In this plot the lower threshold separates signal from background so that spots generated 
with 0 ng/μl DNA show no fluorescence. Fluorescence of CFP spots was measured up to an 
intensity value of 256, the limit of the detector. The grey bar in Figure 3C shows a range 
of comparable, ranked pixels with non-saturated fluorescence above the lower threshold 
at all four concentrations tested. For these pixels, intensity reports the direct relationship 
between protein expression and DNA concentration. 
In Figure 3D boxplots of all pixel intensities within the pixel range of Figure 3C are shown. 
A two-fold increase in CFP fluorescence is observed from 10 and 20 ng/µl, but between 
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10 and 40 ng/µl there is almost a ten-fold increase in CFP expression, suggesting that the 
relationship between protein expression and total DNA concentration is not linear. Since 
standard deviations increase with increasing DNA concentration, a linear relationship with 
the log-transformed CFP intensities can be expected. This indeed leads to a high R2 value 
of 0.89 (compared to 0.68 for the untransformed CFP intensities).
Effect of co-transfection on protein expression
To investigate non-linear effects of DNA concentration on protein expression, two arrays 
were prepared keeping either the CFP plasmid DNA concentration or the total DNA 
concentration constant. With a constant CFP plasmid DNA concentration, the dependency 
of cell transfection on total DNA would be established and with a constant total DNA 
concentration, the dependency of CFP expression on DNA plasmid copy number would 
become visible. Figure 3E shows the intensity of CFP fluorescence with increasing total 
DNA concentration, but at a constant CFP plasmid DNA concentration of 10 ng/µl. This 
figure follows the same pixel intensity increase as in Figure 3D. This indicates that, in 
this concentration range, CFP expression almost entirely depended on the total DNA 
concentration rather than the specific CFP plasmid DNA concentration. Figure 3F shows 
the intensity of CFP fluorescence with 33 ng/µl total DNA concentration and an increasing 
proportion of CFP plasmid DNA. Despite the large variation, there was a linear relationship 
between the concentration and the average CFP intensity, described by the following 
formula:
pixel intensity = 39.6[CFP] + 534
This indicates a background fluorescence of 534 and a slope coefficient of 39.6 for the 
increase of CFP fluorescence in this array, with an R2 value of 0.985. Also at the highest DNA 
concentration no clear saturation effects were visible.
Effect of DNA concentration on NK1 receptor calcium signaling 
Considering the observed effects of DNA concentration on protein expression, we next 
studied the effects of the coding DNA concentration on the functional activation of the 
G-protein coupled receptor neurokinin 1 (NK1). The transient cytoplasmic calcium signal was 
measured with the co-transfected calcium sensor protein Cameleon YC3.6. All spots were 
transfected with the same amount of calcium sensor resulting in similar total fluorescence 
levels between spots. The optimum gain was set to maximize the number of fluorescent 
pixels. This led to some overexposed pixels which were omitted from the analysis. 
The first question we addressed was the relationship between receptor DNA concentration 
(ranging from 0.3 ng/µl to 15.8 ng/µl in print solutions of 33 ng/µl total DNA) and the 
receptor activation response. Transfected arrays were assembled in a microfluidic flowcell 
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with a continuous flow of 100 µl/min culture medium. Samples of Substance P (SP), an 11 
amino-acid neuropeptide which activates the NK1 receptor, were injected using a 50 µl 
sample loop, resulting in a transient exposure to SP of about 30 seconds. Fluorescence 
emission of the calcium sensor protein was ratio-imaged every 5 sec. After 2 minutes the 
cytosolic calcium ion level had returned to basal levels, indicating a rapid and full recovery. 
SP was re-injected every 5 minutes. Figure 4A shows the changes in fluorescence ratio 
of the YC3.6 sensor after injections of 500 pM SP. The inset of Figure 4A shows a linear 
Figure 4, Calcium ion dynamics after SP exposure to arrays co-transfected with NK1 receptor and 
YC3.6 calcium sensor. Calcium ion dynamics are displayed in YFP/CFP signal ratio obtained from the 
YC3.6 calcium sensor and normalized by dividing the CFP and YFP signals by the average of the first 
images before sample exposure. A, Cytosolic calcium ion transients after 500 pM SP exposure rise 
with increasing NK1 plasmid DNA concentration ranging from 0.3 ng/µl to 15.8 ng/µl while total 
DNA concentration was kept at 33.3 ng/µl. Inset chart shows a correlation between NK1 plasmid 
DNA concentration and peak height. B, Repeated injections of 500pM SP on an array with total DNA 
concentration of 33.3 ng/µl and NK1 plasmid DNA concentration ranging from 3.1 ng/µl to 29.8 ng/
µl. C, Bar chart of B showing the peak height and standard error for each injection of 500pM SP at the 
different NK1 plasmid DNA concentration. D, Dose response curve for NK1 receptor and SP ranging 
from 50 pM to 5 nM SP. The curve was measured over two arrays as shown by the interruption in 
the curves. All values in this figure represent an average of over 20 spots each, distributed equally 
over an array.
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correlation of the calcium signal maxima to the log of the concentrations between 0.6 and 
10.3 ng/µl NK1 plasmid DNA. Spots with the lowest NK1 plasmid DNA concentration of 
1% of total DNA yielded a calcium response which was only ~4-fold less than the response 
of spots with a 50-fold higher NK1 plasmid DNA concentration. In a second array (Figure 
4B) we used an NK1 plasmid DNA concentration of 3-30 ng/µl relative to 33 ng/µl total 
DNA. This array was exposed to three sequential injections of 500 pM SP. While there was 
response variation (3 to 10% in peak height) between spots, at the spot level, responses 
were highly reproducible and quickly returned to baseline after each stimulation. Yet, at 
all NK1 plasmid DNA concentrations except the spots with ~3 ng/µl NK1 plasmid DNA, 
a slight decrease in peak height was observed for subsequent injections at that high SP 
concentration. The largest decrease in signal, about 20% of peak height, was found in the 
spots where the highest NK1 plasmid DNA concentration has been used (Figure 4C). Not 
surprisingly, two-way ANOVA showed that both NK1 concentration and injection number 
were highly significant (p < 1e-4).
Using this array we made dose response curves by sequentially injecting 3x 50 pM, 3x 100 
pM and 2x 500 pM SP onto one array and 3x 500 pM, 3x 1 nM and 1x 5 nM SP onto a 
second one. The averages of peak heights are shown in Figure 4D. We observed increasing 
peak heights for spots with increasing NK1 plasmid DNA concentrations up to 500 pM SP. 
Thereafter, the trend reversed for spots with 15.8 ng/µl or more NK1 plasmid DNA. After 
the 500 pM SP injection, the subsequent injections of 1 and 5 nM SP resulted in increasingly 
lower peak heights for those spots with high NK1 plasmid DNA concentrations. In contrast, 
a single injection of 5nM SP on a freshly prepared array resulted in the highest peaks from 
spots with the highest NK1 plasmid DNA (data not shown). The lowered maxima for the 
final 5nM injection in spots with 15.8 ng/µl or more NK1 plasmid DNA were a result of the 
injection sequence of this experiment.
Specific receptor responses to repeated challenges 
In the previous section we described that within a certain receptor DNA concentration 
and amount of ligand , repeated injections produce similar receptor responses. Receptor 
responses are reproducible with repeated injections. In this section we show how receptors 
respond to a series of repeated sample injections in a large array containing >60 replicates 
of three types of transfected spots; one carrying the NK1 receptor, one the bitter R8 
receptor, and one the control with mock DNA, all printed at 25 ng/µl for high sensitivity 
and all with 25 ng/µl YC3.6 coding DNA of the calcium sensor. Reverse transfection was 
performed with HEK293 cells that stably expressed the chimeric Galpha
16GUST44
 G-protein 
to allow calcium signaling from bitter receptors [75]. The ready array was mounted into 
the flowcell and dose response curves were determined for each receptor for activation 
by chloramphenicol and SP (Figure 5A). At a selected non-saturating concentration ligands 
for both receptors were then intermittently injected every 3 minutes during a period of 
>50 min (Figure 5B). We observed specific and reproducible response patterns for each 
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Figure 5, Repeated challenges of two distinct GPCR’s by a series of samples. A, Dose response 
curves of both NK1 and TAS2R8 for SP and chloramphenicol on a different array. B, Average response 
profile of NK1, TAS2R8 and the no receptor control of the whole injection series. The first injection 
is a blank injection of assay buffer, injections 2 to 15 are sample exposures of 30 seconds to either 
SP at 250 pM or Chloramphenicol at 100 µM and the last injection 16 is ATP at 10 µM. Response 
profiles are an average of about 60 spots per spot type. For easier visual interpretation, responses 
were normalized by dividing the CFP and YFP signals by the average of the first images before sample 
exposure. C, Estimates and confidence intervals for receptor-specific responses (peak heights) to 
injections, compared to the blank injection.
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receptor / ligand combination relative to the control. Figure 5C summarizes receptor-
specific responses to specific injections, expressed as differences with the response of 
the blank injection. NK1 gives a significant response to SP but not to Chloramphenicol; R8 
shows the reverse behavior. All spots including the control respond to the last injection of 
ATP because it triggers the P2Y receptor which is natively expressed by the HEK293 host 
cells [187].
Discussion
In this study, we have laid out the methodology and critical steps to use reverse transfected 
cell arrays in microfluidic flowcells [95, 96] for the robust, quantitative screening of GPCR 
libraries.
Our first experiments were aimed at studying reverse transfection and expression efficiency 
and revealed considerable differences in protein expression levels between individual cells 
(see Video S2). These differences may partially derive from uneven deposition of DNA on 
the glass surface or random differences in DNA uptake between cells [188], but most likely 
mainly reflect the well-known effect of the variation in cell cycle within the cell population 
used during reverse transfection [175]. Before plasmid DNA is taken up by the nucleus it can 
be continuously broken down in the cytoplasm [176], and trafficking of plasmid DNA to the 
nucleus is only optimal during mitosis. As a result, the sub-population of cells transfected in 
their late S or G2 phases will transfer higher amounts of plasmid DNA to the nucleus during 
M phase than those cells transfected during the G1 / G0 phases. Therefore, to generate a 
more homogeneous and high gene expression, one could either synchronize the cell cycle 
prior to reverse transfection [189, 190], or alternatively, add nuclease inhibitors during the 
reverse transfection process [191] to reduce plasmid breakdown. In our experiments we 
did not synchronize the cells because the transfected DNA was well expressed and allowed 
sufficient receptor readout in our cell line. However, with other cell lines, smaller spots or 
poor signals, it may be advisable to synchronize cells for higher and more homogeneous 
gene expression.
In large reverse transfected cell arrays, the variation in individual cell expression was 
captured in the variation of pixel intensities. To analyze these large cell arrays, we introduced 
thresholds to separate fluorescent pixels from background and over-exposed pixels. 
Resulting spots were defined as the collection of pixels with values between the upper 
and lower thresholds. Using this method we examined the optimal DNA concentration in 
the print solution by assessing the expression of fluorescent proteins and found a non-
linear increase in average fluorescence per spot with increasing total DNA concentration. 
Examination of the effect of DNA concentration in the print solution on protein expression 
revealed that, within a certain range, the total DNA concentration has a much greater 
influence on protein expression than the relative specific DNA concentration. The 10-fold 
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increase in fluorescence signal that we observed could be accounted for almost entirely 
by the quantity of total DNA [192]. By contrast, when keeping the total DNA concentration 
constant, we observed a linear increase in fluorescence relative to the specific DNA 
concentration. A similar linear increase of fluorescent protein expression with constant 
total DNA was obtained by Woodruff et al. [84]. Overall the results indicate that, in the 
tested concentration range, the efficient nuclear uptake of DNA is controlled more by the 
total DNA concentration than by the specific DNA concentration, thus suggesting strong 
differences in DNA survival. Also other studies have shown that adding non-coding plasmid 
DNA can improve expression efficiency by serving as a protection buffer against nucleases 
in the cytoplasm [192].
The goal of our experiments was to develop a versatile microfluidic system to screen GPCRs 
libraries by sequentially injected samples. Co-transfection with the fluorescent cytosolic 
calcium ion sensor Yellow Cameleon YC3.6 enabled the monitoring of transient calcium 
ion changes and discrimination of transfected and non-transfected cells on the cell array. 
Additionally, co-transfection allowed us to tune expression of both genes independently 
and to analyse the effect of receptor coding DNA concentration separately from the calcium 
sensor concentration. We observed that the lowest concentration of specific, NK1-encoding 
DNA, 1% of total DNA (0.3 ng/µl), still yielded sufficient gene expression for a significant 
increase in intracellular calcium in response to 500 pM SP. This suggests that sufficient 
numbers of intact plasmids reach the cell nucleus to facilitate NK1 gene expression even at 
those ratios. Studies have shown that during a transfection event, individual cells can take 
up about 105 to 106 copies of a plasmid [178]. However, as discussed earlier, plasmids also 
need to reach the nucleus in order to be expressed, but are prone to rapid degradation 
by nucleases naturally present in the cytoplasm [176]. The nuclear plasmid copy number 
was determined by Cohen et al. in 2009 [177] to range 40-fold from 75 to 3000 copies 
per nucleus, and they also demonstrated a direct correlation between nuclear plasmid 
concentration and gene expression. We used a 50-fold difference in NK1 receptor DNA 
concentration in the spot mixes and found that the lowest concentration NK1 coding DNA 
resulted in only a 4-fold decrease in calcium ion signal. It will be interesting in the future to 
use the reverse transfected cell array format to evaluate the effect of receptor expression 
level on the signalling function of other GPCRs or ion-channels, because the highest 
expression level may not be optimal for gene function. Similarly, these arrays are highly 
suitable to evaluate permutated cofactor genes and to discover orphan receptor function.
We subjected the NK1 receptor cell array to sequential injections of ligand and monitored 
the calcium responses. This revealed that spots with higher amounts of NK1 plasmid DNA 
and higher response maxima were subject to losing signal strength more rapidly compared 
to spots with lower amounts of NK1 plasmid DNA. Such declining receptor responses are 
generally known for GPCRs and are thought to be caused by receptor internalization and 
recycling after (over) activation [47, 139]. Scarce endogenous co-factors of the signaling 
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pathway (G-proteins, beta-arrestins, etc), specifically associated with the activated 
receptors may be depleted more rapidly in the presence of a high receptor density during 
this process of internalization, and possibly explain our observations [67, 193]. Therefore, 
by controlling the GPCR DNA concentration in reverse transfection, the sensitivity and 
robustness (a reproducible response to repeated challenges) of the receptor response can 
be optimized. This is shown in the last experiment where we have exposed two different 
receptors sequentially to alternating samples. These receptors proved to be highly 
specific for their ligand since no cross reaction was observed and responses were highly 
reproducible at the given non-saturating concentrations. The analysis required an approach 
where inter-spot variation was eliminated, focusing only on comparisons within the time 
profile of individual spots. The mixed-model approach taken here, where each spot has a 
random intercept, provides a simple and natural way of fitting these data, demonstrating 
reproducible responses for sequential injected samples.
Overall, the GPCR library screening platform presented here is complementary to multiwell-
based systems as it is simple, fast and efficient for screening receptor libraries with small 
amounts of ligand (see Video S1). It is perhaps less suitable for screening compound 
libraries because it depends on sequential rather than parallel injection. Previously, reverse 
transfection arrays encoding GPCR libraries were printed in static multiwell formats [81, 85] 
and not yet as part of a microfluidic platform. We believe that the microfluidic properties 
and the potentially very large size of the arrays creates significant potential to make this 
system a useful high throughput and high content screening tool for GPCR and ion-channel 
libraries. A single sample exposure of 50-150 microliters for 30 seconds (depending on 
flowspeed and flowcell volume) can reach hundreds of different receptors in parallel. 
This screening platform is in that sense complementary to systems with multiple micro-
chambers that are independently addressed [84, 181]. On-chip corrections for fluorescence 
quenching and sample fluorescence could be implemented with Cameleon mutants that do 
not bind calcium for example. Receptor saturation levels could be monitored by including 
calibration injections. Cameleon expressing control spots lacking recombinant receptors 
can be used to monitor the build-up of intracellular calcium in time and endogenous cell 
responses and other artefacts affecting the intracellular calcium ion concentrations. 
Conclusion
In conclusion, this paper has studied the main parameters for optimization of reverse 
transfection cell arrays for the detection of GPCR signaling in a microfluidic system. We 
observed an intrinsic, large variation in expression levels between the cells of one array spot. 
On optimization of protein expression efficiency we found that the total DNA concentration 
is a critical parameter to achieve high expression levels. Functional co-transfections were 
performed showing a fine-tuning of receptor expression levels by changing the input 
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plasmid DNA concentration. Concentrations down to 1% of total DNA still yielded specific 
receptor responses. Finally, repeated receptor challenges showed a highly reproducible 
signal. These findings provide a confident outlook on introducing this system as a novel 
high throughput GPCR library screening tool.
Supplementary Materials
The following are available online at www.mdpi.com/1424-8220/18/2/602/s1: Video S1. 
Animation of the preparation, measurement and analysis of GPCR arrays. Video S2. Reverse 
transfection time laps movie. Supplemental Figure S1. Overview of slide preparation and 
slide measurement. Figure S2. Printed DNA array before and after reverse transfection. 
Figure S3. Fluorescence image of a large reverse-transfected cell array. 
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Supplementary Figures
Figure S1, Overview of slide preparation and slide measurement. A, Uniform printed array (top 
left and right) with spot size of 200 µm and a spot spacing of 600 µm. A flexiPERM chamber for cell 
growth mounted on the array (lower left), and an assembled flowcell (lower right) mounted in the 
flowcell holder below. B, Imaging setup using a stereo-fluorescence microscope that records both 
CFP and YFP FRET emissions of the whole cell array. The bright field image shows the uniform cell 
layer of HEK293 cells after growth in the flexiPERM chamber.
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Figure S2, Printed DNA array before and after reverse transfection. A, Printed DNA array after 
effectene treatment and drying. Spot size is 200 µm, spot spacing is 400 µm. B, Hollow needles used 
to print spots. The sharp tip on the left yielded spots of about 100 µm and the blunted one on the 
right yielded spots of 200 µm. C, Total DNA concentration in ng/µl for the corresponding spots of A. 
D, Array of A 24 hours after reverse transfection with HEK293 cells. Spots expressed the fluorescent 
proteins CFP, RFP or YFP. The spacing of 400 µm risked spot cross-contamination therefore an inter- 
spot distance of 600 µm was used in all other arrays.
Figure S3, Fluorescence image of a large reverse transfected cell array. A, Large cell array of 15x19 
(9x10.8 mm) spots with diameters of 200 µm and a spacing of 600 µm. B, Enlarged section( ~45x 45 
pixels) where one pixel represents ~11 μm (no binning). C, Pixels of section B ranked from highest 
to lowest intensity. The distribution shows some saturated pixels at intensity of 256, fluorescent 
protein expressing cells between intensity ~20 and 256, and background pixels at intensities < 20.
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Abstract
The genetically encoded calcium sensor protein Cameleon YC3.6 has previously been 
applied for functional G protein-coupled receptor screening using receptor cell arrays. 
However, different types of sensors are available, with a wide range in [Ca2+] sensitivity, Hill 
coefficients, calcium binding domains and fluorophores, that could potentially improve the 
performance of the assay. Here, we compared the responses of three structurally different 
calcium sensor proteins (Cameleon YC3.6, Nano140 and Twitch2B) simultaneously, on a 
single chip, at different cytosolic expression levels and in combination with two different 
bitter receptors, TAS2R8 and TAS2R14. Sensor concentrations were modified by varying 
the amount of calcium sensor DNA that was printed on the DNA arrays prior to reverse 
transfection. We found that ~2 fold lower concentrations of calcium sensor protein, by 
transfecting 4 times less sensor-coding DNA, resulted in more sensitive bitter responses. 
The best results were obtained with Twitch2B, where, relative to YC3.6 at the default 
DNA concentration, a 4-fold lower DNA concentration increased sensitivity 60-fold and 
signal strength 5- to 10-fold. Next we compared the performance of YC3.6 and Twitch2B 
against an array with 11 different bitter taste receptors. We observed a 2-8 fold increase 
in sensitivity using Twitch2B compared to YC3.6. The bitter receptor arrays contained 
300 spots and could be exposed to a series of 18 injections within one hour resulting in 
5400 measurements. These optimised sensor conditions provide a basis for enhancing 
receptomics calcium assays for receptors with poor Ca2+ signalling and will benefit future 
high throughput receptomics experiments. 
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Introduction
Bitter taste receptors (T2Rs or TAS2Rs) are a class of G protein–coupled receptors, for which 
25 subtypes have now been identified in the human genome. Some are broadly tuned (e.g. 
TAS2R10,-14,-46), whereas others are more specific (e.g. TAS2R3,-5,-9,-13,-20,-41,-45,-50). 
Next to this, there are also four still remaining with an orphan status (TAS2R19,-42,-45,-60)
[194]. Interestingly, their expression and downstream signalling is not limited to the oral 
cavity and has been found to include other parts of the gastro-intestinal tract, respiratory 
and genitourinary systems, brain and immune cells [16, 195]. These findings suggest roles 
beyond taste, which is further fuelling the search for endogenous and exogenous ligands.
In screening assays used thus far, a number of bitter receptors have shown poor signals 
that could be related to variable functional expression on the cell membrane [32, 196-199]. 
Receptors with lower functional expression may suffer from poor transport to or rapid 
internalization from the cell membrane [197], may have poor glycosylation [198] and with 
certain levels of constitutive activity may become phosphorylated by receptor kinases 
that target them for β-arrestin internalization and may become generally exhausted for 
signalling [55]. Also, when comparing cytosolic calcium signalling of neuropeptide receptor 
1 (NK1) to the relatively strongly responding bitter receptor 8 (TAS2R8), we found that the 
signal amplitude for TAS2R8 was approximately 3-fold lower than for the NK1 receptor 
[100]. When signals are low, it is important to use a probe that is the most sensitive in 
the resting range of cytosolic calcium levels. Previously, in reverse transfected arrays with 
bitter receptors, calcium assays were performed using the Cameleon YC3.6 sensor protein, 
because of its wide dynamic range (5-6 fold change in the ratio of YFP/CFP upon Ca2+ binding 
in vitro) and brightness [131, 200]. The arrays were typically printed using two plasmids 
at identical concentrations; one encoding the G protein coupled receptor (GPCR) and one 
the calcium sensing protein. However, the effect of the concentration and type of sensor 
protein on the sensitivity and signal strength of the assay was not previously considered.
Since the first use of Cameleon calcium sensors [125], many variants of this ratiometric 
calcium probe have been described that are also based on the response of the FRET pair 
CFP and YFP [201, 202]. The palette of probes involves various modifications: The CFP 
and YFP proteins have been optimized to enhance their spectral properties [203], the YFP 
protein has been circularly permutated [131], the linker between CFP and YFP has been 
varied in length [204], and the calcium binding modality has been changed from calmodulin 
to troponin [205]. Ratio-imaging of YFP and CFP is advantageous because it is, in principle, 
independent of the expression level of the calcium sensor, and thus a direct reporter of 
the actual calcium concentration. For a receptomics platform this is relevant because the 
genetically encoded calcium sensor is transiently expressed in a receptor cell array which 
results in highly variable expression levels between cells within a spot. The genetically 
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encoded property of this fluorescent probe further allows the identification of transfected 
cells prior to the start of the experiment and the correct positioning of the array under 
the microscope. Fluorescent calcium sensor proteins like the GECO probes [201] only show 
significant fluorescence emission upon calcium increase. This yields very low fluorescent 
signals of the array prior to the start of a GPCR activation experiment, which are more 
difficult to focus, position and analyse. 
In this study we aimed to evaluate ratiometric probes with a calcium affinity that would 
ensure sufficient sensitivity for relatively minor calcium transients of bitter taste receptors 
above the resting levels of ~100 nM in HEK293 cells [206]. Cameleon YC3.6 [131, 200, 204], 
Nano140 [204] and Twitch2B [205] have K
d
 values of ~140-250nM that fit this criterion 
in principle, but these probes are distinctly different: YC3.6 and Nano140 both include a 
modified calmodulin domain, but with different cooperative binding and dissociation 
constants, and Twitch2B contains a troponin domain with only one calcium binding pocket 
and a more linear calcium binding curve. An added advantage of the use of troponin over 
calmodulin is that it does not potentially interact with host cell calmodulin binding proteins 
[202]. Next to sensor type, we also aimed to evaluate the effect of the cytosolic sensor 
concentration, because a high sensor concentration may increase signal-to-noise levels, 
but may also result in a lower signal intensity because of calcium buffering [200, 207].
Materials and methods
Expression vectors
Reverse transfected cell arrays were prepared and analysed as previously described 
in Roelse et al [100]. The genes encoding TAS2R1, TAS2R3, TAS2R4 (both FVS and SLN 
variants), TAS2R8, TAS2R10, TAS2R14, TAS2R16, TAS2R38 (both PAV and AVI variants), 
TAS2R39, TAS2R43 and TAS2R46 (see suppl. Table 1 for sequence information) were 
obtained from genomic DNA of HEK293 cells by PCR amplification and were cloned into 
pcDNA3 containing the N-terminal sstr3 tag (gift from Dr. Wolfgang Meyerhof, German 
Institute of Human Nutrition Potsdam-Rehbrücke, Germany). Plasmid, pcDNA YC3.6 was 
obtained from Prof. Roger Tsien (UC San Diego). Yellow Cameleon-Nano140 pcDNA3 was 
a gift from Takeharu Nagai (Addgene plasmid # 51966), Twitch-2B pcDNA3 was a gift from 
Oliver Griesbeck (Addgene plasmid # 49531)
Receptomics assay
DNA arrays comprising 15x19 spots were printed and processed as previously described 
[100]. Reverse transfected cell arrays were prepared using HEK293 cells stably transfected 
with Gα
16GUST44
 (a gift from Dr. Takashi Ueda, Nagoya City University, Nagoya, Japan). At 
48 hours after transfection, the cell arrays were taken from the incubator, washed and 
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incubated in assay buffer for 1 hour prior to the measurements. Spots then were typically 
composed of 25-50 cells and imaged by a similar number of pixels. All measurement series 
were performed using a ~150µl flowcell in the flowcell holder (Micronit Microfluidics B.V., 
Fluidic Connect PRO Chip Holder.) The assay buffer C1 (NaCl 130mM, KCl 5mM, Glucose 10 
mM, CaCl
2
 2 mM, HEPES 10 mM at pH 7.4) was set at a continuous flow of 300 µl/min across 
the array and sample injections were performed with a volume of 150 µl (Waters 2795 
autosampler). Agonists used in the injections were ATP (Sigma A6419), Chloramphenicol 
(Duchefa C0113.0100), Aristolochic acid (Sigma A5512), Denatonium benzoate (Wako 046-
23561), Picrotoxinin (Sigma P8390), PROP (Sigma P3755) and D-Salicin (Wako 199-00083). 
The arrays were imaged by a Leica fluorescent stereo microscope (Leica M205FA with DFC 
345 FX camera and 2.0× PlanApo objective with NA 0.35) fitted with a 0.32× C-Mount and 
filters for CFP (ET CFP 10447409, excitation 436/20 and emission 480/40) and YFP FRET (ET 
FRET 10450566, exc. 436/20 and em. 535/30). Lamp intensity (Osram, HXP-R 120W/45C 
VIS) was set at maximum, and the exposure time was 400 ms.
Rmin and Rmax measurement
The Rmin and Rmax signals were measured in a reverse transfected cell array containing mock 
transfected spots with either Twitch2B or YC3.6, according to the method described in [126]. 
In short, the array was equilibrated applying a 200 µl/min flow of C1 buffer for 10 minutes. 
First a blank injection of 300µl C1 buffer was performed followed by a 300µl injection with 
Rmin buffer (C1 buffer without CaCl2 but supplemented with 3mM EGTA and 5µM ionomycin 
(Sigma I0634) adjusted to pH 7.4 using NaOH). One minute after the Rmin injection, when 
the Rmin buffer exposure was maximal, the flow was stopped for 15 min to allow the cells 
to become fully calcium ion depleted. Next, the flow was restarted replacing the Rmin 
buffer with the C1 buffer and cells were equilibrated again in the C1 buffer for 10 min. 
Subsequently, 300µl of R
max
 buffer (C1 buffer with instead 5mM CaCl
2
 and 5µM Ionomycin) 
was injected into the flow and the flow was again stopped after 1 min. Cells were then again 
left for 10 min to become fully calcium saturated allowing the measurement of R
max
. 
Calcium affinity curves were calculated using a Hill coefficient calculation modified from 
[208]: 
F(S)= Rmin+(Δmax * S
n) / (K
d
n * Sn)
Rmin = minimal YFP/CFP ratio
Δmax = difference between Rmin and Rmax
S = calcium concentration [Ca2+]
n = Hill coefficient 
K
d 
= EC
50
 calcium value of the sensors 
Hill coefficient and K
d
 values were used from literature sources. Twitch2B has a K
d
 of 200 
nM and Hill coefficient of 1.3 according to [205]. For YC3.6 conflicting values have been 
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published. The initial publication states a K
d
 of 250 nM and a Hill coefficient of 1.7 [131]. 
However, a more thorough study performed by Horikawa et al. [204] showed a bi-phasic 
calcium affinity curve for YC3.6 with a high affinity range of K
d
 of 215 nM and Hill coefficient 
of 3.6, and a low affinity range of K
d
 of 780 nM and Hill coefficient of 1.2. Here, we used the 
high affinity range of K
d
 of 215 nM and Hill coefficient of 3.6 to plot a comparative curve. 
Data analysis
The analysis of data from the receptor cell arrays was performed as described in Wehrens et 
al [105]. In short, FRET images for the CFP and YFP channels were recorded and converted, 
using the CellProfiler software package [185], into raw CFP and YFP intensity values. Spots 
with less than 15 fluorescent pixels and spot types with fewer than 5 replicates were removed 
from the data analysis. After smoothing and interpolation to remove the differences in 
timing between the CFP and YFP measurements, spot signals were calculated as the ratio 
of the CFP and YFP values. These signal peak heights associated with individual injections 
were calculated as the difference between start and maximal ratio value in the spot signal 
within a time window of 30 cycles (just under two minutes). A representative example 
is shown in the supplementary data to Wehrens et al [105]. These signal peak heights, 
after log-scaling were then used in a mixed model with the injection type as fixed variable, 
and spot number as random variable. This greatly improves statistical power, since the 
between-spot variation is eliminated. Results presented in the figures consist of treatment-
versus-control contrasts, with the blank injection as the control, after back-transformation 
to the original scales. This leads to coefficients that should be interpreted as multiplicative 
effects: a value of 1.1 should be interpreted as a 10% increase in response compared to the 
reference. A value of 1.0 indicates no difference to the reference. Depending on the goal or 
characteristics of the experiments, different choices for reference injections are possible: 
like blank injection(s) or a sample contrast as in Wehrens et al. 2019. 
Results
Effect of sensor type and relative sensor concentration
On a receptor cell array, three sensor types (YC3.6, Nano140 and Twitch2B) and two 
receptor types (TAS2R8 and TAS2R14) were combined in different configurations. The 
sensor plasmids were printed at three concentrations (8, 16 and 25 ng/µl), while keeping the 
receptor coding DNA (25 ng/µl) concentration constant. Empty vector DNA was added to 
maintain the same total DNA concentration (50 ng/µl). The receptor cell array was exposed 
to increasing concentrations of a mixture of chloramphenicol and picrotoxinin, selective 
ligands for TAS2R8 and TAS2R14, respectively. The experiment was repeated twice using 
different cell arrays. Figure 1 shows an example of the raw traces of an injection series for 
TAS2R8 and TAS2R14, representing all three sensor types at a concentration of 16 ng/µl.
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After the blank injection, response peaks increased with increasing ligand concentrations 
for all three sensor types and for both bitter taste receptors. The final injection was a 
positive control injection with ATP at 5 µM. The purinergic receptors, endogenously 
expressed in the HEK293 host cell, are activated by ATP showing a clear positive control 
peak for all spot types. An additional 12 curves were obtained in parallel for the other 
sensor concentrations. The results are summarized in 18 replicated dose-response curves 
derived from the two arrays in 2 x 40 min (Figure 2). These response curves, including 95% 
confidence intervals, are shown in suppl. Figure 1. 
The curve values represent estimates of treatment-versus-control contrasts with respect 
to the 1 µM agonist injection, the lowest sample dilution which does not evoke a specific 
response signal. In this case, the injection with the lowest concentration was chosen as 
the reference since the blank injection in one of the arrays gave an artefact response, 
probably due to inadequate pre-washing of the auto sampler. Spot-based contrasts were 
determined to reduce the variation between the spots. The red and blue curves represent 
replicated experiments using two different arrays. The results for the two arrays are in 
good agreement, taking into account the width of the confidence intervals shown in Suppl. 
Figure 1. In both experiments with TAS2R8, the Twitch2B sensor at a gene dose of 8 ng/
µl gave the highest signal and sensitivity. For TAS2R14, with responses double those of 
TAS2R8, the effects were less pronounced but nevertheless still visible. 
The effects of sensor type and sensor concentration are summarized in Table 1. Responses 
are based on treatment-versus-control contrasts compared to a non-response or blank 
treatment (1 µM agonist in this case): a value of 1.1 should be interpreted as a ten percent 
increase in response compared to the reference, and a value of 1.0 indicates no difference. 
Figure 1, Averaged raw traces of TAS2R8 (A) and TAS2R14 (B) in an injection series of increasing 
chloramphenicol and picrotoxinin concentrations (array 2). Samples were injected sequentially at 
intervals of 5 minutes and with an exposure time of approx. 30 seconds. The ligand concentrations 
were as indicated in the chart. The lines represent averages of 13-16 replicated spots as indicated in 
the legends of the charts. In this example the three sensors were printed at a concentration of 16ng/
µl DNA.
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Figure 2, Response curves of TAS2R8 (A) and TAS2R14 (B) for stimulation with agonist mixture 
(chloramphenicol and picrotoxinin). (A) and (B) show agonist dose responses for the three sensor 
types at sensor gene dose of 8, 16 and 25 ng/µl. The two series represent two independent 
experiments. Response values represent estimates of treatment-versus-control contrasts with 
respect to the 1 µM injection. T2B, Twitch2B.
Looking at a combined effect of sensor type and concentration, YC3.6 at 25 ng/µl (standard 
in [100]) compared to Twitch2B at 8 ng/µl, when exposed to a 250µM ligand concentration, 
results in an 11-fold signal increase from 0.018 to 0.203 for TAS2R8 and a 4-5 fold increase 
for TAS2R14 (0.021 to 0.093). The sensitivity increase is up to 60-fold with lowest significant 
detection at 16 µM instead of 1000 µM. Splitting the sensor and concentration effects, it 
is clear that all probes benefit 4-15 fold from the reduced probe concentration and that 
Twitch2B is generally up to 4-fold more sensitive than the other two probes. 
Comparing YC3.6 and Twitch2B sensors
The striking improvement in response amplitude and sensitivity for the bitter receptors 
TAS2R8 and TAS2R14 using Twitch2B instead of YC3.6, led us to investigate whether this 
also held up for other members of the bitter taste receptor family. To evaluate this, an array 
with 11 different bitter taste receptor genes combined with both sensors at a gene dose of 
8 ng/µl was prepared. The array consisted of the bitter receptors TAS2R1, TAS2R3, TAS2R4 
(both FVS and SLN genotypes), TAS2R8, TAS2R10, TAS2R14, TAS2R16, TAS2R38 (both PAV 
and AVI genotypes), TAS2R39, TAS2R43 and TAS2R46 M228L. Two controls were present on 
the arrays: mock transfected spots to observe and correct for any TAS2R-independent host 
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cell responses and YC- control spots. The YC- is a deletion mutant of YC3.6 (Δ A332-S392) 
with fixed FRET between CFP and YFP to observe and correct for any optical effects of 
the samples during the fluorescence measurement. The receptors or empty vector (mock) 
were printed at a gene dose of 67 ng/µl reaching a total DNA concentration of 75 ng/
µl that appeared optimal in a comparison of gene dosages from 50-150 ng/µl total DNA 
(suppl. Figure 2). Receptor coding plasmid and total DNA concentration of the print mix 
was increased as a potential alternative way to improve the levels of functional receptor 
proteins present on the cell membrane [100]. The array contained 10 spot replicates of 
each bitter taste receptor, combined with either Twitch2B or YC3.6 at 8 ng/µl.
For each array, two dose response experiments were performed by alternating agonist 
injections of pure compounds with increasing concentrations as shown in Figure 3. In 
total, 3 arrays were used to prepare the dose response curves for 6 different agonists 
as presented in Figure 4. The agonist pairs were designed so that each would trigger a 
different receptor type. This resulted in a highly efficient throughput since in only three 
hours of measurement time we were able to generate 150 dose response curves and 12 
mock or negative control curves (Suppl. Figure 3). 
Since each array contained two separate experiments, treatment-versus-control contrasts 
could be calculated with respect to the same blank injection, making it possible to obtain 
all results in a single analysis. The mock control did not show a significant response signal 
to any of the agonist doses confirming that the receptor responses that were observed are 
bitter receptor specific. In Table 2 the results are summarized indicating a response range 
for each receptor-agonist combination with either Twitch2B or YC3.6 as calcium sensor. 
Table 1, Effects of sensor type and concentration. The most optimal and least optimal conditions 
are marked in bold. 
TAS2R8 TAS2R14
Lowest detection*
Response at 
250µM** Lowest detection
Response at 
250µM**
YC3.6 8 ng/µl 64 µM 1.054 250/64 µM 1.031
YC3.6 16 ng/µl 250/1000 µM 1.034 250/1000 µM 1.030
YC3.6 25 ng/µl 1000 µM 1.018 1000/250 µM 1.021
Nano140 8 ng/µl 64 µM 1.146 250/64 µM 1.047
Nano140 16ng/µl 64/250 µM 1.100 64 µM 1.061
Nano140 25ng/µl 250/64 µM 1.051 64 µM 1.045
Twitch2B 8ng/µl 16/64 µM 1.203 64 µM 1.093
Twitch2B 16ng/µl 64 µM 1.122 16 µM 1.112
Twitch2B 25ng/µl 64 µM 1.087 64 µM 1.086
*Detection threshold of agonist that gives a significant response in array 1 and 2, see suppl. Figure 1. When 
thresholds are different both values of array 1/array 2 are given. 
**Response estimate of array 1 for exposure to 250 µM agonist.
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Both sensor proteins were evaluated at similarly low DNA concentrations, but there is a 2-8 
fold increase in sensitivity of Twitch2B compared to YC3.6. Some response signal exhaustion 
may have occurred in the series and the response peak height of the higher compound 
concentrations may be an underestimation. In Wehrens et al. 2019 we have shown how 
dosing order impacts the peak height. In general, a repeated sample injection protocol can 
be incorporated into the analysis model to estimate the global decline of signal. 
Figure 3, Averaged raw traces YFP FRET / CFP from (A) TAS2R10 and Denatonium Benzoate (DB) and 
(B) TAS2R16 and D-Salicin. Traces are shown for both Twitch2B (T2B) and YC3.6 sensor combination. 
Agonist injections were alternated every 3 minutes and agonist exposure was approx. 30 seconds. 
The lines represent averages of 6 to 9 replicated spots as indicated in the legends of the charts. AA, 
aristolochic acid, PTox, picrotoxinin, D-Sal, D-salicin, DB, denatonium benzoate.
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Figure 4, Response curves of Twitch2B (T2B, circles) and YC3.6 (marks) of the responding TAS2R 
receptor spots from the three experiments. The full set of responses are available in suppl. Figure 
3. Response values represent estimates of treatment-versus-control contrasts with respect to the 
blank injection. AA, aristolochic acid, CHL, chloramphenicol, PTox, picrotoxinin, D-Sal, D-salicin, DB, 
denatonium benzoate and PROP, 6-n-propylthiouracil.
To check for metabolic exhaustion, a standard injection of ATP 5 µM or 10 µM was included 
at the end of each series. Such host cell responses triggered by ATP or Somatistatin-14 
are normally used to check the vitality of the cells as they trigger the same IP
3
 pathway 
via PLC1-4 [209-211]. Any changes in ATP response may indicate negative effects of the 
exposure to the standard bitter compounds. Supplemental Figure 4 shows the ATP response 
contrasts to the blank for each spot-type on each array. Spot-types with less than 5 spots 
were removed from the analysis (see also Supplemental Figure 3). The spot-type specific 
ATP signals did not significantly differ between the arrays showing no signs of metabolic 
exhaustion in these experiments. It is however relevant to notice that generally each spot 
type displays a different ATP response level that is usually lower than the mock. This has 
been shown before in Wehrens et al. (2019) and suggests negative interactions between 
bitter receptors and calcium signalling presumably independent of specific triggers [105].
Calcium response curves of YC3.6 and Twitch2B
Twitch2B and YC3.6 have similar dissociation constants of 200 and 215-250 nM respectively, 
but they differ strongly in their Hill coefficient (1.3 vs 3.6). To visualize the effect of the 
differences in Hill coefficient in the predicted calcium response curves of YC3.6 and 
Twitch2B, we measured the Rmin and Rmax of Twitch2B and YC3.6 using the method described 
in [126] (Figure 5A), and used a Hill coefficient calculation [208] to estimate the response 
curves in relation to the calcium ion concentration (Figure 5B). The Rmin buffer containing 
EGTA and ionomycin chelates all calcium ions resulting in an Rmin ratio of 1.4 for YC3.6 and 
0.8 for Twitch2B after about 15 minutes of exposure. Initially, after adding the Rmin buffer 
there was a spike in the ratio signal, showing the calcium depletion from the intracellular 
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Figure 5, (A) Raw traces YFP FRET / CFP from spots expressing either Twitch2B or YC3.6. The flow 
was set at 200 µl/min C1 buffer. After a blank injection, the Rmin buffer (C1 buffer without CaCl2 but 
supplemented with 3mM EGTA and 5µM ionomycin) was injected. The flow was stopped at full Rmin 
exposure and incubated for 15 minutes. Next the flow was started again replacing the Rmin buffer 
with the C1 buffer. Approx. 10 minutes later the R
max
 buffer (C1 buffer with 5mM CaCl
2
 and 5µM 
Ionomycin) was injected and the flow was stopped at full R
max
 exposure. (B), Calculated theoretical 
calcium binding curves for YC3.6 and Twitch2B based on Rmin and Rmax measurements, the known 
dissociation constants for calcium and the Hill equation (See materials and methods section).
Table 2, Difference in sensitivity for the receptor/agonist combinations with either Twitch2B or 
YC3.6 sensor transfected at DNA concentration of 8 ng/µl.
Receptor Agonist
Response 
range* of 
Twitch2B
Response 
range* of 
YC3.6
Fold increase 
in sensitivity
Reference EC50 
values
TAS2R8 chloramphenicol 3.9-125 µM 31.2-500 µM 8 n.d.
denatonium benzoate 250-1000 µM - n.d.
TAS2R10 denatonium benzoate 15.6-125 µM 125-500 µM 8 59 µM ±30 [212]
TAS2R14 picrotoxinin 31.2-250 µM 62.5-250 µM 2 18 µM [213]
TAS2R16 D-salicin 0.312-10 mM 1.25 -10 mM 4 1.2 mM [214], 1.1 
mM ±0.3 [215]
TAS2R38- 
PAV
PROP (6-n-propylthio-
uracil)
10-20 µM - 2.1 µM [216]
TAS2R43 aristolochic acid 62.5-500 nM 250-500 nM 4 81 nM ± 0.0008 
[217]
TAS2R46 picrotoxinin 62.5-250 µM - 70 µM ±5.2 [218]
chloramphenicol 125-500 µM - n.d.
denatonium benzoate 62.5-125 µM 250-500 µM 4 240 µM ±192 [218]
*Concentration range in which an increasing response trend is observed 
n.d. EC50 not determined, but activation published in [33]
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calcium stores. When the flow was started again and the Rmin buffer was replaced by C1 
buffer containing 2mM CaCl
2
, there was a large increase in the ratio signal of both sensors 
because of calcium re-entering the cells. Twitch2B reached an R
max
 ratio of 2.6 and YC3.6 an 
R
max
 of 3.2 when exposed to the R
max
 buffer containing 5mM CaCl
2
 and 5µM ionomycin. The 
dynamic range between Rmin and Rmax is quite comparable for both sensors, however, only 
Twitch2B clearly has an Rmin well below the cells’ resting level (around 100 nM, [206]). Only 
Twitch2B can therefore be used to record very small changes in calcium ion concentration 
both above and below the resting level. Also the Hill curves based on the respective Hill 
coefficients for Twitch2B and YC3.6 (Figure 5B) confirm this.
Discussion 
In this study we have evaluated the effectiveness of different genetically encoded calcium 
sensors, at a range of concentrations, for their ability to measure the comparatively 
low responses of bitter receptors. We observed strong response differences (4-5 fold) 
depending on sensor type and found that sensor Twitch2B yielded the strongest and most 
sensitive responses for eight of the evaluated bitter receptors. When compared to YC3.6, 
sensor Nano140 also yielded an improved calcium sensing, but Twitch2B appeared the best 
choice for bitter taste receptor arrays. In addition, we found a remarkably strong effect 
of the calcium sensor concentration on the sensitivity of the response. Lowering the gene 
dose 4 fold to 8 ng/µl resulted in about 2-3 fold lower protein concentrations [100], but 
improved the sensitivity for all sensors 4-15 fold. Doses lower than 8 ng/µl sensor DNA in 
the print mix yielded arrays with poorly detectable baseline fluorescence (data not shown), 
and therefore 8 ng/µl sensor DNA was determined as optimal in our setup. The observed 
gene dose effects are a clear example of calcium buffering in our reverse transfected cell 
arrays. Endogenous calcium sensors, naturally present in cells, regulate calcium levels 
or transduce signals in response to changes in calcium concentration [219, 220]. These 
endogenous sensors bind and buffer part of the calcium which enters the cytosol. The 
remaining free calcium ions are available to the fluorescent calcium sensor. This calcium 
sensor also binds and buffers a fraction of the free calcium. This buffering by fluorescent 
calcium sensors is problematic when the calcium binding or buffering capacity of the sensor 
is in the same range or exceeding the calcium buffering capacity of the cell itself [221]. An 
effective way of reducing the contribution of this buffering effect and thereby measuring 
true calcium responses, is to lower the fluorescent calcium sensor concentration as much 
as possible [221]. Unfortunately, fluorescence based calcium sensors cannot be diluted too 
much due to fluorescence noise levels and limitations in detector sensitivity. As argued 
by McMahon et al. this means that for most genetically encoded and synthetic calcium 
fluorophores, the observed calcium dynamics are quenched even under our more optimal 
low probe conditions [221]. A future solution would be to switch to bioluminescence-based 
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detection platforms for the measurement of cell calcium ion levels [222]. Photodetectors 
are generally regarded as 10-1000 times more sensitive than fluorescence detectors [223], 
allowing a further reduction in the amount of sensor needed for calcium detection and 
minimizing the calcium buffering. 
Using optimal sensor concentrations, the two sensor types Twitch2B and YC3.6 were 
compared on sensitivity performance for a range of bitter taste receptors. The sensitivity 
was benchmarked against the EC50 values obtained from the literature studies employing 
calcium dyes, for each receptor-agonist pair. Except for the combinations TAS2R14/TAS2R46 
with picrotoxinin and TAS2R38PAV with PROP, the published EC50 values are comparable to 
the response range obtained with receptor-Twitch2B combinations. The TAS2R46 response 
range to denatonium benzoate was lower than published. Deviations from the published 
values may relate to SNP variant differences (Suppl. Table 1) or to differences in the quality 
of the ligand stock solutions. Also the sensitivity of our specific imaging set up (filter, lens 
and camera) may play a role in missing very small effects. We rule out that it relates to 
lack of sensitivity of the Twitch2B probe because we show it is capable of following the 
modulation (lowering) of the resting concentration of cytosolic calcium (Figure 4).
The observed effects of the sensor type for sensors with similar dissociation constants 
can be explained by differences in the cooperative binding of calcium. Sensors with a Hill 
coefficient >1 have smaller ratio changes at calcium levels below their K
d
 because of the 
sigmoidal shape of the calcium binding curve. We have confirmed this by comparing the 
calcium affinity curves of Twitch2B and YC3.6. The Rmin of Twitch2B was found to be well 
below the resting calcium level of the HEK293 cells, while the YC3.6 sensor did not show a 
clear decrease in Rmin after chelating all calcium ions. With a sensitivity range that includes 
the resting values, the Twitch2B sensor is sensitive to minor changes in calcium. This makes 
it well suited for relatively weak responses to receptor agonists or inverse agonists as in 
case of bitter receptors. Furthermore, it has a more linear ratio increase so that it is less 
biased for a certain concentration range. 
Twitch2B may be less suitable for detecting calcium dynamics above 300 nM (as observed 
for some hormone receptors or ion channels) because, in that range, the sensor will 
become saturated (Figure 5 and [205]). YC3.6 may not be a good alternative for such 
receptors either, but other probes might be considered with a K
d
 in the range of >400 nM 
[91, 224, 225]. Twitch2B may also be less suitable for application in ion-channel arrays 
since “leaky” calcium ion-channels can increase the resting levels of calcium within the 
cells [226]. Consequently, depending on the expected calcium signalling range, a well-
considered choice of calcium sensor type has the potential to improve the sensitivity of the 
measurements although the linearity of the response from the resting level up (or down) is 
always an issue that should be taken into account. 
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Conclusion
Overall, we conclude that by choosing sensor Twitch2B in a bitter receptor array, we could 
enhance the sensitivity of bitter taste receptor arrays up to 60-fold compared to the more 
standard YC3.6. The response height increased 5-10 fold when the sensor concentration 
was also optimized. The receptor cell array contained 300 spots and could be exposed 
to a series of 18 injections within one hour. A triplicate experiment lasting three hours 
represents a high throughput analysis comprising 16,200 measurements and thus makes 
receptomics using flow cells a viable alternative to microtiter plate platforms. These 
optimised sensor conditions, together with a flow-through microfluidics format will benefit 
future receptomics experiments involving receptor cell arrays.
Conflict of interests
All authors declare no conflicts of interest. The founding sponsors had no role in the design 
of the study; in the collection, analyses, or interpretation of data; in the writing of the 
manuscript, and in the decision to publish the results.
Funding
This work was supported by the Dutch Topsector Horticulture and Propagation Materials, 
project “HTP phenotyping tomato flavour” KV 1409-025
Acknowledgements
Imaging facilities were offered by the Cell Biology and Immunology Group of Animal 
Sciences at WUR. Data analysis and visualization software was written by Marco van Lenthe 
from BU Biometris, Wageningen University and Research.
Author contributions
Conceptualization: MR, MAJ
Data Curation: MR
Data Analysis: MR, RW 
Funding Acquisition: MAJ
Gene cloning: MGLH, MR
Writing { Original Draft Preparation: MR, RW, MAJ
Writing { Review & Editing: MR, MAJ, RW, MGLH, RDH, RFW
98 Chapter 5 | The effect of calcium buffering and sensor type on bitter receptor assays
Supplemental Figures and Tables
Supplemental Figure 1, Response values of TAS2R8 and TAS2R14 for stimulation with agonist 
mixture (chloramphenicol and picrotoxinin) for both arrays at sensor gene dose of 8, 16 and 25 ng/
µl. Error bars present the 95% confidence interval of the response value. Response values represent 
estimates of treatment-versus-control contrasts with respect to the 1 µM injection. T2B, Twitch2B.
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Supplemental Figure 2, Relation between total DNA and receptor (TAS2R14) coding DNA in the 
print mix. The calcium sensor Twitch2B was added to the mix at 8 ng/µl. PTox, picrotoxinin.
100 Chapter 5 | The effect of calcium buffering and sensor type on bitter receptor assays
Chapter 5 | The effect of calcium buffering and sensor type on bitter receptor assays 101
102 Chapter 5 | The effect of calcium buffering and sensor type on bitter receptor assays
Chapter 5 | The effect of calcium buffering and sensor type on bitter receptor assays 103
Supplemental Figure 3, Response values of TAS2R and mock spots stimulated with alternating 
injected samples. Each series is measured on a separate array. Error bars present the 95% confidence 
interval of the response value. Response values represent estimates of treatment-versus-control 
contrasts with respect to the blank injection. Sets with less than 5 spots were excluded. YC- control 
for optical changes (air bubbles, auto-fluorescence etc.) is a deletion mutant of YC3.6 (Δ A332-S392) 
with fixed FRET between CFP and YFP. T2B, Twitch2B, AA, aristolochic acid, CHL, chloramphenicol, 
PTox, picrotoxinin, D-Sal, D-salicin, DB, denatonium benzoate and PROP, 6-n-propylthiouracil.
Supplemental Figure 4, Metabolic exhaustion measurement by ATP exposure at the end of 
each injection series. ATP responses were compared to the blank for all bitter receptor spot types 
combined with either Twitch2B (A) or YC3.6 (B) for the three arrays. Array 1 was exposed to 10µM 
ATP for and Array 2 and 3 to 5 µM ATP. Array 1 featured alternating injections of D-salicin and 
picrotoxinin which activated TAS2R16 and TAS2R14/TAS2R46. Array 2 featured alternating injections 
of chloramphenicol and PROP which activated TAS2R8/TAS2R46 and TAS2R38PAV. Array 3 featured 
alternating injections of Aristocholic acid and denatonium benzoate which activated TAS2R43 and 
TAS2R8/TAS2R10/TAS2R46. Error bars show a 95% confidence interval for the response estimates.
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Supplemental Table 1, Bitter taste receptor genes
Bitter 
receptor
Alter-
native 
name
Uniprot 
listed 
natural 
variants
Uniprot 
code* 
Variant 
used 
in this 
study
Amino acid sequence used in this study 
with variant positions highlighted**
TAS2R1 TRB7 R111H, 
C141Y, 
R206W
Q9NYW7 111R, 
141C, 
206R
MLESHLIIYFLLAVIQFLLGIFTNGIIV
VVNGIDLIKHRKMAPLDLLLSCLAVS
RIFLQLFIFYVNVIVIFFIEFIMC
SANCAILLFINELELWLATWLGVFY
CAKVASVRHPLFIWLKMRISKLVPWMILG
SLLYVSMICVFHSKYAGFMVPYFLRK
FFSQNATIQKEDTLAIQIFSFVAEFSVPL
LIFLFAVLLLIFSLGRHTRQMRNTVAGS
RVPGRGAPISALLSILSFLILYFSHC
MIKVFLSSLKFHIRRFIFLFFILVIGIYPS
GHSLILILGNPKLKQNAKKFLLHSKCCQ
TAS2R3   Q9NYW6  MMGLTEGVFLILSGTQFTLGIL
VNCFIELVNGSSWFKTKRMSLSDFIIT
TLALLRIILLCIILTDSFLIEFSPNTHDS
GIIMQIIDVSWTFTNHLSIWLATCLGVL
YCLKIASFSHPTFLWLKWRVSRVMVWM
LLGALLLSCGSTASLINEFKLYSVFR
GIEATRNVTEHFRKKRSEYYLIHVLGTL
WYLPPLIVSLASYSLLIFSLGRHTRQM
LQNGTSSRDPTTEAHKRAIRIILSFFFLFL
LYFLAFLIASFGNFLPKTKMAKMIGEVMT
MFYPAGHSFILILGNSKLKQTFVVMLRCES
GHLKPGSKGPIFS
TAS2R4  R3Q, F7S, 
F62L, 
T74M, 
V96L, 
S171N, 
I191V
Q9NYW5 (SLN) 3R, 
7S, 62F, 
74T,96L, 
171N , 
191I and 
MLRLFYSSAIIASVILNFVGIIMNLFITV
VNCKTWVKSHRISSSDRILFSLGITRFLM
LGLFLVNTIYFVSSNTERSVYLSAFFV
LCFMFLDSSSLWFVTLLNILYCVKITN
FQHSVFLLLKRNISPKIPRLLLACVLIS
AFTTCLYITLSQASPFPELVTTRNNTSFNI
NEGILSLVVSLVLSSSLQFIINVTSASLLI
HSLRRHIQKMQKNATGFWNPQTEAHVGAM
KLMVYFLILYIPYSVATLVQYLPFYAGMD
MGTKSICLIFATLYSPGHSVLIIITHPKLK
TTAKKILCFKN
TAS2R4  R3Q, F7S, 
F62L, 
T74M, 
V96L, 
S171N, 
I191V
Q9NYW5  (FVS) 3R, 
7F, 62F, 
74T,96V, 
171S, 
191I
MLRLFYFSAIIASVILNFVGIIMNLFITV
VNCKTWVKSHRISSSDRILFSLGITRFLM
LGLFLVNTIYFVSSNTERSVYLSAFFV
LCFMFLDSSSVWFVTLLNILYCVKITN
FQHSVFLLLKRNISPKIPRLLLACVLIS
AFTTCLYITLSQASPFPELVTTRNNTSF
NISEGILSLVVSLVLSSSLQFIINVTSASL
LIHSLRRHIQKMQKNATGFWNPQTEAH
VGAMKLMVYFLILYIPYSVATLVQYLP
FYAGMDMGTKSICLIFATLYSPGHSVLII
ITHPKLKTTAKKILCFKN
Chapter 5 | The effect of calcium buffering and sensor type on bitter receptor assays 105
Bitter 
receptor
Alter-
native 
name
Uniprot 
listed 
natural 
variants
Uniprot 
code* 
Variant 
used 
in this 
study
Amino acid sequence used in this study 
with variant positions highlighted**
TAS2R8 TRB5 M308V Q9NYW2 308M MFSPADNIFIILITGEFILGILGNGY
IALVNWIDWIKKKKISTVDYILTNLVIARI
CLISVMVVNGIVIVLNPDVYTKNKQQIV
IFTFWTFANYLNMWITTCLNVFYFLKI
ASSSHPLFLWLKWKIDMVVHWILLG
CFAISLLVSLIAAIVLSCDYRFHAIAKH
KRNITEMFHVSKIPYFEPLTLFNLFAIVP
FIVSLISFFLLVRSLWRHTKQIK
LYATGSRDPSTEVHVRAIKTMTSFIFFFF
LYYISSILMTFSYLMTKYKLAVEFGEIAAI
LYPLGHSLILIVLNNKLRQTFVRMLTCRK
IACMI
TAS2R10 TRB2 M156T Q9NYW0 156M MLRVVEGIFIFVVVSESVFGVLGNG
FIGLVNCIDCAKNKLSTIGFILTGLAIS
RIFLIWIIITDGFIQIFSPNIYASGNLIEY
ISYFWVIGNQSSMWFATSLSIFYFLKIAN
FSNYIFLWLKSRTNMVLPFMIVFLLISSLL
NFAYIAKILNDYKMKNDTVWDLNMYKSEY
FIKQILLNLGVIFFFTLSLITCIFLIIS
LWRHNRQMQSNVTGLRDSNTEAHVKAM
KVLISFIILFILYFIGMAIEISCFTVREN
KLLLMFGMTTTAIYPWGHSFILILGNSK
LKQASLRVLQQLKCCEKRKNLRVT
TAS2R14 TRB1 T86A, 
L201F
Q9NYV8 86T, 
201L, 
R299K
MGGVIKSIFTFVLIVEFIIGNLGNS
FIALVNCIDWVKGRKISSVDRILTALAIS
RISLVWLIFGSWCVSVFFPALFATEKM
FRMLTNIWTVINHFSVWLATGLGTFY
FLKIANFSNSIFLYLKWRVKKVVLV
LLLVTSVFLFLNIALINIHINASINGYRRN
KTCSSDSSNFTRFSSLIVLTSTVFIFIP
FTLSLAMFLLLIFSMWKHRKKMQHTVKIS
GDASTKAHRGVKSVITFFLLYAIFSLS
FFISVWTSERLEENLIILSQVMGMAYP
SCHSCVLILGNKKLRQASLSVLLWLKYM
FKDGEPSGHKEFRESS
TAS2R16  V101M, 
I114V, 
L116P, 
P161S, 
N172K, 
Q177P, 
N216D, 
A221V, 
R222H, 
V235M, 
F240V
Q9NYV7 101V, 
114I, 
116L, 
161P, 
172N, 
177Q, 
216N, 
221A, 
222H, 
235V, 
240F
MIPIQLTVFFMIIYVLESLTIIVQSSLIV
AVLGREWLQVRRLMPVDMILISLGIS
RFCLQWASMLNNFCSYFNLNYVLCNL
TITWEFFNILTFWLNSLLTVFYCIKVSS
FTHHIFLWLRWRILRLFPWILLGSL
MITCVTIIPSAIGNYIQIQLLTMEHLPRN
STVTDKLENFHQYQFQAHTVALVIPFIL
FLASTIFLMASLTKQIQHHSTGHCNPS
MKAHFTALRSLAVLFIVFTSYFLTIL
ITIIGTLFDKRCWLWVWEAFVYAFILM
HSTSLMLSSPTLKRILKGKC
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Bitter 
receptor
Alter-
native 
name
Uniprot 
listed 
natural 
variants
Uniprot 
code* 
Variant 
used 
in this 
study
Amino acid sequence used in this study 
with variant positions highlighted**
TAS2R38 TAS2R61 A49P, 
V262A, 
I296V
P59533 (PAV)49P, 
262A, 
296V
MLTLTRIRTVSYEVRSTFLFISVLEFAVG
FLTNAFVFLVNFWDVVKRQPLSNSDCVLL
CLSISRLFLHGLLFLSAIQLTHFQKLSE
PLNHSYQAIIMLWMIANQANLWLAACLSL
LYCSKLIRFSHTFLICLASWVSRKISQM
LLGIILCSCICTVLCVWCFFSRPHFTVT
TVLFMNNNTRLNWQIKDLNLFYSFLF
CYLWSVPPFLLFLVSSGMLTVSLGRHMRT
MKVYTRNSRDPSLEAHIKALKSLVSFF
CFFVISSCAAFISVPLLILWRDKIGVM
VCVGIMAACPSGHAAVLISGNAKLRRAVM
TILLWAQSSLKVRADHKADSRTLC
TAS2R38 TAS2R61 A49P, 
V262A, 
I296V
P59533 (AVI) 
49A, 
262V, 
296I
MLTLTRIRTVSYEVRSTFLFISVLEFAVG
FLTNAFVFLVNFWDVVKRQALSNSDCVLL
CLSISRLFLHGLLFLSAIQLTHFQKLSE
PLNHSYQAIIMLWMIANQANLWLAACLSL
LYCSKLIRFSHTFLICLASWVSRKISQM
LLGIILCSCICTVLCVWCFFSRPHFTVT
TVLFMNNNTRLNWQIKDLNLFYSFLF
CYLWSVPPFLLFLVSSGMLTVSLGRHMRT
MKVYTRNSRDPSLEAHIKALKSLVSFF
CFFVISSCVAFISVPLLILWRDKIGVM
VCVGIMAACPSGHAAILISGNAKLRRAVM
TILLWAQSSLKVRADHKADSRTLC
TAS2R39 TAS2R57 S193F, 
K197E
P59534 193S, 
197K, 
A301T
MLGRCFPPDTKEKQQLRMTKLCDPAE
SELSPFLITLILAVLLAEYLIGIIANGFI
MAIHAAEWVQNKAVSTSGRILVFLSVS
RIALQSLMMLEITISSTSLSFYSEDAVY
YAFKISFIFLNFCSLWFAAWLSFFYFVKI
ANFSYPLFLKLRWRITGLIPWLLWLSVFIS
FSHSMFCINICTVYCNNSFPIHSSNSTKK
TYLSEINVVGLAFFFNLGIVTPLIMFIL
TATLLILSLKRHTLHMGSNATGSNDPS
MEAHMGAIKAISYFLILYIFNAVALFI
YLSNMFDINSLWNNLCQIIMTAYPASHSIL
LIQDNPGLRRAWKRLQLRLHLYPKEWTL
TAS2R43 TAS2R52  P59537 35S, 
212R
MITFLPIIFSSLVVVTFVIGNFANGFI
ALVNSIESFKRQKISFADQILTALAVS
RVGLLWVLLLNWYSTVLNPAFNSVEVRT
TAYNIWAVINHFSNWLATTLSIFYLLKI
ANFSNFIFLHLKRRVKSVILVMLLGPLL
FLACHLFVINMNEIVRTKEFEGNMTWK
IKLKSAMYFSNMTVTMVANLVPFTLTLLS
FMLLICSLCKHLKKMQLRGKGSQDPST
KVHIKALQTVISFLLLCAIYFLSIMISVWS
FGSLENKPVFMFCKAIRFSYPSIHPFILIW
GNKKLKQTFLSVFWQMRYWVKGEKTSSP
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Bitter 
receptor
Alter-
native 
name
Uniprot 
listed 
natural 
variants
Uniprot 
code* 
Variant 
used 
in this 
study
Amino acid sequence used in this study 
with variant positions highlighted**
TAS2R46 TAS2R54 L228M P59540  228L MITFLPIIFSILIVVTFVIGNFANG
FIALVNSIEWFKRQKISFADQILTA
LAVSRVGLLWVLVLNWYATELNPAFN
SIEVRITAYNVWAVINHFSNWLATSLSI
FYLLKIANFSNLIFLHLKRRVKSVVL
VILLGPLLFLVCHLFVINMNQIIWTKEYEG
NMTWKIKLRSAMYLSNTTVTILANLVP
FTLTLISFLLLICSLCKHLKKMQLHG
KGSQDPSMKVHIKALQTVTSFLLLCAI
YFLSIIMSVWSFESLENKPVFMFCEAIAF
SYPSTHPFILIWGNKKLKQTFLSVLWHVRY
WVKGEKPSSS
*https://www.uniprot.org
** variants include known and unpublished amino acid mutations (in bold)
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Abstract
Data analysis for flow-based in-vitro receptomics array, like a tongue-on-a-chip, is 
complicated by the relatively large variability within and between arrays, transfected DNA 
types, spots, and cells within spots. Simply averaging responses of spots of the same type 
would lead to high variances and low statistical power. This paper presents an approach 
based on linear mixed models, allowing a quantitative and robust comparison of complex 
samples and indicating which receptors are responsible for any differences. These models 
are easily extended to take into account additional effects such as the build-up of cell stress 
and to combine data from replicated experiments. The increased analytical power this 
brings to receptomics research is discussed.
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Introduction
Receptomics research with microfluidic receptor cell arrays aims to measure purely 
biological responses without a complicated biological system surrounding it [95, 227, 228]. 
For example, the human tongue can be emulated on a chip by an array containing G-protein 
coupled receptors (GPCRs), e.g., in the form of reconstituted receptor proteins [229] or 
vesicles [230]. Another possibility is formed by living cells expressing the genes coding for 
particular GPCRs, produced by either reverse-transfecting a generic cell line on the chip [100] 
or spotting pre-transfected cells [94]. Such a tongue-on-a-chip allows direct access to the 
original taste signal, before the signal is further transmitted via neurons, and processed 
and interpreted by the human brain. Thus, while a taste panellist would define a sample as 
bitter or sweet, a tongue-on-a-chip provides direct quantitative information on which taste 
receptors are triggered, and by how much. On a more general level, receptomics enables 
identifying compounds or extracts activating or blocking specific receptors active in taste 
sensation as well as in many other processes. Humans have a wide palette of receptor 
proteins. Even considering only GPCRs there are more than 800 receptors for the detection 
of hormones, neurotransmitters, tastants, odorants, and others. Since all receptors play 
an important role in human physiology, there is an advantage to a receptomics approach 
aiming at combining different receptors on a single chip, allowing the researcher to study 
the role of a compound or extract in a wider perspective by including all or at least the most 
relevant receptors.
However, data analysis for flow-based in-vitro biosensor arrays such as a tongue-on-a-chip 
is complicated by the relatively large variability in specific and non-specific responses within 
and between arrays caused by differences in the expression of the transfected receptor 
DNA, variability in spots and in cells within spots. Approaches based on simply averaging 
the response values of spots of the same type therefore lead to estimates with a large 
variability, allowing only the most obvious differences between samples to be detected and 
providing no means to correct for other effects often seen in flow-cell based approaches 
such as time or memory effects. Furthermore, chemically complex samples may trigger 
host-cell responses that vary widely between receptor types, depending on unknown 
interactions with the functional properties of the transfected DNA [231]. To eliminate such 
host-cell responses often hampering the analysis, one may dilute the sample until the host-
cell response is no longer observed, but that often also means losing a large part or even 
all of the signal.
Here, we are focusing on microfluidic receptomics chips containing receptor cell arrays 
generated by reverse transfection of DNA arrays and with ectopic expression of different 
GPCRs and a generic calcium-ion sensor protein, Twitch2B [100, 205]. The chips were printed 
with plasmid DNA encoding a GPCR gene and a calcium sensor gene. Transient expression 
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of the genes was achieved by reverse transfection: HEK293 cell were seeded on top of the 
DNA array, the DNA was taken up and the genes were expressed leading to G-protein-
coupled receptors embedded in the cell membrane and calcium sensor accumulation in the 
cytoplasm. Upon stimulation of the receptor with a ligand, the GPCR signal transduction 
pathway is activated via Gα
16GUST44
 [75]. Activation of this chimeric G-protein leads to a 
transient rise in calcium ion concentration within the cytoplasm. These calcium dynamics 
can be measured using ratiometric calcium sensors that are based on the FRET pair CFP and 
YFP connected by a calcium binding domain.
The principle of the sensor is depicted in Fig 1. Since the array can contain hundreds of 
spots, it is possible to accommodate many different receptors and at the same time have a 
relatively large number of spots for each receptor type, leading to more precise estimates. 
For each spot on the array, fluorescence time series are measured at two different 
wavelengths which are, in a series of steps, transformed in response values for each spot 
upon exposure to a sample [100]. The goal of the statistical analysis, the main focus of this 
paper, is to be able to unambiguously and objectively discriminate between samples in 
terms of receptors affected.
Material and Methods
Cell array experiments
Reverse-transfected cell arrays were prepared and measured as previously described 
in [100]. The genes encoding bitter receptors were obtained from genomic DNA by PCR 
amplification and cloned into pcDNA3 containing the N-terminal sstr3 tag (gift from Dr. 
Wolfgang Meyerhof, German Institute of Human Nutrition Potsdam-Rehbrücke, Germany). 
Plasmid pcDNA3 Twitch2B (Addgene #49531 [205]) was added to the print solution to enable 
ratiometric calcium detection. The arrays contained 24 individual bitter taste receptors, 
including SNP variants TAS2R4-SLN and -FVS, TAS2R38-PAV and -AVI, and TAS2R39-A and 
-T. For a complete overview, see  – in the remainder of this paper, the TAS2 prefix will be 
deleted for clarity. These receptors were placed randomly on the array, to avoid location 
and neighbour effects. Each print mix contained 75 ng/μl receptor-coding plasmid DNA and 
10 ng/μl calcium-sensor-coding plasmid DNA. The low level of sensor expression obtained 
this way prevented buffering of the calcium ions by the sensor itself. Two additional controls 
were printed; one control without receptor-coding DNA but an empty vector instead 
(Mock), and one control without receptor-coding DNA but with a modified calcium sensor 
protein that lacks the ability to bind calcium. This control, named YC-, has a YFP/CFP ratio 
independent of the intracellular calcium concentration. Any environmental influences on 
the spectral properties of the fluorescent calcium probe will be detected by this control, as 
will be fluorescence coming from the sample itself.
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Reverse-transfected cell arrays were prepared using HEK293 cells stably transfected with 
Gα
16GUST44
 (a gift from Dr. Takashi Ueda, Nagoya City University, Nagoya, Japan). At 48 
hours after transfection, the cell arrays were removed from the incubator, washed and 
incubated in assay buffer for 1 hour prior to the measurements. All measurement series 
were performed using a 150 μl flowcell and the flowcell holder (Micronit Microfluidics 
B.V., Fluidic Connect PRO Chip Holder.) The assay buffer (NaCl 130mM, KCl 5mM, Glucose 
10mM, CaCl
2
 2mM, HEPES 10mM at pH 7.4) was set to a continuous flow of 300 μl/min over 
the array. The injections were performed with a manual valve containing a 150 μl sample 
loop. Reagents used in the injections were Adenosine 5’-triphosphate (ATP, Sigma A6419), 
Chloramphenicol (Duchefa C0113.0100), Picrotoxinin (Sigma P8390), 6-propyl-2-thiouracil 
Figure 1, The receptomics principle used in this paper. The microfluidic system A allows sequential 
injections of samples into the flowcell. The fluorescence microscope in B captures CFP- and YFP-
FRET images of the entire cell array that can be analysed to give average values for the YFP/CFP 
fluorescence ratio. C The spots of the array are composed of approximately 50 fluorescent cells, 
each transfected with a receptor-coding gene and a fluorescent calcium sensor coding gene. Both 
receptor and sensor are expressed in each fluorescent cell of an array spot D. Each spot on the 
array expresses a different receptor type. When the receptor interacts with a ligand, the Gα
16GUST44
 
signalling cascade is activated: the Gα protein acts via Phospholipase C (PLC) to convert PIP
2
 into 
second Messenger IP
3
 which can interact with IP
3
 receptors (IP
3
R) on the Endoplasmic Reticulum 
(ER). The IP
3
R are calcium ion channels which, when activated, transiently release calcium into the 
cytoplasm. The Twitch2B calcium sensor, expressed in the cytoplasm, is a fluorescent FRET probe 
which, upon binding of calcium ions, changes conformation and thereby increase the FRET efficiency 
between the CFP and YFP fluorescent proteins. These FRET changes are captured by the camera as a 
ratio change of CFP and YFP intensities.
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PROP (Sigma P3755) and D-Salicin (Wacko 199-00083). The time between injections was 
set to approximately 5 minutes, allowing the intracellular calcium levels in the solution to 
return to pre-injection values.
Image analysis
Upon stimulus by their respective ligands, receptors will induce a signal transduction 
leading to an increased calcium ion concentration in the cytosol. This can be monitored in 
real time by means of FRET (Förster Resonance Energy Transfer) imaging [100], here using a 
Leica fluorescent stereo microscope (Leica M205FA with DFC 345 FX camera). Two channels 
were monitored, CFP (ET CFP 10447409, excitation 436/20 and emission 480/40) and YFP 
(ET FRET 10450566, excitation 436/20 and emission 535/30), respectively. Note that CFP 
and YFP images are taken alternatingly and therefore have different time points. The 
CellProfiler software package [185] was used to separate signal pixels from the background 
to define a grid corresponding with the positions of the spots and to quantify the raw CFP 
and YFP signals. 
Pre-processing
Processing the images leads to a data table containing, for each of the spots, the CFP and YFP 
signals for each measurement cycle. As a first pre-processing step, the data are corrected 
for fluctuations in the lamp output using a reference position outside the flowcell. Next, 
spots containing fewer than fifteen pixels are removed from the data. Receptor types that 
are represented by fewer than five spots are removed altogether. The CFP and YFP signals 
are then smoothed using cubic smoothing splines [232]. The signal of each spot, related to 
the calcium concentration in the cell, is now defined as the ratio of the interpolated CFP 
and YFP signals at specific time points. An example showing CFP and YFP data (after lamp 
correction) for one spot, as well as the derived spot signal, is shown in S1 Fig.
Next, this spot signal is used to calculate the response of a spot to a sample injection. 
This can be done in several different ways: since spot signals often show peak-like shapes, 
obvious candidates are peak height and peak area. Here, we focus on the the increase or 
decrease of a spot signal after the injection, given by the ratio of the extreme value of 
the signal (within a certain time window), and the average of the first three signal values 
directly after the injection. In this case, the time window is chosen to cover 30 cycles 
(approx. 1,5 minutes) directly after the sample introduction, corresponding to the time the 
cells are exposed to the sample. An example is provided by S2 Fig. In this way, a data matrix 
is obtained that describes the quantitative response of each spot to each sample injection, 
independent of the initial signal strength.
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Statistical modelling
Qualitative analysis - To obtain an easily interpretable overview of the differences between 
samples for which multivariate responses are available, Principal Component Analysis 
(PCA [233, 234]) is often used. In PCA, a high-dimensional data matrix is reduced to a 
much lower number of dimensions (for visualization purposes usually two) that contains 
the maximum amount of information. Each new dimension is a linear combination of the 
original variables. So-called score plots show the position of the samples in this reduced 
space; loading plots show the weights of the original variable on the new axes, i.e., which of 
the original variables are important in each new direction. Quantitative statements about 
significant differences between injections cannot be made with PCA. In a context where 
samples are compared to see whether they lead to different taste receptor responses PCA 
therefore is of limited value, and a statistical model is needed.
Mixed models - Here, we are interested in assessing which samples differ significantly from 
each other, and which receptor types are responsible for any observed differences. Our 
approach is based on linear mixed models [235]. In the simplest form, one fits a model 
describing the spot response R with receptor and sample as (fixed) variables, also including 
the interaction between the two. Additional fixed variables could include the injection 
number, to account for any trends in sensitivity over time, and array number, when 
combining several replicated experiments in one analysis. To take account of the fact that 
every spot will have its own characteristics, the spots have to be part of the model, too. 
In order to avoid estimation of individual coefficients for all spots, which would consume 
valuable degrees of freedom, one can include spots as a so-called random variable. That is, 
one assumes that the spot effects follow a normal distribution around zero, and the only 
parameter that is estimated is the width of the distribution, implying that observations on 
the same spot are correlated rather than independent. This leads to the following model 
(in matrix notation):
y=Xβ+Zu+ε
where y is the vector of spot responses to sample injections, β contains the coefficients for 
all fixed variables, and u contains the random effects associated with the individual spots. X 
and Z are design matrices relating the responses to the values of the independent variables: 
i.e. X contains information about the sample type, receptor type and possibly injection 
number and array number, and Z describes the receptor types present at all spots. Finally, 
ε is the vector of residuals. The model is fit, as is common practice, through restricted 
maximum likelihood (REML) [235].
Contrasts - Once the model is obtained, it can be used to estimate the expected response of 
a particular type of receptor to a particular sample (so-called estimated marginal means). 
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By focusing on differences of these estimates for individual spots, the differences between 
the spots are eliminated, removing a major source of irrelevant variation and leading to 
much narrower confidence intervals and increased statistical power. Such differences 
are called contrasts, and can be defined in a number of ways. In treatment-versus-control 
contrasts, for example, one of the injection types is used as a control, and the magnitude 
of the results of the other injection types (usually the study samples) is related to this. In 
this way one can quantitatively assess which receptors show different responses to the 
injection of different samples.
Scaling of the response variable - Although the mixed models can be fitted for the 
intensity ratio described above and shown in S2 Fig, it is more appropriate to use a log-
scaled intensity ratio as the response variable. Comparing samples then will (after back-
transformation) lead to ratios of ratios: a value of 1 corresponds to no change in intensity 
ratio, values lower than 1 correspond to a decrease in intensity ratio, and values higher 
than 1 to an increase. In this way a treatment-versus-control contrast can be expressed in 
terms of simple ratios of the original CFP and YFP responses, which would not have been 
possible if we would have analysed the intensity ratio data without the log transformation. 
The variance-stabilizing effect of the log transform is less important here since all intensity 
ratios are relatively close to one; for other response variables with heteroscedastic residual 
variance, this could be an important reason to employ the log transform.
Software
All statistical analyses described in this paper have been performed using R [236], using 
packages nlme [237] for fitting the mixed models, emmeans [238] for obtaining estimated 
marginal means, contrast estimates and confidence intervals, and lattice [239] for generating 
plots. R scripts and data to reproduce the results in this paper are available in S1 Code, S1 
Data, and S2 Data, respectively.
A stable version of the analysis scripts using defaults also used in this paper has been 
included in our “Receptomics” software, which provides an intuitive and powerful user 
interface allowing inspection of raw data, elimination of bad data points, choice of model 
(“raw” effect sizes or treatment-versus-control contrasts), and inspection of the outcome 
of the statistical modelling. For more information about this software, see http://www.
receptomics.com.
Data
Three experiments, each executed three times, serve to illustrate our approach. In the first 
type of experiment (A), a quality control (QC) mixture of four compounds, chosen because 
they are known to hit specific bitter receptors, was injected at nine different dilutions (see 
Table 1). The sample with the lowest concentration was injected first; each subsequent 
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injection had a double concentration of the QC mixture. In addition, a blank injection, and a 
2 μM ATP injection were performed. The ATP injection elicits a host-cell response, different 
for each receptor type. The second type of experiment (B) was set up to compare 2 μM 
ATP injections with injections where the ATP sample was spiked with the same QC mixture 
as in (A). Also here a blank injection (containing only assay buffer) was included. This 
experiment is a simple example of a case where a specific response should be estimated in 
the presence of a constant background (the host-cell response). Table 2 gives an overview 
of the injections in both experiment types.
Results
Experiment A
Experiment type A investigates spot responses to exposure to a dilution series, and was 
executed three times, using three identical arrays. The QC 8 injection in the first replication 
(experiment A1) did not succeed, so data for that particular dilution are missing. The PCA 
score plots for the three replicated experiments are shown in Fig 2. One can clearly see 
Table 1, QC mixture and target receptors, in order of expected sensitivity [33]. Concentrations 
of compounds in the A-type experiments correspond to the most concentrated sample. The 
concentrations of the QC mixture in the B experiments correspond for all compounds but D-Salicin 
to QC 2 in the A experiments.
Spike Exp A (μM) Exp B (μM) Affected receptors
Chloramphenicol 500 250 R8 > R46 > R1, R10, R43 
> R39
Picrotoxinin 500 250 R14 > R46 > R1, R10
D-Salicin 10,000 1,000 R16
PROP 20 10 R38 PAV
Table 2, Injections for experiments A and B. The numbers after “QC” in Experiment (A) indicate the 
dilution factors: samples have been injected in order of increasing concentration.
Injection Experiment (A) Experiment (B)
1 Blank Blank
2 QC 256 QC
3 QC 128 ATP 2uM
4 QC 64 ATP 2uM+QC
5 QC 32 ATP 2uM
6 QC 16 ATP 2uM+QC
7 QC 8 ATP 2uM
8 QC 4 ATP 2uM+QC
9 QC 2 ATP 2uM
10 QC 1 QC
11 ATP 2uM
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the trend of more concentrated QC injections going away from the blank injection, while 
the ATP injection is in a completely different part of the PCA space. The corresponding 
loading plots, shown in S3 Fig, indicate which variables are involved in the first two PCA 
dimensions. Although some of the receptors, e.g., R8 and R14, seem to be important in 
PC2, the direction of increasing QC concentrations, the loading plots are hard to interpret 
because of the large number of variables and the fairly large variation, also within spots of 
the same receptor type.
More quantitative results are obtained with the mixed-models approach, presenting 
for each receptor type an estimate of the response to the different injections, including 
standard deviations and confidence intervals. By considering the treatment-versus-control 
contrasts, variability between spots is eliminated. These contrasts, estimated from the 
model combining the three arrays in one single analysis, are shown in Fig 3. The Blank 
injection is used as the control. In this figure, significant effects, not including the value 
of 1 in the confidence interval, are shown in red. In total, 42 significant effects are found. 
Going from top to bottom in each panel, concentrations of the QC mixture increase (i.e., 
dilution factors become lower) leading to larger responses for several of the receptors. 
Although the individual arrays show some small differences, the general patterns are very 
similar. Very clear responses are seen for receptors R8, R14, and R16, at somewhat higher 
concentrations also for R10, R38 PAV and R46L. All of these receptors are present in Table 1; 
receptors R1 and R39, also mentioned in the table, only show a significant response at 
the highest concentration. Note that some other receptors not present in Table 1 seem to 
respond, too – this may be a genuine response, since not for all receptors it is fully known 
what triggers them. The full results of the analysis of the individual arrays can be found in 
the supplementary material, S4 Fig – S6 Fig.
Figure 2, PCA score plots for the three replicated experiments, type A. Dots correspond to 
injections. In all three cases, the ATP injections lie in the top right corner, and the blank injections in 
the top left corner. Injections of the QC mixture move away from the blank injection with increasing 
concentrations.
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Figure 3, Control-versus-treatment contrasts from the joint analysis of the three type-A 
experiments. Each panel shows the estimated contrasts and associated 95% confidence intervals of 
a particular receptor. Contrasts are the ratio between the model response for a particular injection, 
and the reference injection, here the blank. Only the injections of the QC mixture are shown here 
to stress the pattern of increasing response with increasing concentration (from top to bottom, 
corresponding to decreasing dilutions indicated with the numbers on the y axis). Significant results, 
not including the baseline value of 1.0 in the confidence interval, are shown in red. For several 
receptors, e.g., R8 and R14, we see a clear relation between response and increasing concentration.
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Experiment B
In Experiment B the goal is to distinguish between two types of injections, both containing 
a large host-cell response. This host cell response, independent of the transfected receptor, 
is set up by means of a sample containing ATP. One type of injection consists of the ATP 
sample; the other adds to this the QC mixture also employed in Experiment A, so that 
both a generic host-cell response and specific receptor-specific responses are elicited. 
The statistical model then should indicate which receptors show significant differences 
between the two types of injections.
The PCA score plots are shown in Fig 4. In all three replicated experiments, the four injection 
types (Blank, QC only, ATP only, and ATP plus QC) are located in four different quadrants. 
Clearly, it is possible to distinguish between the injection types: the first PC distinguishes 
on the basis of the presence or absence of ATP; the second PC does the same for the QC 
mixture. However, when looking at the loading plots (see S7 Fig) it is not at all clear which 
receptors are involved. The two most responsive receptors to the QC mixture, R8 and R14, 
are the ones with the biggest loadings on PC2, but we see appreciable differences, also 
within one type of receptor. 
To be able to concentrate on the most relevant results only, the linear mixed models 
are constructed using only the ATP and ATP+QC injections, leaving out the Blank and QC 
injections. Peak number is included as a (numerical) variable, allowing a trend over time. 
This is necessary: in the score plots of Fig 4 the effect of the injection order is clearly visible. 
Later injections of the same type tend to have higher values on the PC2 axis.
The results for the first of the three experiments, B1, are shown in Fig 5. The two left 
panels show the estimated response values, basically averages of model predictions for the 
two different injection types, for all receptors. It is remarkable to see how the responses 
to the ATP injections vary widely between host cells carrying different bitter receptors. 
Perhaps even more surprising is the fact that the response of the Mock receptor to ATP is 
the strongest of all. The right panel in Fig 5 shows the treatment-versus-control contrast 
calculated by the mixed model, where the ATP 2uM injection is the reference. Since the 
comparisons are effectively made within each spot, the confidence intervals for the contrasts 
are much more narrow than the confidence intervals for the estimated responses, leading 
to increased statistical power. In total, 10 significant treatment-versus-control contrasts, 
not including the value of 1 in the confidence interval, are found here. Note that for both 
control receptors, Mock and YC-, the contrasts are not significant, indicating that the model 
has effectively eliminated the very large host-cell response component to ATP.
The estimated contrasts and confidence intervals for the three replicated B experiments 
are shown in the top panels of Fig 6. Even though the ATP leads to a large signal, varying 
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in size depending on the type of the receptor, the analysis is able to identify the effects of 
the QC mixture on all receptors mentioned in Table 1 – six receptors, R8, R10, R14, R16, 
R38 PAV and R46L seem to stand out in particular. The joint analysis of the ATP-containing 
injections for the three experiments is shown in S8 Fig The two control receptors, Mock and 
YC-, overall have non-significant effects, as expected.
Figure 5, Estimates and 95% confidence intervals for the first B-type experiment. The panels on the 
left show the estimated responses and associated confidence intervals of all receptors to injection 
types. The right panel shows the corresponding spot-wise ratios, the treatment-versus-control 
contrasts. Significant results, not including 1.0 in the confidence interval, are indicated in red. Note 
that the confidence intervals in the right panel are much more narrow than those in the left two 
panels since the between-spot variation is taken out of the equation.
Figure 4, PCA score plots for the three replicated experiments, type B. Dots correspond to injections 
– the name of the injection type is followed by the injection number. In all three cases, injections 
without ATP are on the negative side on PC 1; injections without QCs are on the positive side on PC 2. 
There is a clear trend where later injections are located more towards the top left corner of the plot.
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Figure 6, Validation of mixed-model results in the presence of a strong background. The top 
panels show the estimated treatment-versus-control contrasts comparing spiked and non-spiked 
ATP injections. Even though the ATP will lead to a strong signal it is possible to pick up the receptors 
responding to the compounds in the QC mixture mentioned in Table 1. The bottom panels show 
the results of directly comparing the pure QC mixture injections with the blank, so without the ATP 
background signal. The top and bottom rows are generally in good agreement, even though the 
bottom panels show much more variation and wider confidence intervals due to the lower number 
of replicated injections.
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Corresponding results from the model fitted using only the Blank (the reference) and QC 
injections are shown in the bottom panels in Fig 6. Even though this is supposedly a much 
easier task since the large ATP background is absent in this comparison, the results are 
much more variable: the contrast estimates themselves show large variation between 
repeated experiments, and the estimated confidence intervals are much wider. The main 
reason for this is that the replication level is lower: the blank was injected only once, and 
the QC mixture twice. In contrast, there are four non-spiked ATP and three spiked ATP 
injections. Nevertheless, this clearly shows that the mixed model is able to efficiently pick 
up signal also in the presence of a large background. 
Discussion
Data from sensors based on live cells often lead to highly variable results. At the cell level, 
transfection efficiency and cell-cycle differences cause variation in protein expression, 
leading to variation at the spot level. This can be prominent if relatively few cells make up 
a signal on a receptor-cell microarray. In addition, in the analysis of complex samples both 
receptor-specific and generic host-cell responses are often encountered. 
Here, these issues have been tackled in several ways. First of all, the design of the slide is 
important. The high replication of receptors of interest (typically, ten spots are printed for 
all receptor types) leads to more precise estimates. Perhaps even more importantly, a high 
replication provides a safeguard against “bad” spots – we are working with live cells so 
their behaviour is not always predictable. In the pre-processing phase a number of spots 
showing too little signal are typically eliminated. Since one of the main characteristics of 
the analysis pipeline proposed in this paper is to get rid of spot effects, we still should 
have enough spots for each receptor type to do this. For instance, for experiment B1, using 
only half the number of spots would on average lead to a 7% increase in the width of the 
confidence intervals and more variability in the contrast estimates. Note that the current 
array can easily accommodate all our bitter receptors and achieve high replication; it is also 
possible to simply print larger arrays containing more spots.
Secondly, quality control measures can be taken in the pre-processing, before the statistical 
analysis: removing spots represented by too few pixels in the raw images has already been 
mentioned. Sometimes air bubbles prevent spots from being covered by the fluid containing 
the sample – such spots would be flagged manually and removed from the analysis (this was 
not the case in the data presented in this paper). Additional quality control steps can easily 
be integrated if necessary. Thirdly, and the main topic of the current paper, by choosing 
an appropriate statistical model to describe the behaviour of the system very detailed and 
quantitative information can be obtained. The mixed models proposed here allow one to 
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draw conclusions about whether or not two samples are different, and if so, what receptors 
are involved in sensing the differences between the samples. The results are given as tables 
including estimates and confidence intervals, and can be easily visualized. Of particular 
importance is the fact that the variation between spots of the same type, an important 
factor in the overall variability, can be separated from the relevant information by limiting 
the comparisons to be done within spots. In that sense, the mixed-model approach leads 
to more precise and more easily interpretable answers. This is true not only for the flow 
system described here but also in conventional methods using microtiter plates if repeated 
sample exposure could be achieved. Even the presence of a large generic host-cell response 
does not prevent the analysis from obtaining correct and precise results.
The current data-analysis set-up is very flexible and can be changed and adapted in several 
different ways. We can use other response variables, we can use more complicated models, 
or we can combine the results of the current models in a different way.
Other response variables
In this paper, the response of a spot is expressed as a ratio of the initial signal and the 
signal at the top of the peak. Obviously, other measures could have been chosen, such as 
the difference between the two signal values rather than the ratio. This would correspond 
to a simple measure of peak height. For the statistical analysis, however, this would lead 
to heteroscedastic data: high peaks would show much more variability than low peaks, 
necessitating more complex statistical models. A logarithmic transform of peak heights, 
which would at least partially alleviate the effects of such heteroscedasticity, is usually 
not possible since spot responses may be zero or even become lower after sample 
injection, leading to zero or negative peak heights. Therefore, our default is to use the 
log-scaled signal ratios described in this paper. Nevertheless, there may be cases where 
one is explicitly interested in fitting models for peak height. Also other response variables 
could be envisaged, such as the peak area, the degree of tailing of a peak, or the maximal 
steepness of the slope. Finally, in experiments where the timing of the response (early or 
late) is important one could, e.g., consider the time to reach the top of the peak, or to the 
start of the peak, as the response variable.
More complicated statistical models
The statistical model describing the behaviour of the system can be extended easily – this 
is one of the most attractive features of the current approach and a defining difference 
with the usual strategy of simply averaging spots of the same receptor type. One example 
of a simple extension is the linear term describing the decrease in response over a series 
of injections employed in the data from Experiment B. In this paper, we have used one 
slope to describe all spots, but one could actually fit receptor-dependent or even spot-
dependent slopes, or fit non-linear slopes such as an exponential decay. One could take 
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into account interactions between subsequent injections – cells may respond differently 
to a stimulus depending on what happened in the near past. However, more complicated 
models obviously consume more degrees of freedom (and take more calculation time). 
The goal is to obtain an adequate description (using whatever definition appropriate) of 
the behaviour of the system with minimal resources. The set-up used in this paper takes 
a couple of seconds at most using simple every-day hardware, so is eminently usable in 
practice.
More complicated comparisons
We have shown that it is possible to obtain very good results in comparing spiked samples 
with non-spiked samples: the proposed methodology is able to eliminate the common 
background signal (triggered by ATP) from the receptor-specific signals, even though the 
background is the largest component by far. In more general experiments, where the 
differences between the injection types are more complicated than the simple addition of 
a spike mixture, it may not be so easy to remove host-cell responses: in pathological cases 
host-cell responses may completely cancel out receptor-specific responses. It is clear from 
the results in this paper that each receptor spot has a different host-cell response, and 
it is not correct to simply assume that the Mock spots provide a good estimate. We are 
currently exploring ways to disentangle the effects in a general way. 
Conclusion
In the field of receptomics, microfluidic receptor-cell arrays are a valuable tool in investigating 
human responses to food and in trying to understand the relation between chemical 
composition and taste in food stuffs [96, 100]. We have shown that careful experimental 
design, data processing and statistical analysis can lead to highly informative results, 
opening the way to many diverse applications. One particularly interesting possibility is 
to use these cell arrays as extensions of taste panels for pre-screening: in principle, many 
quantitative comparisons can be made in a rapid and cost-effective way. This receptomics 
tool can be further extended to other receptors of the GPCR gene family and ion channels, 
both of humans and other organisms.
Because of the complexity of the underlying biological processes, statistical analysis is 
non-trivial. In this paper, a consistent and robust strategy has been devised, validated and 
implemented in the form of R scripts to achieve maximum flexibility and transferability. On 
top of these scripts, a software package has been built, focusing on the models described in 
this paper, allowing also non-specialists to access the power of the mixed-model analyses, 
thus greatly reducing the time needed to analyse these complex data sets, and ensuring 
reproducibility of the results.
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Supplemental data
Table S1, Overview of bitter raste receptor genes used in the bitter-receptor array. Polymorphism 
variants are indicated with the aminoacid number of the receptor protein and the variable amino-
acid letter code. In brackets the printed polymorphism is shown. The rightmost column contains the 
number of replications on the array.
Receptor number Name Polymorphisms #
1 TAS2R1 10
2 TAS2R3 10
3 TAS2R4 F7S, V96L, S171N (FVS) 10
4 TAS2R4 F7S, V96L, S171N (SLN) 10
5 TAS2R5 10
6 TAS2R7 10
7 TAS2R8 10
8 TAS2R9 10
9 TAS2R10 10
10 TAS2R13 9
11 TAS2R14 10
12 TAS2R16 10
13 TAS2R19 10
14 TAS2R20 10
15 TAS2R30 10
16 TAS2R31 10
17 TAS2R38 A49P, V262A, I296V (PAV) 10
18 TAS2R38 A49P, V262A, I296V (AVI) 10
19 TAS2R39 A301T (A) 10
20 TAS2R39 A301T (T) 10
21 TAS2R40 10
22 TAS2R41 10
23 TAS2R42 10
24 TAS2R43 10
25 TAS2R46 10
26 TAS2R50 10
27 TAS2R60 10
28 Mock 8
29 YC- 8
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Figure S1, Data processing: from CFP and YFP signals to spot signals. The top panel shows the raw 
CFP and YFP signals for spot 21 from the first type-B experiment (a spot of receptor type R8). These 
raw signals are smoothed and interpolated to obtain values for exactly the same time points (shown 
in the middle panel). The final spot signal is calculated as YFP/CFP, and is shown in the bottom panel.
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Figure S2, Definition of the magnitude of the spot response to an injection. The plots depict the last 
three injections of the data also shown in S1 Fig. The magnitude of the spot response is the ratio of 
the extreme point within a time window (here 30 cycles, indicated by the gray vertical lines), and the 
starting value, the average of the first three points.
Figure S3, PCA loading plots for the three replicated experiments, type A. Spots of types R8 and 
R14 are highlighted to show the variability between spots of the same receptor type. For clarity, the 
largest loadings are shown with arrows, smaller ones are shown with dots only.
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Figure S4, Estimated treatment-versus-control contrasts for individual spotmixes in Experiment 
A1. Each panel contains the result of one receptor type; dilutions are given at the y axis, with stronger 
dilutions towards the bottom. Significant contrasts, not containing the value of one in the confidence 
interval, are indicated in red. The blank injection serves as the reference.
Figure S5, Estimated treatment-versus-control contrasts for individual spotmixes in Experiment 
A2. For explanation, see legend of S4 Fig.
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Figure S7, PCA loading plots for the three replicated experiments, type B. Spots of types R8 and 
R14 are highlighted to show the variability between spots of the same receptor type. For clarity, the 
largest loadings are shown with arrows, smaller ones are shown with dots only.
Figure S6, Estimated treatment-versus-control contrasts for individual spotmixes in Experiment 
A3. For explanation, see legend of S4 Fig. 
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Figure S8, Joint analysis of type-B experiments. For explanation, see the caption of Figure 3. The 
reference level is given by the injection type ATP 2uM.
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The receptomics concept as presented in this thesis involves a microfluidic screening 
platform that captures the response of a receptor cell array during sequential exposure 
of samples. This receptor cell array can potentially study the many different membrane 
receptors of an organism, hence the true –omics nature of the technology. In this last 
Chapter, I will elaborate on the current state and potential future development of this 
technology. Furthermore, I will summarize the challenges and the potential solutions to 
overcome these. 
The potential impact of receptomics
As shown in the previous chapters, receptomics holds promise as a high-content receptor 
screening technology with specific advantages compared to currently used screening 
strategies. 
Conventional receptor screening technologies generally involve end-point assays. These 
assay types are currently the gold standard for industrial and pharmaceutical high throughput 
functional receptor screening. An end-point assay can be compared to a single test-tube 
reaction. All ingredients are mixed and the resulting outcome is measured as a “total well” 
response. A typical end-point receptor assay is based on a multi-well plate containing 
cells, transiently transfected with a DNA construct containing a receptor-coding gene and 
a reporter-based read-out. After adding test samples to the wells, the wells are ideally 
measured in parallel for a response [90]. Such screening assays can be performed relatively 
quickly and are easily automated (e.g. FLIPR assays). Compound libraries are routinely 
screened against a limited number of molecular targets, often receptors or enzymes. 
Methods are well established, technically robust and often utilized by large companies in 
the pharma and flavour sectors [240]. Notwithstanding their obvious advantages, these 
conventional screening platforms carry a number of limitations. The technology described 
in this thesis combines a receptor cell array with a microfluidic set-up, thus enabling a 
dynamic assay rather than a static or end-point assay. It allows the sequential analysis of 
samples while studying interactions with multiple receptors in parallel. This comes along 
with additional benefits in terms of cost savings by reducing sample volumes and flexibility 
towards sample exposure and testing order.
Receptomics, a microfluidic assay
The most fundamental difference between receptomics assays and end-point assays is 
the implementation of a microfluidic system and sequential exposures of the receptor 
cell array. While in an end-point assay the reagent and test mixture remain in the assay 
well, the receptomics cell array, as developed in this thesis, is exposed to the samples in a 
controlled way. The microfluidic system which continuously washes assay buffer over the 
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cell array is combined with an injection system to inject pre-determined volumes of sample 
into the flow thereby controlling the duration of sample exposure. Microarray technology 
and microfluidics are generally acknowledged as a promising combination as for example 
outlined by Sofia Martins in her review on GPCR-based live-cell screening assays [94]. 
Compared to a static, end-point assay, a receptomics assay carries, both advantages and 
disadvantages as outlined below. 
Advantages:
1. Reduction of production and running costs. Preparation of reverse transfected cell 
arrays for a receptomics analysis requires 100x less DNA and transfection reagent 
while no fluorophore dyes are used. The slides and flowcells are reusable omitting 
the use of disposable plastics, while the currently-used imaging setup is more 
economical in terms of acquisition costs compared to that with fully automated plate 
readers.
2. Sample quantity needed to screen an entire receptor library can be reduced (~10-
100x) using microfluidics compared to an end-point assay. This is a significant 
advantage when the sample volume/quantity is limited (for example when using LC-
MS fractions) or costly.
3. In an end-point assay the sample remains available to the receptors after it is added 
to the well, and one basically studies continuous exposure of a single application. 
However, continuous exposure may in itself obstruct the observation of relevant 
aspects of the responses of some receptors, including signal lingering, baseline 
increase or decrease, inactivation of both the receptor and G protein by kinases and 
arrestins, secondary responses etc. By contrast, controlled and repeated exposure in 
a microfluidic system enables the study of such secondary effects. 
4. When cytotoxicity is an issue, lowering the exposure time will cause less cell stress 
and still allow screening for receptor specific responses. In a multi-well assay the 
sample concentration can be controlled, but the exposure duration is continuous. 
In a microfluidics system, the exposure duration can be tightly controlled and even 
reduced to pulses of just a few seconds [95].
5. Microfluidics allows for sequential dosing experiments. A sequential dosing with 
controlled concentration, duration and frequency is better able to mimic physiological 
conditions at the cellular level and thus provides a more realistic setting for, for 
example, organ-on-a-chip (nose, tongue, gut) type platforms. For instance, the rise 
and fall of glucose levels, hormone secretions and immune responses all provide 
sensing cells with a rhythm of activations [241]. The frequency and amplitude of 
these activations determine the extent and mode of cellular responses which may 
vary from transcription regulation, hormone secretion, depolarization etc. Studies 
on the biochemical circuit architecture of receptors in cell lines have profited from 
the development of microfluidic systems that allow repeated temporal exposures 
[242].
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6. Last but not least, the implementation of microfluidics allows the coupling of different 
compartments or modules. An example of this could involve a lab-on-a-chip platform 
where sample handling like mixing or gradients of samples are easily programmed. 
An organ-on-a-chip platform could be designed by connecting organ modules and 
cell array modules to sense, for example, the excretion of endogenous ligands 
such as hormones and cytokines. The coupling of modules could also be extended 
to combine different analytical platforms with the receptomics array. In Chapter 
3 we propose the direct coupling of an LC-MS system with receptomics to create 
on online bioactivity screen. In one chromatography run, a complex extract could 
be separated into its components which are subsequently detected and identified 
by mass spectroscopy upon elution from the column, and, in parallel, continuously 
screened for receptor-ligand binding activity. Figure 1 gives an overview of some 
different microfluidic assemblies that can be envisioned.
Disadvantages:
1. Memory effects of previous exposures. Cultured cells are highly complex and 
continuously process many factors based on their physiological state. Exposing 
cells to both pure and complex matrices will therefore change conditions beyond 
experimental control. Confirmation from both positive and negative controls is 
crucial to provide context to the experiments. 
2. Exhaustion of the receptor response. Exposure to saturating levels of ligands causes 
phosphorylation by kinases of both the receptors and the G proteins. As a result, 
the receptors are for example targeted by the beta arrestin pathway and then 
internalized. This leads to a loss of response signal in subsequent exposures [42, 103]. 
Furthermore, different receptors differ strongly in this respect. These desensitizing 
effects need to be taken into account and require control injections of known 
agonists to monitor the receptor exhaustion dynamics [243, 244] . 
Receptomics as a high content screening platform 
As mentioned above, the traditional end-point assays have evolved into highly efficient 
compound screening assays. Their high-throughput nature - due to advances in automation 
in this field - makes them very efficient for screening large libraries of compounds against 
a few target receptors. But also, vice versa, compounds may be screened against receptor 
libraries in a multi-well plate format. This type of receptor library screening is offered 
commercially making a receptor-omics type screening feasible also in the conventional 
system.
The end-point assay is also very efficient in screening for/discovery of response modulators 
like blockers and enhancers for target receptor-agonist combinations. In this case, a well 
is pre-incubated with a modulator and the agonist is then added. This method is called a 
2-addition assay and may be used to study agonist, antagonist or partial agonist effects [91]. 
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Our microfluidic assay, in combination with a cell array, offers a different perspective on 
the screening of response modulators. It may best be used to study the effect of known 
response modulators to several receptors simultaneously. For example, bitter taste 
modulators may have different modulating effects on different bitter receptors. Some 
compounds have antagonistic effects on one bitter receptor but have agonistic effects 
on another bitter receptor. Sequentially exposing a full array of bitter taste receptors to 
alternating samples of agonists and agonists combined with known modulators would yield 
extensive information on the modulating effects on all bitter receptors. Obtaining such 
insights would be much more laborious when using multi-well plate platforms. 
The receptomics platform cannot compete with the existing high throughput receptor 
screening technology in terms of rapid screening of sometimes several thousands of potential 
ligands from a compound library. Instead, it offers a new paradigm; the microfluidic assay 
advantages as mentioned above can be employed to facilitate new directions of research.
Figure 1A shows how the sequential injection nature of the receptomics assay allows the 
study of inter-sample differences. With several alternating and repeated injections, a spot-
Figure 1, possibilities for microfluidics-based research in combination with a receptor cell array. 
A, By alternating injections of two unknown samples or extracts, the receptors that are responding 
differentially to one extract can be analyzed in a direct comparison or contrast between the extract 
responses. B, Coupling two flowcells in series. The first flowcell can be used to culture a specialized 
organ tissue and the second flowcell can containing a receptor array to measure real-time cellular 
responses from e.g. secreted hormones. C, Coupling of an LC-MS system to a receptor cell array and 
detect bioactivity in peaks as they elute from the column (see next paragraph for a more detailed 
perspective)
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based response trend can be discovered showing these inter-sample differences based on 
a linear mixed model. This spot-based data analysis (see Chapter 6) considers each spot as 
a separate measurement. And because each spot is serially exposed, this allows us to draw 
conclusions about differences between samples and disregard the variability between 
spots. In this way we can separate the biological variability between spots of the same type 
from the relevant information, that is, the variation in responses between two samples. 
The two samples may for example be extracts of two plant varieties, a reference and a 
test product or an agonist in the presence of absence of a response modulator (antagonist, 
allosteric modulator, inverse agonist etc.). This strategy allows the receptomics system 
to discover sample differences even in samples that carry factors that induce a host cell 
response (ECRO 2018 conference poster [245]). 
In Figure 1B and C the receptomics platform is coupled to another type of platform, for 
example, an organ on a chip (B) or an LC-MS (C) system. The microfluidic nature of the 
platform allows the coupling with other microfluidic platforms, thereby potentially gaining 
advantages in terms of assay speed, costs and the sample quantity needed for the assay. 
Perspectives on the coupling of LC-MS to receptomics
There is an increasing interest in natural extracts for use in food and medicine. Such 
extracts have complex compositions and the bioactive components are often unknown. 
The characterization of the bioactive compounds in an extract is costly and time consuming. 
Often, crude extracts from plants with strong bioactivity can be significantly diluted without 
loss of relevant receptor responses. 
The receptomics technology is efficient for screening receptor libraries with small amounts 
of sample as in the case of LC-MS fractions (see Chapter 3), and the flow cell feature of 
the system creates the unique opportunity for direct coupling to other microfluidic 
platforms like liquid chromatography MS. Such fluidic coupling would enable simultaneous 
identification of the molecular mass and any specific bioactivity of compounds eluted from 
the column. This one step process, as shown in Figure 2, could greatly accelerate bioactive 
compound discovery. 
To answer the question whether LC-MS-receptomics is feasible by coupling the eluent 
(waste) of an LC-MS directly to the receptomics platform as suggested in Chapter 3, a 
pilot study was performed that aimed at monitoring the cell responses under physical and 
chemical conditions that may be expected in such a setup. In this study we chose to focus 
on compatibility with acetonitrile (ACN) and formic acid (FA) in the running buffer since ACN 
and FA are commonly used organic solvents to elute LC columns. ACN concentrations may 
go as high as 60%, therefore, to decrease cytotoxicity, we propose at least 100 fold dilution 
of the eluent. In addition, we looked at the effects of increasing the flow rate to a speed 
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to allow peak separation within the volume of the flow cell (one peak per volume, see 
Figure 2). The preliminary results were encouraging, demonstrating that the receptomics 
assay is compatible with low concentrations (<0.6%) of organic solvent in the running buffer. 
An increased flowrate is also not likely to influence the receptomics assay performance 
either. A remaining concern may be the effect of a shorter exposure (<30 seconds) on signal 
strength. Shorter sample exposures have not been tested in this pilot study, but Chapter 
1 reports that the response peak maximum of the NK1 receptor was reached within the 
first 10 seconds of exposure. It is, however, unknown how this translates to other receptor 
types, and, therefore, the short exposure remains a point of attention. In principle, the 
fluidic parameter that determines the exposure time is the LC flowrate, so the exposure 
time could be optimized by tuning the LC setup once a setup is realized.
Envisioned benefits of coupling receptomics to LC-MS 
The extracts from plants, microbes and other organisms represent a huge reservoir of 
biologically active molecules that have not yet been deeply probed by industry. For the 
Figure 2, Process diagram of the coupling of a receptor cell array to the eluent of an LC-MS. A 
regular LC-MS set up with a standard column can be injected with a maximum of 10 µl sample. At 
a standard flow rate of 180 µl/min, this will broaden from a peak width of 3.3 seconds (10 µl) to a 
peak width of 20 seconds and a corresponding volume of 60 µl (Ric de Vos, Wageningen UR, personal 
communication). The most relevant high concentration part (87% of the peak area) is contained 
in a window of 10 seconds and 30 µl. The peak is part of a continuous flow from the LC-MS that is 
continuously split to the MS, the fraction collector and the receptor assay. For this step a fraction of 
the flow is mixed with assay buffer and diluted 100-fold to reach sub-toxic levels of acetonitrile (ACN) 
and formic acid (FA). Currently we use flowcells of 150 µl volume and 300 array spots. To prevent 
further peak broadening, we typically aim to inject a quantity of sample equivalent to the volume of 
the flow cell (Chapter 1). To replace the flowcell volume every 10 seconds we need to split the LC-MS 
flow 1/20, resulting in a flow of 9 µl/min to the flowcell. Diluting this 100x, to 900 µl/min, the flowcell 
may be filled with 87% of a peak in 10 seconds, thus representing a 345 fold dilution of the original 
extract in 10 seconds.
Plant extract + 0.1% FA
10 µl
LC column
180 µl/min
MS detector
• 10 µl extract à 20 sec, 60 µl peak 
• X1-X2 = 10 sec, 87% of peak area
• 10-60% ACN, 0.1% FA
Fraction collector
• 100 x dilution, 9 µl/min to 900 µl/min 
• 150 µl in 10 sec, exposure to 87% peak area
• 0.1-0.6% ACN, 0.001% FA
• Final ca 350x dilution of plant extract
Running 
buffer
Receptomics 
flowcell 150 µl
Splitter
Mixer
9 µl/min
900 µl/min
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current 135 known drugs of plant origin for example, 60.000 plant species have been 
screened but only using a narrow range of receptors [246-249]. The remaining 300.000 
species and the ones screened already could yield many times more novel drugs if the 
screening would be exhaustive in examining all potential targets in parallel as proposed for 
this receptomics platform. The screening could involve a pre-screening for bioactivity of the 
total extract at various dilutions before proceeding to LC-MS coupled receptomics analysis. 
Direct fluidic coupling of the receptomics assay to acetonitrile containing LC-eluent in the 
example of Figure 2 can be attempted if bioactivities are found in ~350x diluted extracts. 
There are many naturally occurring metabolites that have such concentrated bioactivities. 
A few examples: the glycoside sweeteners in the leaves of Stevia rebaudiana can vary 
between 4-20% of dry weight and are up to 250-fold sweeter than sugar [24]. The sweet 
receptor can sense sweetness from concentrations as low as 4 µM stevioside [250], while 
an average extract may contain up to 4 mM. The pungent capsaicinoids found in pepper 
(Capsicum) fruits have to be diluted 100-1000 fold for a functional bioactivity screen [96, 
152]. In a crop like tomato (Solanum lycopersicum), some metabolites like ATP, GABA and 
Glutamate, are present in 10-50 millimolar ranges [251, 252], while the sensitivities of target 
receptors are in the micro- to nanomolar range [28, 253]. When bioactive compounds are 
too low in concentration one can retroactively screen the collected fractions with an auto-
sampler set up. The fractions may then be freeze-dried and re-absorbed in assay buffer at a 
higher concentrations to remove toxic solvents, similar to the methods in Chapter 3. 
Current limitations and opportunities for receptomics
This section discusses the technical and experimental limitations that currently exist in the 
application of the receptomics platform for the analysis of various types of samples with 
various types of receptors and suggest solutions to overcome these limitations. A summary 
of the key points in this section is given in Table 1.
Calcium buffering and cooperative binding
In Chapter 5, improvements in receptor sensitivity and signal-to-noise ratio are discussed. 
Initially, in Chapters 2, 3 and 4, Cameleon YC3.6 was used in all our receptomics arrays 
because of its high quantum yield, large dynamic range of >800% and sensitive Kd of ~250nM 
[131, 204]. However, two aspects had been overlooked in the initial experimental design: 
the negative effects of calcium buffering by high sensor concentrations [207, 221] and the 
calcium affinity curves (cooperative binding) of Cameleon YC.6 compared to other sensor 
types [204, 205]. Both aspects were optimized in Chapter 5 using bitter taste receptors for 
validation, but within the limitations of the current measurement setup. For example, the 
Leica stereo fluorescence microscope cannot accurately record fluorescence at expression 
levels below those used in Chapter 5. Lower sensor concentrations would have further 
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lowered the calcium buffering and would have yielded in more sensitive and more accurate 
measurements. The measurement set-up, therefore, presents some physical limitations. 
This may be overcome, for example, to some extent by changing to a bioluminescence 
based setup where probe concentrations can be further reduced while acceptable signal to 
noise levels are maintained [254].
Membrane display efficiency
A general issue in receptor screening platforms is the efficiency of cell membrane expression 
of the receptors. Some GPCR’s are notorious for poor cell surface expression and need 
additional signalling peptides and chaperones to guide the expression in the plasma 
membrane. One such class of GPCR’s with poor cell surface expression are the olfactory 
receptors which need a signal peptide [255, 256] and several accessory proteins to enable 
functional expression and even then, the levels are still low [257]. There are many factors 
that can play a role in the trafficking of receptors to and from the cell surface that are 
still poorly understood. In some cases it could be beneficial to use tissue-specific cell lines 
instead of a generic cell line like HEK293. In this case, the transfection efficiency of those 
alternative cell lines needs to be optimized. One of the possible strategies could be the use 
of lentiviral transfection systems [167]. 
Response variation
A general issue in receptor screening platforms is the variable levels of protein expression 
due to the transient transfection process and differences in cell cycle. Inherent to transient 
transfection, the plasmid DNA content and transcription levels will vary from cell to cell, 
leading to a variable expression within one array spot (or within one well of a multi-well 
plate) but also between array spots and between arrays. The use of a ratiometric calcium 
sensor partly solves this problem because the calcium measurement is independent of 
indicator concentration, due to ratiometric imaging. Furthermore, the spot-based model 
that we introduced in Chapter 6 reduces inter-spot response variation by estimating the 
spot variation of contrasts of two injections per spot (e.g. sample / blank, or sample-1 / 
sample-2), rather than the absolute response variation of a single injection. 
Next, the receptomics platform strategy of sequential sample injections has an inherent 
problem of receptor response desensitization [42]. This is caused by receptor signalling 
termination pathways (e.g. GRK-mediated phosphorylation and β-arrestin coupling) that 
lead to receptor internalization. Repeated receptor stimulations will therefore generally 
lead to a declining response amplitude and –in some instances- absence of a second 
response. This is shown for example for the CXCR1 and CXCR2 receptors activated by IL-
8. The desensitization was partly rescued by truncation of the GPCR C-terminal tail which 
prevents the phosphorylation and subsequent desensitization process [244]. Besides 
removing the C-terminal phosphorylation sites of the receptor, receptor internalization 
can also be prevented by silencing the kinases/arrestins or by co-expression of other 
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(decoy) receptors that reduce the β-arrestin recruitment for the target receptor [258, 259]. 
Another option would be to use the detection of G-protein coupling by miniG proteins and 
split luciferase [260]. These miniG proteins remain associated with the receptor during the 
agonist binding and thereby protect the receptor from GRK-mediated phosphorylation. 
These solutions, however, require some molecular engineering and have not yet been 
applied on a larger scale for many different receptors. A more practical strategy to deal 
with both variation in receptor expression and response saturation is to use a quality 
control injection (QC) to index the spot responses. The QC sample is a combination of 
different agonists targeting the receptors displayed on the array. Ideally, a QC sample 
injection can trigger all receptor types on the array (except for the control spots that lack a 
recombinant receptor). A specific response to a QC characterizes the degree of functional 
surface expression in combination with the signalling capacity of that particular receptor 
of one cell to another. The height of the response may correlate to the relative surface 
expression/signalling capacity of the receptor within the cells of an array spot. This is 
shown in Chapter 4 for the expression of the NK1 receptor. Using the QC response height, 
one could, hypothetically, calibrate each receptor array spot separately for their response 
capacity towards a standard mix of agonists. By using re-injection of the QC sample several 
times in a measurement series one may also account for a potential gradual or complete 
signal loss of saturating responses. Software models can be designed to determine and 
correct for the response drift due to repeated exposures.
Cell vitality and stress levels
The success of a receptomics calcium assay depends on the viability and functionality of 
the cells. Obvious factors like temperature, pH, osmotic or shearing stress are kept under 
control. But if the cells are stressed by toxic samples, by the receptor or G protein they 
express, or by depletion of the energy to pump calcium ions in and out for example, then 
the measurement of transient calcium dynamics from receptor signalling is impaired. 
Therefore, the question how long a cell array may last for reliable experiments cannot 
easily be answered. This depends on the number of exposures, exposure duration and 
concentration of the agonists, but also the cell surface expression of the receptors and 
toxicity of the samples etc. Our own experience has shown that, given un-saturating agonist 
levels, up to 8 sequential agonist doses in a time range of about 1 hour did not reduce the 
calcium response amplitudes (Chapter 4). Some studies use a cytotoxicity test with ATP 
or somatostatin to estimate the cell functionality. Somatostatin is particularly appropriate 
as control in bitter receptor arrays, because in HEK293 cells, the somatostatin receptor 
couples to the same chimeric Gα
16GUST44
 protein as the bitter taste receptors to report a 
calcium signal [209, 210]. In Chapter 6 we have used ATP to mimic a host cell response and 
we have observed an effect on dosing order with responses declining in time. The use of a 
functionality control both before and after a measurement series would indicate the level 
of decrease in cell viability and responsiveness and allow spot specific correction models. 
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The use of a control for viability and functionality, like ATP, reports calcium responses that 
are triggered via similar Gα
q
 – IP
3
 signalling pathways. However, the use of these compounds 
as functionality control may not always be informative because these molecules interact 
with different host cell receptors and may use alternative pathways or G proteins [261]. 
Another option to evaluate cell viability may be the implementation of a mitochondrial 
activity staining using for example, tetramethyl-rhodamine, methyl ester (TMRM), JC-1 or 
MitoTracker. Mitochondria are the providers of the cellular energy (ATP) in eukaryotic cells 
through oxidative phosphorylation, during which electrons are transferred from electron 
donors to electron acceptors such as oxygen. Maintenance of the mitochondrial membrane 
potential is vital for keeping up ATP production. Mitochondrial membrane potential assays 
have been developed, even in HTP screening format [262-264]. The use of stains that 
actively show the mitochondrial membrane potential during a receptomics experiment and 
that do not interfere with the calcium assay, could also allow us to monitor the viability of 
the receptor cell arrays.
Monitoring all potential signalling pathways
Even though GPCR activation can often induce a number of different downstream signalling 
events by coupling to different G proteins (see Chapter 1) [52], our receptomics assay 
currently only measures events that generate changes in cytoplasmic calcium [91]. Other 
signalling pathways involving for example the modulation of cAMP levels or phosphorylation 
cascades of other proteins (RhoA and ERK1/2) are not monitored. Furthermore, G-protein-
independent signalling, such as β-arrestin recruitment, are also not detected with the 
current platform. 
For optimal calcium signals, or to steer the response to a calcium second messenger, 
chimeric G-proteins, like Gα
16GUST44
 for taste receptors, are popularly used. These couple 
the C-terminal receptor binding domain of the Gα
Gustducin
 to a Gα
15
 domain which efficiently 
triggers the IP
3
 pathway [74, 75, 265, 266]. Gα
16GUST44
 was used for bitter receptor arrays in 
Chapters 4, 5 and 6 by means of a stable expression cell line. In this case, with the use of a 
recombinant expression system and redirected calcium pathway, any native cell context is 
missing. This leads to biased agonism; only agonist interactions leading to the introduced 
functional calcium pathway are measured. Any agonist which recruits other G proteins and 
elicit a distinct read-out by affecting an alternate or even similar pathway are not detected 
[53, 267]. These distinct G proteins and read-outs are a major concern because they may 
be an important reason for the remaining large number of orphan receptors (>20 years 
after identifying all members in this family). For example, the short chain free fatty acid 
receptor FFA2 is activated by propionate through Gαi and Gαq/Gα11 pathways with distinct 
physiological effects. This has been confirmed by the finding of an allosteric modulator for 
FFA2 that enhances the Gαi pathway [268]. With our current receptomics platform the Gαi 
activation or modulation would not be measured leading to a considerable “blind spot” 
for these compounds and their physiological effects. To overcome bias in the detection of 
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GPCR activation, the receptomics assay can include receptor spots with probes to measure 
other secondary messengers like cAMP [269]. The disadvantage of using probes other 
than calcium probes especially in receptor cell arrays is that the other signalling events 
usually take much longer to measure. Calcium rise and fall takes seconds to minutes [91], 
while changes in cAMP and β-arrestins may take minutes to hours. This makes them less 
suitable in high throughput screening methods. A solution could be to use the G-protein 
- receptor interaction itself as a signal for receptor activation. FRET or BRET modified 
G-protein and receptor systems have been developed to measure receptor and G-protein 
interaction [270, 271]. However, a more elegant approach may be the use of the recently 
developed miniG proteins [260, 272]. These mini- or minimal Gα proteins are engineered 
GTPase domains of Gα subunits that are left after removal of the membrane anchor, the 
Gβγ interaction domain and N and C-terminal sequences. The remaining miniG protein will 
not be phosphorylated to its GTP state and as a result it forms a stable interaction with the 
receptor in its activated or agonist bound state. The miniG proteins are turned into a BRET 
sensor or a luminescence sensor using a split luciferase fusion to the N-terminus of the 
miniG and the C-terminus of the receptor. So far, miniG proteins have been made for Gαs, 
Gαi, Gαq and Gα12. By studying different receptor-miniG protein combinations in parallel 
the G-protein subtype biased agonists can be studied without changing the bioluminescent 
read-out system. 
Host cell responses
As mentioned in the previous section, an advantage of the microfluidic receptomics 
platform is that it enables sequential injection of samples and determination of differences 
between samples. But when these samples are complex mixtures, extracts or even food 
products, there generally are additional cellular calcium responses triggered other than 
those from specific receptor activations. These endogenous cellular responses or host cell 
responses may be caused by pH or salt perturbations in the samples, but usually effects 
of these parameters can be minimized by adjusting the conditions of the assay. However, 
samples may also contain compounds that activate a host cell receptor or even contain toxic 
compounds, and then the assay will measure a host cell response in the mock transfected 
spots (spots without recombinant receptor). One straightforward solution is to dilute the 
sample until the host cell response is below threshold. In Chapter 3, a crude chilli pepper 
extract was measured for bioactivity with the TRPV1 ion channel. At a 300-fold dilution of 
the extracts, no host cell response was measured anymore in the control cells. Similarly, 
results with raw pulp of bitter gourd showed specific responses of a bitter taste receptor 
in a sample of the water phase. The bitter receptor activations were measured at 100-200-
fold dilutions and in the absence of a host cell response. 
However, it is not always possible to dilute a sample sufficiently to dampen the host cell 
response, without also diluting the compounds of interest too much as well. Chapter 6 
shows how a simulated host cell response – in this case a host cell response to ATP- can be 
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normalized in a spot-dependent manner using the ATP injections as a reference in a two 
sample contrast. Bitter receptor spikes were retrieved from the sample comparison even 
though the host cell response size was variable between spot types. This result shows that 
a receptor-specific calcium response may be cumulative to a host cell response.
We, therefore, propose to use a host cell response mimic to estimate the host cell 
response per spot and to use the mimic to normalize host cell responses. This approach 
was demonstrated using tomato juice samples spiked with bitter compounds (ECRO 2018 
conference poster [245]). Tomato is naturally rich in ATP [251] which likely causes the 
large host cell response of tomato juice samples by activating the nucleotide receptors in 
HEK293 [253]. In a direct contrast between 5-fold diluted tomato juice with and without 
a bitter compounds spike and using ATP response to normalize the responses, 50% of the 
bitter spikes were recovered. However, the approach of using an ATP host cell response 
correction only works when it accurately mimics the host cell response which can be 
determined in a response correlation. Other sources of intracellular calcium modulation, 
like opening of ion-channels for example, may introduce artefacts. 
As long as a calcium read out system is used to detect receptor activation, the host cell 
response remains something that must always be considered. There is a need for another 
read-out system that is receptor-specific and not influenced by host cell activation. The 
earlier mentioned miniG system is such a system. The target receptor is modified with a 
split luciferase and starts to emit light once fused with the counterpart linked to a miniG 
protein. This system promises to offer an elegant way of reducing host cell response 
interference by keeping those responses in the dark. 
Auto-fluorescence
The last limitation that will be discussed is the interference that some samples may cause 
with the measurement of the fluorescence signal. To monitor any effects on the fluorescence 
caused by the sample we have introduced a fluorescence control (YC-, Chapters 5 and 6). 
This is a modified version of YC3.6 where a deletion in the calmodulin and M13 domain 
makes the protein inactive in sensing calcium. This allows the monitoring of any sample 
effects on the baseline fluorescence. Samples that display auto-fluorescence at CFP 
excitation wavelengths usually give signals in both the CFP and YFP emission channels. 
When auto-fluorescence occurs in a sample, how can we remove its effects on the calcium 
signal? One solution would again be to dilute the sample until auto-fluorescence effects 
are gone, but this will also dilute the sample’s bioactivity. Current solutions are sought in 
computational methods to separate background from actual signal. Using the ratiometric 
properties of the probe it is possible to separate the auto fluorescence –a signal that 
increases in both CFP and YFP channels- from a signal that originates from the ratiometric 
calcium probe - a FRET signal that decreases in the CFP channel and increases in the YFP 
channel. This method is under development, but is already showing promising results in 
removing artificial auto-fluorescence from calcium signals (samples spiked with fluorescein) 
148 Chapter 7 | General discussion
and removing auto-fluorescence from natural samples like coffee (unpublished data). 
Another solution is based on a reference sample that mimics auto-fluorescence with a 
compound like fluorescein which does not evoke a calcium response. The auto-fluorescence 
from this sample could be used to standardize the auto-fluorescence proportional to its 
relative contribution in each channel. This method is being tested and its effectiveness also 
looks encouraging.
Another way to work with auto-fluorescent samples is not to use a fluorescence read-
oud system at all. As mentioned throughout this paragraph, current developments in 
bioluminescence are very promising and may finally provide the best solution.
Table 1. Troubleshooting receptomics. Current limitations and strategies that may be employed to 
solve the limitations.
Current limitations Proposed solutions References
Receptor cell arrays 
current arrays may lack uniformity Add transfection agent to the spotmix for 
a more uniform transfection
[273]
At higher densities spots are at risk of 
cross-contamination 
Make use of hydrophobic spacing’s 
between the spots
[274]
Large expression differences between 
individual cells
Synchronize the cell culture [175] 
Transfection efficiency of other cell lines Switch to virus-based transfection 
(Lentivirus)
[165]
Receptor activation read-out
Calcium buffering by the sensor- the 
sensor concentration cannot be lowered 
due to detection limits
Lower sensor levels can be achieved 
by changing from a fluorescence to a 
bioluminescence setup
[221]
Receptor inactivation due to kinases and 
arrestin recruitment
C-terminal kinase activation sites can be 
removed (truncated), 
Kinases/arrestins may be silenced
Co-expression of other (decoy) receptors 
(muscarinic receptor)
MiniG proteins protect the activated 
receptor state 
[42, 259, 260]
Calcium and cAMP measurements are too 
generic and may be induced by host cell 
receptors as well 
Detection of G-protein coupling by miniG 
proteins and split luciferase is receptor 
specific and will not detect host cell 
responses
[260, 272]
Fluorescence measurements pick up auto 
fluorescence of the matrix
Correct using spotbased axis rotation or 
indexing using fluorescence standard
Use luciferase based probes; cAMP 
GLOsensor, Calcium BRET Calflux-VTN
Methods are 
currently 
being 
developed,
[222]
Host cell response of complex samples Dilute the sample until the host cell 
response is below detection limit 
Correlate with a host cell response mimic 
and eliminate by computation
Use receptor specific response readout 
like miniG proteins
[105] [260]
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Current limitations Proposed solutions References
Imaging
Simultaneous CFP and YFP emission 
recordings – to eliminate time difference 
between recordings
Use light path with beam splitters and 
dual read-out on two camera’s or a split 
camera
Switch to measuring a single wavelength
[91]
Noise levels Use a stable light source
Use other synthetic probes like Fluo-4 in 
combination with RFP to obtain better 
signals
Use more sensitive cameras. Eg cooled 
camera (EmCCD or CMOS)
[91]
Long working distance causes signal loss Cell array with a mini camera on top of a 
sensor
Creating a lens-free system with an array 
directly on top of a sensor chip
Data processing
Background auto fluorescence elimination Implementation of data processing 
module to remove background 
fluorescence
Methods are 
currently 
being 
developed
Spot based processing to pixel based; a 
spot contains ~25 cells that are averaged
Pixel based processing gives information 
on signal distribution within a spot. 
Receptomics: towards a plug-and-play platform
Downsizing technology, miniaturization and the development of hand-held devices have 
led to a break-through in sensitivity, throughput and cost savings in sensor technology and 
have led to new application areas [275, 276]. Also for biosensors, if we can downscale the 
biological components, such as using a cell array of 1 cm2 instead of a multi-well plate of 
~50 cm2, we may potentially reach higher sensitivity, higher throughput and save costs 
[94]. Current receptomics cell arrays contain about 300 spots composed of 25-50 cells 
each. The cell layer that covers a surface of about 1 cm2 contains over 1 million cells. The 
optical detection converts one cell into approximately one pixel (Chapter 4) making one 
pixel currently the smallest detection unit. 
The receptomics platform has been developed with the aim in mind of non-targeted 
analysis of the biological function of compounds in extracts and for potentially downscaling 
the technology and even developing hand-held functional receptor screening assays. It was 
soon realized that in order to measure a 1 cm2 cell array expressing hundreds of different 
receptors, a different microscopy platform was needed. In Chapters 2 and 3, the Zeiss 510-
META confocal laser scanning microscope was used to image the calcium responses from 
stable receptor expressing cell lines. However, even at the lowest possible magnification, 
this microscope could only image 1 mm2 equivalent to maximum 9 cell array spots at the 
time (3x3 array). A larger scanning area was needed. The BD Pathway Imager system with 
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its moving objective, was able to make sequential scans of the flowcell area, but the scan 
speed of 30-60 seconds for 1 cm2 was not fast enough to accurately capture the calcium 
dynamics of each spot across the array. The Leica stereo fluorescence microscope (M205 
FA) did suffice but with a loss of resolution (~1 pixel/cell). It met our criteria for acquisition 
speed (~3 seconds/frame), dual read-out (CFP and YFP emission), and large scanning field 
(~1 cm2). However, the disadvantages of this imaging platform were the longer working 
distance (loss of signal or increase of noise), the filter-based excitation and emission (allows 
bleed through of CFP emission light) and an unstable light source. Solutions to some 
shortcomings could be realised via the receptomics software. While the original purpose of 
the software was to sort and combine the data parameters, it was soon extended with an 
interpolation algorithm (smoothing) to compensate for the timing difference of the CFP and 
YFP images and to reduce the noise levels. This interpolation of the time difference between 
the images was necessary for an accurate YFP/CFP ratio of the FRET sensor. A simple marker, 
placed outside the flowcell, but in the field of view, was able to capture any fluctuation of 
the light source and allowed for auto correction of the data. Finally the mixed-model for 
sample comparisons was added the software (used in Chapters 4, 5 and 6).
The receptomics platform is not yet a plug-and-play platform and still needs trained 
personnel to culture the cells, prepare cell arrays, operate the fluidic system and fluorescence 
microscope. To perform a comprehensive analysis of the experimental outcome, one needs 
an understanding of the signalling pathways and design the experiments accordingly. If we 
want to continue developing the receptomics technology and eventually reach the goal 
of becoming a high content screening technology with applications as described in more 
detail in the next section, the platform will need to continue to evolve. Table 1 gives several 
suggestions for further development of the receptomics technology. 
Tailor made receptomics arrays
Receptomics technology has the potential to become a versatile platform because it 
combines low costs with obtaining functional information on ligand-receptor interactions, 
generating novel applications. It allows assaying of a sample against endless variations and 
combinations of printed receptors, G-proteins, sensors, co-factors etc. in a flow context 
with a wide range of possibilities for pre- and post-measurement calibration. 
The versatility extends to the use of different cell types. Even though the reverse 
transfection is best performed with an “easy” cell line like HEK293 cells, the use of other 
cell lines have already been reported for reverse transfection [273]. Using different cell 
types, different transfection approaches may be necessary like virus-based transfection 
systems [165]. An important consideration in the choice of cell type is the profile of native 
expressed receptors and signalling molecules. Studies show that these may vary [73], 
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and hence have important implications for host cell response to samples. On the other 
hand, there are studies that utilize the unique receptor repertoires of specialized cells for 
functional screenings. Studies show that exposure of bitter compounds to gastric parietal 
cells trigger the secretion of gastric acid [277, 278]. Even without knowing which bitter 
receptors are involved, researchers were able to study bitter modulating compounds based 
on the increase or reduction of gastric acid secretion. Though no receptor-compound 
interactions were measured directly, these findings did give important leads to discovering 
new bitter modulating compounds. Our platform could be used to transfect these cells with 
siRNA silencing or CRISPR-Cas knock outs of such specialized cells. In this way, the direct 
receptor-compound relations could still be shown. Similarly, dCas9-VPR like systems could 
be used for (inducible) upregulation of genes without the need to clone them [279].
Application areas for receptomics
Pharmaceutical and medical applications
If a low cost receptomics chip could be produced that, for example, involves all human 
receptors in combination with all G proteins (~800 GPCR-s x 30 G-proteins combinations), 
with a suitable detection system (miniG bioluminescence system) this would offer 
unprecedented research opportunities to discover novel drugs and investigate modes of 
action. If this could then be expanded with all SNP variants it could also become a significant 
tool to understand genetic causes underlying human diseases. 
However, one of the many hurdles, as mentioned in the previous section, is that GPCR’s 
may employ different signalling pathways depending on their cellular context. Activation 
of a receptor may lead to different physiological effects depending on the ‘wiring’ of the 
receptor. An odorant receptor expressed in the epithelium of the nasal cavity has a different 
functionality and signalling pathway than an odorant receptor expressed on spermatozoa 
[280]. But even without understanding the cellular context, the knowledge that may be 
obtained by a receptomics wide screen of potential drug targets will at least provide leads 
for further, tissue specific, studies. Since about 40% of today’s drugs target a GPCR [86-
88], the development of tools to further improve the specificity and effectiveness of these 
drugs is highly justified.
About 140 GPCR’s are still called orphans [1, 107], meaning that their function(s) and 
endogenous activating ligand(s) have not yet been identified. Receptomics approaches 
could tap into this huge unknown and contribute to finding novel targets for drug discovery 
due to its potential to lower costs for the screening of huge libraries of all potentially 
relevant combinations of factors (receptors vs. G protein vs. co-factor x vs. ..) and screen 
complex biological samples [87]. This “reverse pharmacology” strategy uses an orphan 
receptor as bait to find novel interactions with target compound libraries [240].
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Flavour: Taste and olfaction
The off-taste of a drug may be experienced as side-effects. A bitter taste can have serious 
consequences on the palatability and the acceptance of the drug by patients. Especially 
in paediatric medicines, tablets or oral liquids may be too bitter to swallow which makes 
acceptance of paediatric medicinal products of great importance to patient recovery 
[281]. Many active pharmaceutical ingredients have an adverse bitter taste including 
chloropheniramine and diphenhydramine, both potent antihistamines that work well against 
allergic reactions. Other examples of drugs that can activate T2Rs include antimalarial drugs 
like quinine and chloroquine, and antibiotics like erythromycin and ofloxacin. 
Masking may be an option and there are different routes to achieve masking of the bitter 
taste [282]. An alternative can be modulating bitter taste at a molecular level by creating 
a “molecular barrier” or coating for the medicinal compounds obscuring of the taste, or at 
the receptor level by using sweeteners and other flavouring agents as masking agents or by 
removing the bitter taste by blocking the relevant bitter receptors. For many years flavour-
researchers have been looking for bitter taste modulators using bitter taste receptor 
functional assays in order to find blockers or masks which can reduce some of the bitterness 
of medicines [283, 284]. Besides established multi-well techniques to characterize bitter 
taste modulators, the receptomics assay may be a helpful tool to detect the modulation of 
a dynamic response for all bitter receptors (and SNP variants) simultaneously.
Aroma and flavour are key determinants in acceptance and hence preference, of consumers 
for particular (new) products. However, often the bioactive molecules responsible for a 
certain sensory experience have remained unknown. Considering that we are now in the 
era of low sugar and low salt trends, both with known flavour enhancers, it has never been 
more important to discover which molecular ligands present in different foodstuffs play 
the most dominant role in our aroma and taste experience. For taste and flavour research 
the most promising feature of the receptomics platform is the possibility of screening and 
comparing complex samples (matrices). In product development or crop breeding, subtle 
sample differences in taste are difficult to measure using taste panels where subjectivity 
can be an issue. If a receptomics platform could provide a means of pre-screening samples 
/ varieties, particularly for the presence of off-flavours, this could become a valuable tool. 
Preliminary results have indicated that indeed the receptomics platform is able to measure 
vegetable sample differences despite the complexity of the samples (host cell responses 
and or auto-fluorescence, unpublished data). Before the receptomics system is up to 
such task, interpretation algorithms may need to be developed to link receptor activation 
profiles to a taste perception. 
Technology roadmap
A way to visualise the possible developments for a new technology is by means of a 
technology road map as shown below in Figure 3. 
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Societal impact 
After the technological and scientific aspects of the receptomics technology have been 
discussed above, some final words on the potential social impact of this technology. As this 
technology brings us a step closer to realizing a nose-on-a-chip or a tongue-on-a-chip, taste 
and smell may no longer be exclusive qualities of the consumer [285] as the technology 
aims to replicate these senses [286, 287]. Nowadays, flavour and fragrance companies rely 
heavily on the expertise of their taste panels and even on single individuals (the ‘Nose’). 
With the introduction of devices that can measure taste or smell, these panels may be 
partially replaced, especially in the early phases of R&D, when technology is able to properly 
emulate the human senses. Theoretically, a taste and smell sensor can predict the overall 
palatability of a product better because we could also incorporate the impact of genetic 
variation and rule out environmental/societal/cultural differences that lie at the base of 
differences in individual taste experiences [110]. So a single receptomics chip might come 
to represent receptors of many different panellists. But - can all taste panels be replaced? 
This doesn’t seem te be very likely, because taste perception is not merely the sum of 
the receptor responses. Even if the technology is able to measure all aspects of the signal 
transduction there are parameters that an artificial taste sensor is not able to measure. 
Texture, colour and ambiance play a hedonic role in food choice and consumption [285]. 
They determine, together with flavour, the palatability of the food. 
Figure 3, A technological roadmap for receptomics. The envisioned timeline is shown from left to 
right. From bottom to top the evolution of technology into products and markets is given.
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Our western society is more and 
more based on individualism. We 
all want maximum choice and to be 
offered a wide range of products in 
the supermarket. We all make our own 
choices and every person is unique. The 
idea that the uniqueness of individuals 
can be measured by generic chips for 
taste and smell might, to some, be a 
bit disturbing. And we may even find 
ourselves outsmarted by these electronic 
tongues and noses in the future. But 
the technology of the future will also 
embrace the uniqueness of humans with 
a tailor-made receptomics array that 
carries your unique genetic make-up. 
Since individual sequencing projects are 
increasing in popularity - companies like 23andme (www.23andme.com) advertise that 
you can “meet your genes”. Medical treatments will become more personalized to fit your 
unique biochemical make-up. A receptomics chip that allows the display of your unique set 
of receptors could play a role in the field of personalized foods and medicines [288-291] so 
that you may “meet your receptors” as well. 
Figure 4, The electronic nose and tongue
technology may be difficult to comprehend and 
cause naïve associations in society.
Photo by Margriet Roelse
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This thesis describes the development of a G Protein-Coupled Receptor (GPCR) screening 
technology that combines a receptor cell array (~300 spots) with microfluidics. This 
technology was developed for the purpose of sensing the taste of, or active components 
in complex samples. GPCR activation was monitored using a genetically encoded calcium 
indicator (GECI) which was based on a change in Förster Resonance Energy Transfer (FRET) 
between two fluorescent proteins linked by a calcium binding domain which, upon binding 
of calcium, induces a conformational change between the fluorophores. The receptor 
cell arrays were created by reverse transfection of printed plasmid DNA. The arrays were 
assembled in a flowcell, connected to a microfluidic system, and mounted on a stereo 
fluorescence microscope. This setup allowed for controlled and importantly, repeated 
sample exposure while monitoring the changes in intracellular calcium in real-time. 
GPCRs play an important role in many physiological or disease-related processes. These 
membrane proteins have evolved to sense a wide range of molecules that can be of either 
exogenous or endogenous origin. Their sensing mechanisms are complex and potentially 
involve many cellular signalling events depending the cell type. The introductory chapter of 
this thesis presents a brief overview of the GPCR types and their signalling pathways with a 
focus on taste signalling. This chapter also places the microfluidic receptomics technology 
within the framework of existing receptor screening technologies.
The second chapter explores the general principles, setup and characterization of the 
microfluidic biosensor to measure GPCR activation via imaging of [Ca2+] changes in 
recombinant human HEK293 cells. These cells expressed a combination of the Neurokinin 
1-receptor and Cameleon YC3.6 protein as calcium indicator. Here, a stable cell line was 
employed for robust expression with little variation
Next to GPCRs, the system was also used for the detection of transient receptor potential 
channel Vanilloid 1 (TRPV1) ion channel activation by means of the Cameleon YC3.6 calcium 
sensor as is reported in Chapter 3. This assay was performed with LC-MS fractions and 
whole extracts of chilli pepper fruits which led to the identification of new ion channel 
agonists. This chapter also discusses the possibility of coupling the receptomics assay 
directly to an LC-MS as an additional on-line bioactivity detector. The general discussion of 
this thesis (Chapter 7) elaborates on this topic with additional perspectives on the feasibility 
of coupling the two systems. 
Chapter 4 provides an extensive technical characterization of the preparation and 
measurement of reverse transfected cell arrays using fluorescent proteins. The response of 
the Neurokinin 1-receptor in relation to its gene dose in reverse transfection was studied, 
as well as response reproducibility during repeated activations. 
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These results led to a study of bitter taste receptors in relation to sensitivity-determining 
parameters such as sensor type and calcium buffering (Chapter 5). This chapter aimed to 
enhance the sensitivity and robustness of the receptor assay and showed proof of concept 
with bitter receptor arrays that performed in the same range as existing state-of-the-art 
platforms. Such bitter taste receptor arrays may be employed for future screenings of new 
bitter taste agonists or modulators and the identification of bitter principles in foods.
Development of software and statistical models -the linear mixed model, as presented 
in Chapter 6- to analyse this new type of data showed that a spot-based comparison of 
sequentially-tested samples yielded the most reliable data and largely eliminated inter-spot 
differences in signal strength. The method could also visualize receptor specific differences 
between samples in the presence of a simulated host cell response. A host cell response, 
induced by ATP, was used to show that specific bitter receptor responses from compound 
spikes were cumulative to the host cell response and can be retrieved from a host cell 
response signal by means of comparative analysis. 
The general discussion (Chapter 7) critically discusses the advantages and limitations of 
this new micro-fluidics approach and details which additional developments are needed to 
advance the technology further. The receptomics technology as described in this thesis is 
argued to be complementary to microplate screening technologies and represents a new 
analytical paradigm. The microfluidics aspect and overall assay size reduction are more 
cost efficient and allow both a high content dynamics analysis as well as the development 
of novel applications such as direct identification of bioactive compounds by coupling of 
LC-MS to receptomics. 
All in all, this thesis presents an enabling receptor screening technology that is based 
on new design principles. This receptomics technology offers novel applications and has 
potential in the bioactivity screening of crude extracts.
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Dit proefschrift beschrijft de ontwikkeling van een technologie om G eiwit gekoppelde 
receptoren (GPCR’s) te onderzoeken door middel van een gerangschikt raster (array) 
van receptor producerende cellen (~ 300 spots) omsloten in een microfluidisch systeem. 
Deze technologie is ontwikkeld met het doel om smaak en/of de actieve ingrediënten in 
complexe monsters te bepalen. De activatie van de GPCR’s wordt gemeten met behulp 
van een genetisch gecodeerde calcium indicator (GECI). Deze indicator is gebaseerd op het 
principe van FRET (Förster Resonance Energy Transfer) tussen twee fluorescente eiwitten 
welke gekoppeld zijn door middel van een calcium bindend domein. Wanneer deze indicator 
calcium bindt, dan verandert de conformatie tussen de fluoroforen. Het cel-array van 
verschillende receptoren is gemaakt door middel van een omgekeerde transfectie techniek 
waarbij geprint plasmide DNA opgenomen wordt door de cellen. De rasters worden 
vervolgens geassembleerd in een vloeistof kamer (flowcell), welke aangesloten wordt op 
een microfluidisch systeem, en geplaatst onder een stereo fluorescentie microscoop. Met 
deze opzet is het mogelijk om het cel-array gecontroleerd en herhaaldelijk bloot te stellen 
aan monsters en de cellulaire reacties door middel van de calcium indicator te meten.
GPCR’s spelen een belangrijke rol in veel fysiologische en ziekte gerelateerde processen. 
Deze membraan eiwitten zijn geëvolueerd om een breed scala aan moleculen te herkennen, 
van zowel exogene of endogene oorsprong. Het signaal mechanisme is complex en heeft 
de potentie veel verschillende signaleringsstappen te omvatten, afhankelijk van het cel 
type. Het hoofdstuk “Introduction” van dit proefschrift geeft een kort overzicht van de 
verschillende GPCR types en hun mogelijke signaleringsstappen, met een focus op de 
smaak signalering. Dit hoofdstuk laat ook zien waar deze microfluidische techniek staat 
binnen het bestaande GPCR onderzoek veld. 
Het tweede hoofdstuk onderzoekt de algemene principes, de opzet en de karakteristieken 
van het microfluidisch systeem om GPCR activatie te meten door middel van calcium 
veranderingen in HEK293 cellen. Deze cellen produceerden een combinatie van de 
Neurokinine-1 receptor en het Cameleon YC3.6 eiwit als calcium indicator. Er is een stabiele 
cel lijn gebruikt welke zorgt voor een robuuste productie met weinig variatie.
Naast GPCR’s is het systeem ook gebruikt om activatie te meten van calcium ion kanaal 
TRPV1 met behulp van Cameleon YC3.6 zoals te lezen is in hoofdstuk 3. Deze analyse, 
uitgevoerd met LCMS fracties en volledige extracten van chili peper vruchten, leidde tot de 
ontdekking van nieuwe TRPV1 agonisten. Dit hoofdstuk bespreekt tevens de mogelijkheid 
om de receptomics techniek direct te koppelen aan de LCMS en te gebruiken als een 
gekoppelde bio-activiteit meter. De algemene discussie van dit proefschrift (hoofdstuk 7) 
gaat hier verder in op met verdere perspectieven over de haalbaarheid van de koppeling 
van deze twee systemen. 
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Hoofdstuk 4 geeft een uitgebreide technische karakterisatie van de vervaardiging en de 
meting van omgekeerd getransfecteerde cel-arrays met gebruik van fluorescente eiwitten. 
Het signaal van de Neurokinine-1 receptor in relatie tot de gen dosis tijdens de transfectie is 
bestudeerd en daarbij ook de reproduceerbaarheid van reacties gedurende herhaaldelijke 
blootstellingen. 
Deze resultaten leidden tot een studie naar de gevoeligheid van de bittere smaak 
receptoren en gevoeligheidsbepalende factoren zoals sensor type en calcium buffering 
(hoofdstuk 5). Het doel van dit hoofdstuk was om de gevoeligheid en robuustheid van 
de receptor meet techniek te verhogen en leverde een proof-of-concept dat arrays met 
bittere smaak receptoren kunnen presteren met vergelijkbare gevoeligheid als bestaande 
technieken. Deze bittere smaak receptor arrays kunnen gebruikt worden voor toekomstige 
onderzoeken naar nieuwe bittere smaak moleculen of modulatoren van bittere smaak en 
de identificatie van bitterheid voeding.
De ontwikkeling van software en statistische modellen –het lineair mixed model, zoals 
gepresenteerd in hoofdstuk 6- om deze nieuwe data te analyseren, toonde aan dat een 
analyse gebaseerd op herhaaldelijke blootstellingen van een enkele spot de meest 
betrouwbare gegevens opleverde en de verschillen in signaalsterkte tussen de stipjes 
grotendeels uitschakelde. Deze methode kon ook receptor specifieke verschillen tussen 
monsters aantonen in de aanwezigheid van een gesimuleerd moeder cel signaal. Een 
moeder cel signaal, geïnduceerd door ATP, is gebruikt om aan te tonen dat een specifieke 
bitter receptor signaal door toevoeging van een bittere stof een cumulatief signaal 
opleverde boven op het moeder cel signaal en dat deze onttrokken kon worden van het 
moeder signaal door middel van vergelijkend onderzoek.
De algemene discussie (hoofdstuk 7) bevat een kritische bespreking van de voordelen en 
beperkingen van deze nieuwe microfluidische benadering en gaat verder in op aanvullende 
ontwikkelingen die nodig zijn om de technologie vooruit te helpen. De receptomics 
technologie zoals beschreven in dit proefschrift wordt als complementair beschreven aan 
de bestaande receptor onderzoeks methoden en vertegenwoordigt een nieuw analytisch 
paradigma. Het microfluidisch aspect en algemene afname van de afmetingen van een 
proefopzet zijn kosten efficiënter en maken het mogelijk om zowel een hoog inhoudelijke 
analyse uit te voeren en nieuwe toepassingen te ontwikkelen zoals de directe identificatie 
van bioactieve stoffen door de koppeling van LCMS aan de receptomics. 
Welbeschouwd presenteert dit proefschrift een techniek voor receptor onderzoek 
gebaseerd op nieuwe ontwerp principes. Deze receptomics techniek biedt nieuwe 
toepassingen en heeft potentieel om bio-activiteit te meten in ruwe extracten.
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AA Aristolochic acid
AC Adenylate Cyclase
ACN Acetonitrile
AMP Adenosine Monophosphate
ATP Adenosine triphosphate
AU Airy Unit
BRET Bioluminescence Resonance Energy Transfer
CAM Calmodulin
cAMP Cyclic Adenosine Monophosphate
CFP Cyan Fluorescent Protein
cGMP cyclic Guanosine Monophosphate
CHL Chloramphenicol
CNG Cyclic Nucleotide Gated
CSO Centrum voor Smaakonderzoek
DAG Diacylglycerol
DB Denatonium benzoate
DMEM Dulbecco’s Modified Eagle Medium
DMSO Dimethylsulfoxide
D-Sal D-Salicin
ECRO European Chemoreception Research Organization
EGTA Ethylene glycol-bis(ß-aminoethyl ether)-N,N,N’,N’-tetraacetic acid)
ER Endoplasmic Reticulum
FA Formic Acid
FBS Foetal Bovine Serum
FLIPR Fluorescent Imaging Plate Reader
FRET Förster Resonance Energy Transfer
FU Fluorescence Units
FW Fresh Weight
FWHM Full Width at Half Maximum
GDP Guanosine Diphosphate
GECI Genetically Encoded Calcium Indicators
GECO Genetically-Encoded Ca2+ Indicator for Optical imaging
GFP Green Fluorescent Protein
GLP-1 Glucagon-Like Peptide 1
GPCR G-Protein-Coupled Receptors
GRK G-Protein-Coupled Receptor Kinase
GTP Guanosine Triphosphate
HEK293 Human Embrio Kidney cells 
HPLC High-Performance Liquid Chromatography
HRP Horseradish Peroxidase
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HTS High Troughput Screening
IMP Inosine-5’-Monophosphate
IP
3
 Inositol1, 4, 5-Trisphosphate
IP
3
R IP
3
 Receptors
LC-MS Liquid Chromatography–Mass Spectrometry
LGIC Ligand Gated Ion Channels
MCS Multiple Cloning Site
MSG Mono Sodium Glutamate
NAM Negative Allosteric Modulators
NK1 Neurokinin receptor 1
OR Olfactory Receptor
PAM Positive Allosteric Modulators
PCA Principal Component Analysis
PDA Photodiode Array detector
PDE Phosphodiesterase
PIP
2
 Phosphatidylinositol 4,5-Bisphosphate
PKA Protein Kinase A
PKC Protein Kinase C
PLC Phospholipase C
PLCβ2 Phospholipase C Beta 2
PROP 6-n-propyl-2-thiouracil
Ptox Picrotoxinin
QC Quality Control
RFP Red Fluorescent Protein
RGS Regulators of G protein Signaling
ROI Region Of Interest
RT Room Temperature
RU Response Units
SNP Single Nucleotide Polymorphisms
SP Substance P
T2B Twitch2B
TRPV1 Transient Receptor Potential Channel Vanilloid 1
VFT Venus Flytrap domain
YC3.6 Yellow Cameleon v. 3.6
YFP Yellow Fluorescent Protein
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